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Bacteriophages (phages), the most abundant entities in the biosphere, play a central role 
in the shaping of natural populations of bacteria. Phages have also been the focus of several 
studies due to their potential as tools for therapeutic purposes. Notably, detailed analysis 
carried out in different bacterial species established that phages have a prominent influence in 
virulence. The abundance of lysogenic phages in Streptococcus pneumoniae isolates associated 
with infection was suggested some years ago, and recently, it has been proposed that lysogens 
account for as much as 76% of the samples analyzed. However, the role of pneumococcal 
prophages in the pathogenic potential of its host remains so far unknown.  
Bacterial lysis promoted by the major autolysin LytA has been implicated in the capacity 
of pneumococcus to cause infection, essentially due to the release of proinflammatory cell wall 
compounds and intracellular virulence factors. Even if no phage-encoded virulence factors 
were ever found, prophage-mediated host lysis by itself may contribute significantly to 
pneumococcal pathogenesis. Therefore, investigating the phage lysis system is clearly 
important in furthering our understanding of this effect. This work explores the exact 
mechanism underlying the lysis strategy of S. pneumoniae phages to release their progeny and 
also the implications of lysogeny, particularly due to induced cell lysis, in the host ability to 
form biofilms, a bacterial lifestyle associated with pneumococcal human infections.    
Pneumococcal phages lyse their bacterial hosts, and consequently release the newly 
formed phage particles, at the end of the vegetative cycle through the combined action of 
holins that form lesions in the cytoplasmic membrane and lysins that degrade the bacterial 
peptidoglycan. The powerful lytic activity of the S. pneumoniae autolysin raised the possibility 
that it could play an important role in this process.  
By deleting the bacterial and phage lysins in both lysogenic and lysogenized strains, the 
contribution of LytA to phage release was evaluated based on bacterial culture lysis monitoring 
and phage plaque assays. It was found that, independently of the host genetic background, the 
bacterial autolysin is activated during phage-mediated lysis. Flow cytometry assessment of the 
membrane integrity after phage induction revealed that LytA triggering results from holin-
induced membrane disruption, similarly to the activation of the phage lysin. These results 
provide evidence that the energy status of the membrane may be involved in autolysin 
regulation at the cell surface.  
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We were able to demonstrate that, in the absence of the phage lytic enzyme, LytA by 
itself mediates extensive bacterial lysis, accompanied by the release of a large amount of fully 
functional phages capable of completing their life cycle since phage plaques were clearly 
detected. The overwhelming majority of phages of other bacterial species are absolutely 
incapable of bacterial lysis, trapping the phage progeny within the host cell, when the genes 
encoding lysins are deleted. Moreover, those rare mutants that bring about lysis depend only 
on phage-encoded factors. Nevertheless, exclusive dependence on the autolysin delayed the 
lysis timing and reduced the lysis extent. Accordingly, phage plaques were detected later than 
those in the presence of both host and phage lysins and a significant decrease on the number 
of virions released was observed. Therefore, lysis strictly dependent on LytA can lead to phage 
fitness impairment by retaining phage progeny longer within the host and reducing the 
amount of particles that actually escapes from entrapment. Nonetheless, under normal 
conditions, it was found that the concurrent activation of LytA with the phage lysin increases 
the total number of phages that exit the cell when the infective cycle is completed. Hence, 
pneumococcal phages use the ubiquitous host autolysin to accomplish an optimal phage 
exiting strategy and are unique among lysin-equipped phages in their dependence on bacterial 
lytic factors to achieve such task. 
Although the function of holin and phage lysin is characterized, the interplay between 
them to achieve lysis in S. pneumoniae was never fully determined. It has been shown that 
pneumococcal phage lysins are structurally and functionally similar to LytA, thus, they may 
share the same cellular localization and control mechanisms. Our finding that holin-induced 
membrane lesions trigger the bacterial cell wall autolysin prompted a deeper study of the 
pneumococcal lysis strategy.  
For this purpose, deletions of the holin and autolysin were performed in a lysogenic 
strain, in which the resident phage has a typical holin-lysin cassette. In the absence of these 
functions, western blot analysis and the effect of membrane permeabilizing and proton motive 
force (pmf)-dissipating agents on culture lysis allowed concluding that pneumococcal phage 
lysins accumulate with time across the lytic cycle and are continuously targeted to the cell 
wall. The phage lysin remains inactive associated with the choline residues within this 
structure. Therefore, the access of pneumococcal phage lysins to the bacterial surface is holin 
independent, hence they can be classified as exolysins. These findings are in contrast to what 
is observed in the large majority of holin-lysin phages where endolysins accumulate in the 
cytoplasm since they lack an intrinsic secretory signal sequence and consequently depend on 
holins to reach the peptidoglycan target. In addition, the involvement of the host Sec pathway 
in the phage lysin export was investigated. We assessed the cell wall localization of the phage 
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lysin by the same experimental procedures after culture treatment with the Sec inhibitor 
sodium azide. It was found that the phage lytic enzyme is possibly exported by the Sec system 
of pneumococci in spite of the striking absence of a signal sequence that could target it to the 
extracytoplasmic environment. This may constitute the first evidence, on phages encoding 
only holins and lysins in their lytic cassettes, of an exolysin without a secretion signal that is 
translocated through the membrane by the host Sec machinery. Furthermore, since the cell 
wall located autolysin also lacks obvious motifs or signals for an external localization, these 
results may provide clues for its transport mechanism.      
Dependence exclusively on the pmf-dissipating agent for complete host lysis, together 
with the previous observation of holin’s permeabilizing effect, showed that collapse of the 
cytoplasmic membrane electrochemical gradient achieved by the holins is the triggering signal 
to activate the phage lysin. In this study, it was further confirmed that activation of the 
externalized bacterial autolysin LytA, previously shown to contribute to phage progeny release, 
is also equally related to perturbations on the energized membrane. Thus, these results 
demonstrate that in S. pneumoniae phages, holin is not required for lysin export but is crucial 
to trigger the phage and bacterial lysins already residing in the cell wall by pmf dissipation 
upon formation of lesions on the membrane. In this regard, holins are the timing device that 
dictates when lysis takes place.  
After the characterization of the phage lytic mechanism, the contribution of lysis 
mediated by lysogenic phages to pneumococcal biofilms was investigated. S. pneumoniae 
lysogens are associated with human infections and pneumococcal biofilms have been 
implicated both in colonization and infection. It was explored if prophage spontaneous 
induction and consequent bacterial lysis enhance pneumococcal biofilm development 
providing a source of extracellular DNA (eDNA), a major factor in the biofilm matrix.  
Monitoring biofilm growth of lysogens and nonlysogenic bacteria by biomass 
quantification, viable cell counts and confocal laser scanning microscopy (CLSM), indicated that 
lysogenic bacteria are more prone to form biofilms, yielding structures with higher biomass 
and cell viability and showing denser biofilms in CLSM. Spontaneous phage induction was 
demonstrated to occur continuously as phages could be detected throughout biofilm 
formation through measurement of the total number of PFUs (plaque forming units) at specific 
time points. When comparing biofilm development between wild-type lysogens and those 
deleted in the phage lysin, bacterial autolysin LytA or both lysins, it was observed that phage-
mediated lytic events influence positively the biofilm structure. These results established that 
prophage promotes biofilm development due to bacterial lysis upon spontaneous induction. In 
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agreement, lysis inside biofilms also occurs in other bacterial species and it might be related to 
increased biofilm fitness.  
However, the effects created by the ablation of either the phage or bacterial lysins were 
overcome by the addition of external DNA. Additionally, in independent experiments, it was 
found that treatment with DNase I resulted in sparser and thinner biofilms while 
supplementation with DNA resulted in a thicker and more densely packed structure, 
confirming the important role of eDNA in pneumococcal biofilms. The quantification of eDNA 
released within these structures by real-time PCR also supported that lytic events promoted by 
phage are an important source of this matrix component, as biofilms of lytic strains contained 
more eDNA than those of nonlytic strains. Therefore, limited phage-mediated host lysis 
constitutes an important source of eDNA in S. pneumoniae biofilms favoring biofilm formation 
by lysogenic strains. Interestingly, massive phage induction leading to a high proportion of lysis 
was observed to disrupt severely biofilms of pneumococcal lysogens with a significant 
decrease in biofilm mass confirmed by CLSM visualization. These findings corroborate previous 
studies that show the potential use of lytic phages to destroy bacterial biofilms. 
The presented results and conclusions are of great value not only to directly increase our 
knowledge on phage biology and their relationship with the host bacteria, but ultimately to 
uncover the role of lysogeny in pneumococcal virulence. In this context, massive prophage-
induced lysis of the host could mimic the major bacterial autolysin by releasing factors known 
to contribute to the course of infection. On the other hand, lysis due to spontaneous levels of 
induction, characteristic of prophage carriage, may have an impact in pathogenesis by 
enhancing S. pneumoniae biofilm formation, which has been implicated in the processes of 
colonization and disease. A deeper understanding of the mechanisms underlying 
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Os bacteriófagos (fagos) são entidades extremamente abundantes na natureza que 
desempenham um papel central na modulação das populações bacterianas. Devido ao seu 
potencial como ferramentas para fins terapêutico, os fagos têm sido alvo de diversos estudos. 
A análise detalhada realizada em diferentes espécies bacterianas permitiu estabelecer que os 
fagos têm uma influência marcante na virulência. A abundância de estirpes lisogénicas de 
Streptococcus pneumoniae responsáveis por infecção foi sugerida há alguns anos e, 
recentemente, foi proposto que correspondem aproximadamente a 76%. No entanto, o papel 
dos profagos no potencial infeccioso dos pneumococos é ainda desconhecido.       
A lise bacteriana promovida pela principal autolisina LytA foi implicada na capacidade de 
S. pneumoniae causar infecção sobretudo por promover a libertação de componentes da 
parede celular com actividade pro-inflamatória e factores de virulência intracelulares. Mesmo 
que, até à data, não tenham sido identificados factores de virulência nos genomas fágicos, a 
lise bacteriana mediada pelos profagos pode por si só contribuir significativamente para a 
patogenicidade do pneumococo. Desta forma, é importante estudar o sistema de lise dos 
fagos. O presente trabalho explora os mecanismos da estratégia de lise adoptada pelos fagos 
de S. pneumoniae para libertar a descendência fágica e as implicações da lisogenia, 
particularmente devido à indução de lise, na capacidade do hospedeiro formar biofilmes, uma 
forma de crescimento bacteriano associada com infecções pneumocócicas.  
Os fagos de S. pneumoniae lisam as células hospedeiras, e consequentemente libertam as 
partículas fágicas recém-formadas, no final do ciclo lítico através da acção conjunta de holinas 
que formam lesões na membrana citoplasmática e lisinas que degradam o peptidoglicano da 
bactéria. No entanto, como a autolisina de S. pneumoniae é caracterizada por uma extensa 
actividade lítica, é possível que possa desempenhar um papel importante neste processo. 
A contribuição de LytA na libertação dos fagos foi avaliada através da eliminação das 
actividades das lisinas fágica e bacteriana em estirpes lisogénicas e lisogenizadas, subsequente 
acompanhamento da lise das culturas bacterianas e realização de ensaios de placas fágicas. Foi 
determinado que, independentemente do contexto genético do hospedeiro, a autolisina 
bacteriana é activada durante a lise mediada pelo fago. A avaliação da integridade da 
membrana por citometria de fluxo após indução do fago revelou que a activação de LytA 
resulta, tal como a activação das lisinas fágicas, dos danos na membrana induzidos pelas 
holinas. Estes resultados sugerem que o estado energético da membrana está envolvido na 
regulação da autolisina na superfície celular. 
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Na ausência da enzima lítica do fago, demonstrou-se que LytA medeia uma lise bacteriana 
extensa acompanhada da libertação de uma grande quantidade de fagos funcionais capazes de 
completar o ciclo infeccioso, uma vez que foram claramente detectadas placas fágicas. A 
grande maioria dos fagos que infectam outras espécies bacterianas é absolutamente incapaz 
de causar lise bacteriana, aprisionando a descendência fágica dentro da célula hospedeira, 
quando são eliminados os genes que codificam as suas lisinas. Além disso, os poucos mutantes 
capazes de lisarem as bactérias hospedeiras dependem unicamente de factores codificados 
por si próprios. No entanto, a dependência exclusiva na autolisina adiou o momento da lise e 
reduziu a sua extensão. Em concordância, as placas fágicas foram detectadas mais tarde do 
que as observadas na presença de ambas as lisinas (bacteriana e fágica) e observou-se uma 
diminuição significativa no número de viriões libertados. Assim, a lise estritamente 
dependente de LytA pode influenciar negativamente o “fitness” do fago ao reter a 
descendência fágica durante mais tempo no interior do hospedeiro e ao reduzir a quantidade 
de partículas que de facto escapam ao aprisionamento. No entanto, em circunstâncias normais 
de infecção bacteriana, verificou-se que a activação de LytA em simultâneo com a da lisina 
fágica aumenta o número total de fagos libertos da célula hospedeira uma vez completo o 
ciclo infeccioso. Logo, os fagos de S. pneumoniae utilizam a ubíqua autolisina bacteriana para 
optimizar a sua estratégia de libertação da descendência sendo, entre os fagos equipados com 
lisinas, os únicos que dependem de factores líticos bacterianos para a libertação óptima.              
Embora as funções da holina e da lisina fágica estejam caracterizadas, a interacção entre 
estas proteínas para alcançar a lise em S. pneumoniae não foi integralmente determinada. 
Como as lisinas fágicas são estrutural e funcionalmente similares a LytA, é possível que 
partilhem a mesma localização celular e mecanismos de regulação. A observação de que as 
lesões na membrana provocadas pelas holinas activam a autolisina bacteriana localizada na 
parede celular, incitou a um estudo mais detalhado sobre a estratégia de lise do pneumococo.  
Para isso, foram eliminadas as funções da holina e da autolisina numa estirpe lisogénica 
em que o profago contém uma cassete holina-lisina típica. Na ausência destas actividades, a 
análise por “western blot” e a avaliação na lise das culturas do efeito de agentes que 
permeabilizam a membrana e dissipam a força motriz protónica (fmp) permitiram concluir que 
as lisinas fágicas de S. pneumoniae acumulam-se ao longo do tempo durante o ciclo lítico e são 
continuamente transportadas para a parede celular, onde permanecem inactivas associadas 
aos resíduos de colina. Assim, o acesso das lisinas fágicas à superfície bacteriana é 
independente das holinas, podendo ser caracterizadas como exolisinas. Estes resultados 
diferem do que se observa na grande maioria dos fagos dependentes do sistema holina-lisina. 




sequência sinal secretória intrínseca e, consequentemente, dependem das holinas para 
alcançarem o peptidoglicano. Foi também estudado o envolvimento do sistema Sec do 
hospedeiro na exportação da lisina fágica. A localização da lisina fágica na parede celular foi 
avaliada pelos mesmos procedimentos experimentais após tratamento das culturas com azida 
de sódio, um inibidor desta via de transporte. Demonstrou-se que a enzima lítica fágica é 
possivelmente exportada pelo sistema Sec de S. pneumoniae apesar da ausência de sequências 
sinal que a possam dirigir para o compartimento extracitoplasmático. Estes resultados podem 
constituir a primeira evidência experimental, nos fagos que codificam nas suas cassetes líticas 
apenas as funções de holina e lisina, de uma exolisina sem sinal de exportação que é 
translocada através da membrana pelo sistema Sec do hospedeiro. Além disso, uma vez que a 
autolisina bacteriana localizada na parede celular também não apresenta motivos nem 
sequências de sinalização que justifiquem uma localização externa, estas observações podem 
ajudar a elucidar o seu mecanismo de transporte.             
A lise completa devido exclusivamente ao agente que dissipa a fmp, conjuntamente com a 
observação anterior do efeito permeabilizante das holinas, demonstrou que o colapso do 
gradiente electroquímico da membrana citoplasmática provocado pelas holinas constitui o 
sinal para activar a lisina fágica. Neste estudo, foi também confirmado que a activação da 
autolisina bacteriana externalizada, que se tinha verificado anteriormente contribuir para a 
libertação da descendência fágica, está igualmente relacionada com perturbações no estado 
energético da membrana. Logo, estes resultados demonstram que nos fagos de S. 
pneumoniae, a holina não é necessária para a exportação da lisina mas é crucial para activar 
tanto a lisina fágica como a bacteriana residentes na parede celular por dissipação da fmp 
aquando da formação de lesões na membrana, determinando o momento da lise.                
Após a caracterização do mecanismo fágico de lise, foi investigada a contribuição da lise 
mediada por fagos lisogénicos nos biofilmes do pneumococo. Em S. pneumoniae, as estirpes 
lisogénicas estão associadas com a infecção e os biofilmes foram implicados em ambos os 
processos de colonização e infecção. Foi estudado se a indução espontânea dos profagos e a 
consequente lise bacteriana favorece o desenvolvimento de biofilmes de S. pneumoniae por 
ser uma fonte de DNA extracelular (eDNA), um factor importante na matriz dos biofilmes.  
O desenvolvimento de biofilmes de estirpes lisogénicas e não lisogénicas foi analisado por 
quantificação da biomassa, determinação da viabilidade celular e por CLSM (“confocal laser 
scanning microscopy”). Observou-se que as estirpes lisogénicas são mais propensas a formar 
biofilmes, os quais se caracterizam por maior biomassa e viabilidade celular relacionadas com 
a maior densidade observada por CLSM. Foi demonstrado que a indução espontânea do fago 
ocorre continuamente uma vez que se detectaram partículas fágicas durante todo o 
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desenvolvimento do biofilme por medição do número total de UFPs (unidades formadoras de 
placas) a tempos específicos. Por comparação da formação do biofilme entre estirpes 
lisogénicas com e sem a lisina fágica, a autolisina bacteriana ou ambas, foi observado que 
eventos líticos mediados pelo fago influenciam positivamente a estrutura do biofilme. Estes 
resultados estabeleceram que o profago promove o desenvolvimento do biofilme através da 
lise bacteriana aquando da indução espontânea. Em concordância, a lise em biofilmes também 
ocorre noutras espécies bacterianas e parece estar relacionada com o aumento do 
crescimento do biofilme.  
No entanto, os efeitos da eliminação quer da lisina fágica quer da lisina bacteriana, foram 
anulados pela adição de DNA. Em experiências independentes, verificou-se que o tratamento 
com DNase I resultou em biofilmes menos compactos e densos enquanto a suplementação 
com DNA originou estruturas mais robustas, confirmando o papel importante de eDNA nos 
biofilmes de S. pneumoniae. A quantificação de eDNA presente nestas estruturas por PCR em 
tempo real também demonstrou que eventos líticos promovidos pelo fago são uma fonte 
importante deste componente da matriz pois biofilmes de estirpes capazes de lise continham 
mais eDNA do que as estirpes sem lisinas. Desta forma, a lise limitada mediada pelo fago 
constitui uma fonte importante de eDNA nos biofilmes de S. pneumoniae favorecendo o seu 
desenvolvimento no caso de estirpes lisogénicas. Interessantemente, a indução substancial do 
fago, levando a uma elevada proporção de lise, destrói gravemente os biofilmes de estirpes 
lisogénicas diminuindo significativamente a massa do biofilme como confirmado por CLSM. 
Estas observações corroboram estudos anteriores que demonstram o potencial do uso de 
fagos líticos para eliminar biofilmes bacterianos. 
Os resultados e conclusões apresentados são importantes não só por alargarem 
directamente o conhecimento acerca da biologia do fago e da sua relação com o hospedeiro 
bacteriano, mas em última análise para permitir atribuir à lisogenia um papel claro na 
virulência do pneumococo. Neste contexto, a indução substancial de lise bacteriana pelo fago 
pode, tal como a lise promovida pela autolisina LytA, libertar factores que contribuem para o 
curso da infecção. Por outro lado, a lise devido à indução espontânea característica do estado 
de profago pode ter um impacto na patogenicidade por influenciar a formação de biofilmes, os 
quais têm sido implicados nos processos de colonização e infecção. A compreensão dos 
mecanismos subjacentes à infecção pneumocócica é de extrema relevância para poder 
controlar este importante agente patogénico.  
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AIM AND OUTLINE OF THE THESIS 
 
The aim of this study was to identify and characterize factors involved in bacteriophage 
lysis strategy in the pneumococcal model phage SV1 and subsequently reveal the molecular 
mechanisms leading to phage release in S. pneumoniae. Upon characterization of the phage 
lytic mechanism, the focus shifted to explore the impact of lysogeny, through phage-mediated 
lysis, on the bacterial host particularly in the capacity to form biofilms as recent studies 
demonstrated the potential of S. pneumoniae to produce biofilms in vivo and propose that 
pneumococcal biofilms play a relevant role both in colonization and infection.  
 
In Chapter I, a detailed overview of the relevant literature introduces and describes the 
theme. The influence of lysis on S. pneumoniae virulence and the lysis strategy of their phages 
are presented. In addition, current knowledge regarding pneumococcal lysogenic phages as 
potential contributors to virulence, with special focus on induced host lysis, is reviewed.  
 
In Chapter II, the characterization of S. pneumoniae phage-mediated lysis is described, 
aiming at evaluating the possible role of the bacterial autolysin LytA in phage progeny release. 
The investigation of the putative control function of phage-encoded holins over both phage 
and bacterial lysins is also reported.  
 
Chapter III addresses the detailed phage lysis mechanism operating in S. pneumoniae with 
a particular focus on the localization of the lysins. The studies on the precise role of each lysis 
component of the holin-lysin system and how they work together to accomplish phage 
progeny release are presented. 
 
The study of the influence of lysogenic phages, through induced lysis, in the host ability to 
form biofilms is presented in Chapter IV. The results comprise mainly the in vitro evaluation of 
the effect of spontaneous induction of the phage lytic cycle on those complex bacterial 
structures.   
 
The concluding remarks in Chapter V provide an integrative framework of the findings 
presented in this thesis. The relevance of this work and perspectives for further studies are 
also highlighted in this chapter. 
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What is the 
contribution of the 
S. pneumoniae 




Deletions of the bacterial autolysin 
(LytA) and phage lysin (Svl) were 
done in S. pneumoniae lysogenic 
strains. Bacterial culture lysis was 
monitored after MitC phage 
induction and phage release was 
estimated by phage plaque assays.                     
Cell membrane integrity during this 
process was assessed by flow 
cytometry to study the function of 





MitC, mitomycin C 
1. The bacterial LytA is 
activated during the phage lytic 
cycle mediating host lysis and 
consequent phage release.           
2. LytA activation, just like the 
phage lysin triggering, is due to 
holin-induced membrane 




LytA, however, impairs phage 
release that may negatively 
influence phage fitness.                                            





























Holin and autolysin LytA activities 
were deleted from S. pneumoniae 
lysogenic strains.  The possible cell 
wall localization of the phage lysin 
(Svl) was investigated by western 
blot.                                                   
The effect of the membrane pmf-
dissipating agent DCCD on lysis was 
tested after phage induction to 
assess the triggering signal for Svl 
activation.                                       
Host Sec pathway involvement in 
Svl export was explored using the 
sec inhibitor NaN3. After NaN3 
treatment, Svl cell localization was 
analyzed by western blot and 
followed up of lysis with DCCD.  
 
Pmf, proton motive force; DCCD,  N,N´-
dicyclohexylcarbodiimide 
1. Pneumococcal phage lysin is 
targeted to the cell wall in the 
absence of holin function, 
where it remains in an inactive 
form.   
2. Lysin export is possibly 
mediated by the host Sec 
pathway despite the absence 
of signal sequences.  
3. The phage exolysin is 
activated by membrane pmf 
collapse resulting from holin 
lesions, like the externalized 
bacterial LytA.  
4. In pneumococcal phage lysis 
strategy, the phage exolysin 
accesses the cell wall 
independently of the holin but 
holins are crucial for phage and 




















Is host lysis due to 
phage 
spontaneous 






Biofilm development of lysogenic 
and nonlysogenic pneumococcal 
strains was followed by biomass 
quantification, viable cell counts 
and CLSM.  
Phages released during biofilm 
formation were measured by PFUs.  
Biofilm development in the absence 
of the phage lysin and bacterial 
autolysin LytA was also evaluated.  
We tested the effect of the addition 
of external DNA and DNase I and 
measured the amount of eDNA 
released within biofilms by real-
time PCR. 
 
CLSM, confocal laser scanning 
microscopy; PFU, plaque forming unit 
 
1. Lysogenic bacteria are more 
prone to form biofilms 
characterized by higher 
biomass and cell viability.  
2. Spontaneous phage 
induction occurs continuously 
within the biofilm during its 
development.   
3. Ablation of either the phage 
lysin or bacterial lysin impairs 
biofilm development, which is 
overcome by addition of DNA. 
4. Spontaneous phage-
mediated host lysis is an 
important source of  eDNA 
favoring biofilm formation by  
S. pneumoniae lysogenic 
strains.   
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1. STREPTOCOCCUS PNEUMONIAE  
 
Streptococcus pneumoniae, or pneumococcus, causes a wide variety of human infections 
ranging from potential fatal septicaemia, meningitis and pneumonia to more uncomplicated 
conditions including otitis media, sinusitis and bronchitis [1]. In most instances, S. pneumoniae 
will not cause infection in humans and can simply be carried by the host, colonizing the upper 
respiratory tract. Carriage of the bacterium is, however, believed to be the first step in the 
pathogenesis of this organism [2,3].  
The treatment of pneumococcal infections is done with antibiotics, although they remain 
associated with high morbidity and mortality [4]. With the increasing prevalence of antibiotic 
resistant strains [5], a strategy of prevention by vaccination has been developed to counter the 
problem. Current vaccinations target the capsular polysaccharide that coats S. pneumoniae. 
However, over 90 different chemical variants of this polysaccharide exist within the species [6-
9], and all the available vaccines only protect against a few of the capsular types (serotypes) 
[2,3]. Alternative vaccination approaches using other components of the pneumococcal 
surface are currently being studied but issues in their development include lack of 
immunogenicity or variability in different strains [2,3]. 
Considering these growing difficulties it is crucial to design novel therapeutic regimes 
which imply better knowledge of the factors and processes implicated in the virulence of this 
species.  
 
2. BACTERIOPHAGES OF PNEUMOCOCCUS 
 
Bacterial viruses or bacteriophages (phages) are profoundly involved in bacterial 
pathogenesis. They are essential vehicles for the transmission of virulence genes within 
bacterial populations [10-14]. Taking into account the abundant presence of lysogenic phages 
(that integrate its genome into the bacterial chromosome) among S. pneumoniae strains 
associated with infection (76%) [15], pneumococcal phages have been studied to understand 
their putative impact in virulence.  
 
2.1. GENERAL CHARACTERISTICS   
 
Pneumococcal phages were first isolated in 1975 from throat swabs of healthy children 
[16,17]. Since then, several phages of this bacterium from different origins have been isolated 
and characterized [18,19]. They have, like most phages, double stranded DNAs encapsulated 
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into a protective head (capsid) attached to a tail [18-23], and comprise three families, 
belonging to the Caudovirales order (tailed phages), with varied morphologies (Fig.I.1) [18,24]. 
Dp-1, Dp-4, ω, HB-3, MM1 e VO1 phages belong to the family Siphoviridae and have long 
noncontractile tails [18,21,22,25,26], whereas EJ-1 is classified as Myoviridae with a long 
contractile tail [27]. On the other hand, Cp phages (Cp-1, Cp-5, Cp-7 and Cp-9) have a short 
noncontractile tail and belong to Podoviridae (Fig.I.1) [18,19]. Also, the SV1 phage, identified in 
S. pneumoniae strain SVMC28 responsible for human infection, has a typical viral morphology 




Figure I.1. Electron micrographs of purified pneumococcal phages. (A) Dp-1; (B) Cp-1; (C) HB-3; (D) EJ-1. Electron 
microscopy magnifications are not indicated. From [18]. 
 
 
Generally, their host range is restricted to S. pneumoniae, that is, they infect specifically 
pneumococcal cells [18]. Cp-1 phage represents an exception because it can infect and 
replicate in Streptococcus oralis, which is taxonomically related to pneumococci and shares a 
common habitat in humans [28]. Pneumococcal phages may also infect specific strains within 
this species [18]. For instance, EJ-1 was purified from cultures of the pneumococcal strain 
101/87, but repeated attempts to infect S. oralis or even several pneumococcal strains with 







2.2. LIFE CYCLE 
 
Phages, like all other viruses, are obligate intracellular parasites and thus, in order to 
replicate they require a specific host. In the extracellular environment, phage particles are just 
inert packages that protect the viral genome from damaging environmental factors until the 
vital nucleic acid is delivered into a susceptible host [23]. Pneumococcal infection by phages 
can lead to either of two responses, the lytic or the lysogenic cycle [18,24]. 
 
2.2.1. LYTIC PHAGE INFECTION 
 
The phage vegetative growth or lytic pathway starts with phage attachment or adsorption 
to the bacterium (Fig.I.3) [23]. Phage tails are known to interact with receptors present on the 
bacterial surface [23]. The majority of phages are highly specific for their host receptors [23]. 
In S. pneumoniae, adsorption of phage Dp-1 was shown to be dependent on choline, a 
structural component of the teichoic acids of the pneumococcal cell wall [29]. In fact, a protein 
contained in Dp-1 tail, besides binding to other molecules, also attaches to choline residues 
[20]. A detailed analysis of the open reading frame (orf) encoding such a protein identified a 
motif similar in amino acid sequence to that characteristic of the choline binding domain of 
pneumococcal proteins [20]. Curiously, four repeats of this motif were found [20], which 
appears to be the minimum required for efficient binding of the protein LytA (section 3.3) [30].  
After adsorption, phage genetic material penetrates into the host cell with the capsid 
remaining externally (Fig.I.3) [23]. Once inside the host, phage gene expression and genome 
replication begin (Fig.I.3). Phage gene expression generally occurs in different stages [23]. At 
the initial phase of infection, genes involved in genome replication are expressed (“early 
genes”). Only afterwards, occurs the expression of the genes encoding structural components 
of the phage particles and factors involved in their assembly (“late genes”) [23]. This temporal 
synthesis has been demonstrated in pneumococcal Cp-1 phage and apparently occurs similarly 
Figure I.2. SV1 phage particles of pneumococcal strain SVMC28. The 
larger electron micrograph shows a pneumococcal cell with multiple 
phage tails attached and a cluster of phages and phage tails in the top 
left corner. The inset shows a complete SV1 phage. Black bar, 0.3 μm; 
white bar (inset), 0.1 μm. From *15+. 
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in all phages of this bacterium [31,32]. Synthesis of viral structural proteins usually overlaps 
with the nucleic acid replication. The new virion building material accumulates within the cell 
and when there are plenty of replicated genomes and structural proteins available, assembly 





Figure I.3. Phage lytic and lysogenic life cycles. Phage infection starts with adsorption to the cell surface receptor 
and genome penetration into the host (1). In the lytic infection, it follows genome replication (2), head and tail 
production (3), synthesis of lysis proteins (4), genome packing (5) and phage particles assembly (6). In the end of the 
lytic cycle, disruption of the cell and release of the phage progeny occurs (7). In the lysogenic cycle, after genome 
penetration, phage genome is circularized (8) and integrated into the host genome (9). From [33]. 
 
 
Finally, the newly formed and fully assembled virions exit the host by cell lysis (Fig.I.3) 
[18,20,23]. Proteins involved in phage release are also expressed late in infection by phage 
Cp-1 [31]. Besides Cp-1, pneumococcal phages Dp-1, Dp-4 and Cp-7, replicate exclusively by 
vegetative growth and therefore are classified as virulent or lytic [18,20,24] since infection is 
shortly followed by their bacterial host death and lysis.  
 
2.2.2. LYSOGENY AND PROPHAGE INDUCTION  
 
In the lysogenic phage infection (lysogeny), the phage genome can be integrated into the 
chromosome of the bacteria and replicated along with the host genome, existing in a latent 
prophage state (Fig.I.3) [34,35]. This arrangement offers the virus an alternative mechanism 
for making more copies of its genome. Bacteria that carry prophage are said to be lysogenic (or 
lysogens) and generally became resistant to infection by other related phages. Phages that can 
undergo lysogeny, such as MM1, HB-3, VO1, EJ-1 and SV1 of S. pneumoniae [15,18,25,36,37], 
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are called temperate or lysogenic. However, the mechanisms leading to the decision, soon 
after phage genome penetration, whether to follow the lytic or the lysogenic pathway remain 
largely unknown [34,35].   
The phage genome integration occurs by a site-specific recombination process [38]. Two 
specific attachments sites, one on the bacterial chromosome (attB, bacterial attachment site) 
and the other on the phage genome (attP, phage attachment site), are recombined by the 
activity of a phage-encoded integrase. Although the integration system of pneumococcal 
phages is poorly documented, the attP-containing phage DNA, the bacterial attachment site 
attB or the host-phage junctions attL and attR have already been identified in some prophages 
such as MM1, EJ-1 and VO1 [25,26,37]. Even more, in the surrounding region of the attP of 
EJ-1, there are nucleotide sequences that share similarity with a sequence that was suggested 
to participate in the binding of integrases [18].  
During lysogeny, the expression of phage genes whose products are required for the lytic 
pathway is prevented by the action of the viral repressor (CI) [34,35]. Although the prophage 
state is relatively stable, it can be induced to enter the lytic growth leading to the production 
of progeny virions, through the host machinery, and cell lysis [34,35]. At high levels of 
prophage induction in a lysogenic culture, triggered by external events, lysis can occur in all or 
nearly all of the cells [35]. In addition, even in the absence of an inducer, spontaneous 
induction occurs, although at a lower level, resulting in the lysis of a small fraction of the cells 
[35,39-41].    
In the Escherichia coli phage λ, the mechanism of prophage induction is well 
characterized. It is triggered by treatments that damage DNA and inhibit DNA replication. This 
elicits the action of the host SOS regulatory system (SOS response), which involves the action 
of proteins LexA and RecA, to repair the DNA and restore replication [34,35]. Upon inducing 
treatments, RecA is activated and catalyzes the proteolytic self-cleavage of LexA. Since during 
normal cell growth LexA represses a large set of genes (SOS genes) normally with a basal level 
of expression, its cleavage inactivates the repressor function and the SOS genes are expressed 
at high levels, including recA. In parallel, activated RecA also promotes the cleavage of CI 
phage repressor, leading to derepression of the prophage (which causes the phage to excise 
from the host chromosome and enter the lytic cycle) [35]. When the damaged is repaired, 
RecA is no longer activated and LexA builds up rapidly to normal levels that again ensure 
repression of the SOS genes. It should be noted that, in the λ system, spontaneous switching 
still requires the activation of SOS response [35] nonetheless, even in this well-studied phage, 
the factors that lead to this spontaneous process are poorly understood.  
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Since the first isolation of lysogenic phages from S. pneumoniae [42], lysogeny was found 
to be very frequent among pneumococcal strains recover from human infections [15,43] (with 
as much as 61% of strains carrying functional prophages [15]). Although it was initially 
suggested that lysogeny was associated with only certain pneumococcal capsular types causing 
disease [44], the presence of fully functional, defective (noninducible) or remnant prophages in 
the chromosome is indeed a general trait among S. pneumoniae isolates [15,26], including 
nonencapsulated pneumococci [27]. Despite this widespread presence, prophage induction 
mechanisms are still little studied. However, in the lysogenic cluster of phage MM1, it was 
recently demonstrated that a protein with a putative repressor function (repressor CI) [36] is 
indeed involved in the maintenance of the lysogenic state [45]. Moreover, the treatment with 
mitomycin C (MitC), which induces the lytic growth from the prophage state in lysogenic E. coli 
[46] since it crosslinks the complementary strands of the DNA double helix [47] blocking the 
replication fork, was also proven to induce pneumococcal prophages [15]. In MitC-treated 
pneumococci the presence of phage particles inside the cell were visualized just before lysis 
occurred (Fig.I.4). Another interesting characteristic shared with the E. coli system is the effect 
of MitC, at nonbactericidal concentrations used to induce prophages, on cell elongation as a 
result of a block in cell division with a concomitant increase in cell mass (Fig.I.4) [15,46,48]. 
Furthermore, even though S. pneumoniae lacks a canonical SOS system, a RecA protein was 
identified as being involved in DNA repair [49]. It was shown that RecA controls directly or 
indirectly lysogenic induction since MitC treatment results in increased recA expression and in 






Figure I.4. Intracellular SV1 phage particles in S. pneumoniae 
strain SVMC28 induced with mitomycin C. Lysis was prevented 
by a high concentration of choline in the medium. Similar 
observations were obtained with MitC-induced cells just before 
lysis, without choline treatment. Collapse of the membrane is 
evident from the white background in the cytoplasmic space. 
Escape of phage particles is prevented by the integrity of the cell 
wall. Arrowheads indicate fully assembled phage particles. Bar, 
0.3 mm. From [15]. 
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2.3. PHAGE LYSIS STRATEGY  
 
Phages use two basic strategies to escape from the infected cell [51-53]. All known phages 
release their progeny by lysis of the host, except the filamentous phages, such as M13, that 
can extrude themselves through the host envelope without fatal consequences to the bacteria 
[23]. To lyse the host, phages have to compromise the bacterial cell wall [51-53]. Small phages 
with single stranded (ss) genomes (ssDNA and ssRNA) encode a single lysis protein (without 
cell wall hydrolyzing activity) that typically inhibits a specific step in cell wall synthesis during 
active bacterial growth [51-54]. Since cell wall synthesis is coupled with turnover and recycling 
of the preexistent cell wall (see section 3.1), the action of the phage protein weakens the cell 
wall and eventually results in cell rupture due to the osmotic pressure difference between the 
internal and external environments. The E protein of ssDNA phage φX174 of E. coli is an 
example of this strategy [54]. On the other hand, dsDNA phages, that correspond to the great 
majority of phages (about 96%) [23], generally encode at least two proteins that together 
promote cell wall degradation accomplishing rapid cell lysis, known as the holin-lysin system 
[51-53,55].  
 
2.3.1. HOLIN-LYSIN SYSTEM 
 
In the holin-lysin lysis strategy, the lysin is a cell wall hydrolyzing enzyme and the holin is a 
lethal protein with transmembrane domains that permeabilizes (making holes) the cytoplasmic 
membrane [51,56-59]. On both Gram-positive and Gram-negative hosts, the phage lysin is 
generally deprived of a secretory signal sequence hence it is sequestered in the cytoplasm and 
designated endolysin. Therefore, it requires the holin to gain access to its cell wall substrate 
(Fig.I.5A) [51-53,56,57,60]. In fact, it was observed for some phages that in the absence of 
holin function cell lysis is prevented but endolysin activity accumulates in the cell with no 
deleterious consequence on the growth despite being enzymatically active [61,62]. 
Accordingly, cell culture mass and intracellular phage titers continue to build up for an extent 
period of time [61-63]. When the endolysin function is impaired, in the presence of holin, lysis 
is also abolished. However, in contrast to what happens without holin, cell death (culture 
viability loss) occurs at the normal time of lysis and macromolecular synthesis stops with no 
further increase in biomass and virion production [57,61,63,64]. Thus, the holin permeabilizing 
function determines the timing of lysis [56]. 
It was shown that the precise moment of lysis is critical for phage fitness [65]. On one 
hand, if lysis occurs too early in the infection cycle few progeny virions are released. Delay of 
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lysis, on the other hand, prevents progeny virions from infecting new hosts, despite producing 
more progeny [65]. It is therefore understandable that host lysis, hence holin activity, must be 
a fine-tuned event [56]. Based essentially on E. coli phage λ studies, a model for lysis regulation 
was proposed [66]. During the late stage of phage development holins progressively 
accumulate inactive in the membrane without detrimental effects in membrane integrity 
[67,68]. Meanwhile, these small proteins dimerize and then assemble into oligomers 
eventually leading to the formation of protein aggregates or rafts, largely excluding lipid from 
the interior [66,69,70]. At a specifically programmed time during the growth of a raft, the 
protein accumulation would result in protein-protein interactions weakening, which would 
cause the opening of a momentary channel or hole (local membrane disruption) in the protein 
array. This leads to an instantaneous local depolarization of the membrane which in turn 
causes conformational changes in the holins that further destabilize the interactions, triggering 
rapidly lesion formation (massive membrane disruption) [66,70]. Consequently, sudden global 
membrane proton motive force (pmf) collapse occurs only seconds before lysis (Fig.I.6) [67]. 
Recently, it was observed that λ holins accumulate in a uniformly distributed fashion in the 
membrane and raft formation (redistribution into holin aggregates) only occurs at the time of 
holin triggering [71]. In this case, it was proposed that the holin rafts form suddenly when the 
holin reaches a critical concentration and are inherently incapable of supporting the 
membrane potential, likely because the raft interior is lipid depleted, leading to the local 
depolarization [71]. Generally, the holin primary structure of a specific phage was implicated in 
the decision of the lysis timing, i.e. the moment of the first disturbance in the protein array, in 
accordance with the observation that different phages exhibit different lysis times [56,69,72]. 
In the overall process, the energized membrane is essential for holin control preventing 
deleterious anticipation of membrane disruption and guaranteeing that phage production 
within the cell is not compromised until just the optimal moment of release [67]. This can 
explain the well-known effect of premature lysis triggering by energy poisons during the period 
when holin accumulates in the membrane [52,56,67].  
Additional means to achieve a precise lysis timing, at least in some cases, rely on the 
synthesis of a holin inhibitor [68,73-75]. In phage λ, the antiholin was shown to directly 
interact with the holin probably resulting in mixed arrangements of holins and antiholins 
accumulated in the cytoplasmic membrane that are nonfunctional for hole formation [68,76]. 
As long as membrane potential is maintained, antiholin delays hole formation by the holin 
since accumulation of the holin functional arrangements to trigger the local disruption of the 
membrane simply takes more time. However, upon dissipation of membrane potential, the 
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antiholin no longer functions as a lysis inhibitor since its activity is converted into active holin, 




Figure I.5. Holin-lysin system for triggering of lysis. (A) Classical model for endolysin-equipped phages, based on 
phage λ. (B) New model for phages encoding exolysins, based on the SAR lysin of phage P1 attached to the 




Figure I.6. Original proposed model for the formation of a holin lesion. Holins progressively accumulate in the cell 
membrane, oligomerize and ultimately form large protein aggregates (“death rafts”) from which lipids are largely 
excluded by intimate interaction between individual holins via their transmembrane domains. Each circle represents 
a single holin molecule. Spontaneous opening of a local hole at some point in the growth of the raft with 
consequent localized depolarization of the membrane causes conformational changes in the holins and subsequent 
dispersion of the subunits into the holin lesion in the membrane. This results in generalized membrane pmf collapse 
before lysis. From [66].  
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Regardless of the mechanisms involved in lesion formation, in some endolysin-equipped 
phages, the holin-induced lesions have actually been shown to be large enough for fully folded 
lytic enzymes to pass through the membrane into the extracytoplasmic environment 
[51,56,57,66], supporting the classical paradigm of holin-dependent transport of the endolysin. 
However, recently, experimental evidence arose opposing to the common belief that 
intracellular accumulation of phage lysins is a universal feature of phage lysis systems. A phage 
lysin with a signal peptide (called exolysin) was first found in fOg44 lysogenic phage of the 
Gram-positive bacterium Oenococcus oeni [78]. The lysin Lys44 export to the extracytoplasmic 
environment does not require the holin action since the typical cleavable N-terminal signal 
sequence allows host Sec-mediated membrane translocation as phage infection progresses 
[78]. A surprising observation was the fact that the phage also encodes a holin, Hol44 [79]. 
Treatment with nisin, which permeabilizes the cytoplasmic membrane (forms 2.5 nm pores) 
mimicking holin-induced disruption, triggered Lys44-mediated lysis. Pmf-dissipating agents 
also elicited a lysis response, although not as effectively as nisin [79]. Thus, it was suggested 
that membrane pmf dissipation due to holin permeabilizing lesions is necessary for lysin 
activation. However, based on these results the authors also proposed that pmf perturbations 
are not sufficient to trigger the full activity of Lys44 [79]. 
Phage lysins with intrinsic export signals were also identified in Gram-negative bacteria 
[77,80,81]. The lysins of E. coli phages P1 and 21 have an atypical SAR (signal-arrest-release) 
sequence in the N-terminal domain that mediates their translocation across the membrane 
into the periplasm through the host Sec machinery without proteolytic cleavage. In the 
extracytoplasmic compartment, the lysin accumulates anchored to the energized membrane in 
an inactive form by its N-terminal (transmembrane) SAR domain (Fig.I.5B) [77,80,81]. Again, 
lysin access to the cell wall is holin independent. However, similarly to fOg44 phage, the holin 
function is still required for cell lysis [77,79-81]. The collapse of the membrane pmf upon 
formation of holin lesions detaches the SAR domain and consequently activates the lysin, then 
available in the periplasm enzymatically active to degrade the cell wall (Fig.I.5B) [77,80-83]. 
Furthermore, the phage 21 holin was shown form small holes (pinholes) in the membrane, in 
contrast to the large holes formed by λ holins that allow release of fully folded proteins [66], 
supporting its role of only bringing about membrane depolarization [81,84]. Indeed, this 
pinholin was not able to function with the λ lysin in inducing cell lysis, i.e. its lesions do not 
allow the passage of this lysin [81]. Holins do not specifically interact with the endolysins and 
most holins tend to complement λ holin mutants [56,57]. Apparently, phage 21 holin only 
promotes lysis when paired with SAR lysins [81]. Interestingly, in both 21 and P1 systems, 
without holin function phage plaque formation and culture lysis could also be observed, 
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although the latter characterized by a gradual nature [77,81]. Thus, holin function is not strictly 
essential for phage release to take place as SAR lysins are apparently detached spontaneously 
from the membrane albeit at a lower rate [77,81]. 
Furthermore, it was revealed, mostly by sequence comparisons, that other phage lysins 
from Gram-positive and Gram-negative bacteria also have N-terminal export sequences, which 
possibly explore the Sec system [55,85-87]. One peculiar case is the mycobacteriophage Ms6 in 
which the lysin LysA transport also occurs in a holin-independent manner. Although no export 
signal was associated with its lysin, this phage additionally encodes a chaperone-like protein 
(Gp1) in its unusually complex lytic cassette that interacts with the phage lysin and this 
interaction is necessary for LysA delivery to the cell wall [88]. When tested in E. coli, the Sec 
system was found to be also involved in Gp1-assisted export of the mycobacteriophage lysin 
[88]. A depolarizing role of the holins in LysA activation was also suggested using 
permeabilizing drugs [88]. While the holin Gp4 of Ms6 has a N-terminal SAR domain, a 
characteristic described for the phage 21 pinholin [82,84], it was able, like the canonical P1 
holin, to promote the release of the λ lysin [81,89]. With both classical and new holin-lysin 
models in mind (Fig.I.5A and B), it is clear that there are two different mechanisms by which 
holins can control lysis timing but both can be viewed as activation of the phage lysins. 
 
2.4. HOLIN-LYSIN STRATEGY OF S. PNEUMONIAE PHAGES 
 
In the pneumococcal system there is evidence that the holin-lysin strategy is present in 
every phage analyzed so far [20,24,25,36,90,91]. The holin and lysin genes, like in the majority 
of phages described, are located adjacent to each other and clustered in a lytic cassette that 
may also encompass an antiholin function [20,24,36,90,91]. For instance, the MM1 phage 
contains two genes, orf50 and orf51, just upstream of the lytic gene, which encode two 
proteins (138 and 110 amino acids, respectively) that display the characteristic sequence 
signatures of holins (gp50) or antiholins (gp51), although the actual roles of these proteins in 
the host lysis machinery are still uncertain [24,36]. For the lytic Cp-1 and lysogenic EJ-1 phages, 
a detailed characterization of the lysis system was undertaken by cloning and expression of the 
two genes involved in the release of phage progeny [90,91].  
Phage Cp-1 encodes a holin (Cph-1) of 134 amino acids (14.5 kDa) with 3 potential 
hydrophobic transmembrane regions and the cph1 gene is found upstream of the cpl1 gene 
encoding the lysin Cpl-1 [91]. A antiholin function is not enclosed in its lytic cassette [91]. The 
cloning and expression of the holin in E. coli heterologous system did not induce lysis but 
dramatically affected cell viability, whereas the concomitant expression of both holin and lysin 
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resulted in cell lysis and the viability loss was similar to that observed with the holin alone [91]. 
Moreover, the single expression of lysin did not affect either growth or cell viability. In an S. 
pneumoniae mutant deleted in the major autolysin, the expression of cph1 and cpl1 genes had 
the same effect as in E. coli cells, inducing culture lysis and cell viability loss to a similar extent 
[91]. In addition, the holin itself did not lyse the culture nevertheless, there was no noticeable 
reduction in cell viability besides the observation of a reasonable impairment in the culture 
growth rate [91]. Again, pneumococcal lysis was never observed in the presence of Cpl-1 alone 
before the normal time of lysis [91,92]. From these results it was clear that the phage lysin is 
activated through holin function [91]. Since the Cpl-1 lysin does not exhibit a secretory signal 
sequence that could target it to host translocation systems [20], and the viability loss as well as 
the growth inhibition induced by the holin is compatible with the formation of membrane 
lesions, it was suggested that, similarly to the majority of holin-endolysin equipped phages, 
Cp-1 holin might disrupt the cytoplasmic membrane to release the lysin onto its cell wall 
substrate. The observation that Cp-1 holin complemented the λ phage lysin in producing phage 
plaques, indicative that it functionally replaced the λ holin in allowing the lysin passage to the 
cell wall, seemed to corroborate this hypothesis [91].  
Similar to Cp-1 phage, EJ-1 phage simply encodes a holin (Ejh), of 85 amino acid residues 
with two hydrophobic regions, and a lysin (Ejl) with no signal sequence, in which the ejh gene 
precedes the ejl lysin gene in the lytic cassette [90]. In both Gram-negative bacteria E. coli and 
Pseudomonas putida, cell lysis was only induced by the combined expression of ejh and ejl 
while expression of the ejh gene resulted in reduced viability attributed to the formation of 
lesions in the cytoplasmic membrane, as detected by electron microscopy [90]. In agreement, 
EJ-1 phage holin was also capable of efficiently complementing phage λ lysin to produce phage 
progeny and an immediately lysis by Ejl was observed after addition of chloroform, that makes 
membranes permeable [90]. Additionally, for both Cp-1 and EJ-1, it was observed the lysis of E. 
coli cells expressing concomitantly the phage holin and the bacterial major autolysin LytA that 
is functionally similar to pneumococcal phage lysins (see section 3.3). 
Recently, a deeper insight into the function of Ejh was achieved [93]. Ejh is translated as a 
single polypeptide chain that inserts into the membrane and folds as a helical hairpin directing 
both terminal ends towards the cytoplasmic face. Upon a given concentration of monomers in 
the membrane it readily oligomerizes. The self-assembling tendency correlates with the 
formation of transmembrane holes (Fig.I.7) [24,93]. The hole size allows the exchange of 
components between the cytoplasm and the external environment, passage of dextrans of 






Figure I.7. Model for Ejh holin function. Putative transmembrane regions of Ejh are depicted as green cylinders. 
From [24].  
 
 
Based essentially on the nature of the Cph-1 and Ejh holin lesions, large enough for lysins 
to pass through, and considering that, not only Cp-1 and EJ-1 lysins but all pneumococcal 
phage lysins lack any known secretory signal sequence (see also Fig.I.12) [20], it is assumed 
that the holin-dependent delivery of the lysin to its target is a widespread strategy among S. 
pneumoniae phages.   
It should be mentioned that long before the holin-lysin system was identified in S. 
pneumoniae, a possible role of the host autolytic enzyme LytA in the release of phage progeny 
from Dp-1 infected pneumococci was proposed [94,95]. Nevertheless, those studies were not 
conclusive mainly because the existence of phage-encoded lysins had just begun to be 
unravelled [95] and the majority of the conditions used to specifically address the function of 
the host LytA most likely interfered with that of the phage lysin as well [94,95], since 
pneumococcal phage and bacterial lytic enzymes have vastly common structural and 
functional features [20].  
Given these exceptionally similarities, further insights into the localization, structure and 
biological role of the bacterial autolysin will be presented, as well as an overview of the shared 
properties of the S. pneumoniae phage and bacterial lysins.  
 
3. PNEUMOCOCCAL PHAGE AND BACTERIAL LYSINS 
3.1. CELL WALL  
 
The cell envelope of the pneumococcus, a Gram-positive bacterium, consists of a 
cytoplasmic membrane and a thick outer cell wall lying under the bacterial capsule. Being the 
physical surface of the bacteria the cell wall serves as the anchor for capsular polysaccharides 
(generally covalently bound although the site and nature of the bond remains elusive) as well 
as for a variety of surface proteins [96,97]. It maintains the integrity of the cell against the 
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osmotic pressure. Despite being the major determinant for cell shape the cell wall still has to 
retain certain flexibility since it is involved in key physiological processes such as bacterial 
growth and cell division. 
The cell wall is mainly composed of peptidoglycan (PG), of which the basic structural 
components are long glycan strands (polysaccharides) consisting of alternating N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues, bound by β-1,4 
linkages, and small peptides (tri, tetra and pentapeptides) (Fig.I.8) [97-99]. The peptides are 
linked by the N-terminal region to the glycan strands through the carboxylic group of MurNAc 
and consist of alternating L and D amino acids, with a pentapeptide corresponding to the 
sequence L-alanine, D-isoglutamine, L-lysine and two consecutive C-terminal D-alanine residues 
(L-Ala – D-iGln – L-Lys – D-Ala– D-Ala). Adjacent glycan strands can be crosslinked via peptides 
bound (by the L-lysine of a peptide with the D-alanine of another peptide) directly or by short 
dipeptide bridges containing L-serine and/or L-alanine (L-Ser – L-Ala or L-Ala – L-Ala) (Fig.I.8 and 
I.10) [97-99]. Generally, the composition and degree of crosslinking seem to be highly specific 
of each S. pneumoniae strain [97,99,100]. For instance, a preponderance of indirectly 
crosslinked components was demonstrated in several penicillin-resistant clinical isolates [99], 
with the penicillin-resistance of strain Pen6 highly correlated to the preferential incorporation 




Figure I.8. Structure of the pneumococcal cell wall. The cell wall is built up by several layers of peptidoglycan, 
forming a dense network. Other constituents include cell wall teichoic acids (WTA) and lipoteichoic acids (LTA), 
proteins and polysaccharides. Peptidoglycan strands consist of alternating N-acetylglucosamine (G) and N-
acetylmuramic acid (M) molecules and are linked to each other through peptides (attached to M) connected directly 
or via short dipeptide bridges. WTAs are attached to the M residues by an unknown linkage and LTAs are bound to 





The biosynthesis of the peptidoglycan starts at the cytoplasm with the intracellular 
synthesis of lipid II, the linear muropeptide precursor (GlcNAc-MurNAc-pentapeptide) 
anchored on the membrane through a carrier lipid, followed by its processing with the 
addition of L-Ser – L-Ala or L-Ala – L-Ala dipeptide branch to the L-lysine of the muropeptide 
(Fig.I.9). The completed precursors are then transferred from the cytoplasm across the 
membrane onto the bacterial surface and extracellularly assembled to form the 
macromolecular PG. The polymerization of the glycan strands is mediated by a 
transglycosylation reaction and the covalent linkage of peptides of close proximity among 
neighbouring glycan strands (between the D-alanine of one peptide and the L-lysine of 
another) by a transpeptidation reaction (Fig.I.9). The transglycosylation and transpeptidation 
biosynthetic reactions are carried out mainly by the penicillin binding proteins (PBPs), that are 
also the major targets of β-lactam antibiotics [97,102,103]. Expression of low affinity 





Figure. I.9. Peptidoglycan synthesis. Lipid II is composed of N-acetylated disaccharide units of N-acetylglucosamine 
(G) and N-acetylmuramic acid (M) with the pentapeptide chain attached to the M residues. Lipid II is anchored on 
the cytoplasmic membrane through a carrier lipid (ziz-zag line). The addition of a L-serine or L-alanine residue to the 
L-lysine in the pentapeptide is followed by the addition of an L-alanine to complete the dipeptide branch. 
Attachment of the completed precursor to the preexisting cell wall occurs on the outer surface of the cytoplasmic 




Another important group of surface polysaccharides, embed in the cell wall of all 
pneumococci, comprises the structurally related cell wall-bound teichoic acid (WTA) and the 
membrane-associated lipoteichoic acid (LTA) (Fig.I.8) [97,98,104]. The teichoic acid (TA) 
backbone is common to both WTAs and LTAs and consists basically of a repeating unit that 
includes two N-acetylgalactosaminyl residues (GalNAc) [104]. Due to their characteristic 
attachment sites on the pneumococcal surface the two teichoic acid derivatives only differ in 
one structural property: while WTA is covalently linked by an unknown linkage unit to the 
MurNAc residues of the peptidoglycan, the incorporation of LTA into the bacterial membrane 
is achieved through a terminal lipid-anchor [97,104]. As they are negatively charged, TAs are 
partially responsible for the negative charge of the cell surface [105].  
A characteristic feature of S. pneumoniae is the unusual presence of the aminoalcohol 
choline in its cell wall [106]. Choline is incorporated as phosphorylcholine (PCho) into WTA and 
LTA [98,104,107,108] and, depending on the particular S. pneumoniae strain, up to two PCho 
residues can be covalently linked, via GalNAc residues, per repeating unit of the teichoic acid 
backbone [104,109,110]. The biosynthesis of cholinated teichoic acids is a cooperative 
interplay of several parallel enzymatic reactions only partially known. While the teichoic acid 
precursor backbone is intracellularly assembled, choline has to be taken up from the 
extracellular environment, processed within the cell and ligated, as PCho, to the teichoic acid 
precursor backbone, apparently before the cholinated teichoic acid can be flipped across the 
membrane and connected to the peptidoglycan scaffold of the cell wall [97,111]. It was 
proposed that teichoic acid precursors without choline moieties are not transferred to the 
outer surface of the membrane [111]. Pneumococci are not able to synthesize choline and a 
potential exogenous source in the in vivo environment could be the degradation of 
phospholipids by appropriate enzymes to free choline, since phosphorylcholine does not fulfil 
the nutritional requirement of S. pneumoniae [97,112].  
Although choline can also be found on the surface of few other respiratory tract 
pathogens, including streptococcal species (e.g. S. oralis and S. mitis) [113-115], S. pneumoniae 
has a unique dependence on choline for growth [97,112,115]. It was suggested that the 
biosynthesis of peptidoglycan and teichoic acid is interdependent in pneumococci since the 
synthesis of PG, which is the basis of cell growth, was inhibited by choline deprivation [116]. 
The carrier lipid intermediate may be shared by precursors of peptidoglycan and teichoic acid 
units, i.e TA may be also synthesized in linkage to the carrier lipid, and it is likely that only 
cholinated TA is transferred across the membrane [97,111]. Thus, teichoic acid units lacking 
the PCho residue would not be transfer but remain attached to the carrier lipid making this 
important lipid unavailable for the transport of the muropeptides precursors to the outer 
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surface of the membrane resulting in the inhibition of cell wall synthesis and bacterial growth 
[111,117].  
The nutritional requirement for choline can be fulfilled in vitro by other amino alcohols 
[118,119] however, choline is absolutely required for normal physiological properties 
[109,118,120]. S. pneumoniae strains growing in medium in which choline has been replaced 
by the structural analogue ethanolamine show numerous abnormalities including formation of 
long chains due to block of cell separation at the end of cell division, inhibition of stationary 
phase lysis (autolysis), inability to undergo genetic transformation and resistance to 
bacteriophage infection [118]. Phosphorylethanolamine is incorporated into LTA and WTA in 
place of phosphorylcholine, but it cannot fully replace phosphorylcholine functionally 
[118,121]. 
Choline was also shown to be necessary in many stages of pneumococcal virulence 
[109,122,123]. For example, in a recent study, the absence of choline in the cell wall was 
demonstrated to inhibit the bacterial capacity to adhere to human nasopharyngeal cells and to 
completely block invasion [123]. Furthermore, the bacterium was rapidly eliminated from its in 
vivo habitat (nasal passages of mice) and its virulence in both the intraperitoneal and 
intravenous models was dramatically reduced [123]. The relevant properties for virulence 
were definitely associated with choline as exposure to this molecule resulted in rapid reversion 
in vivo and in vitro to the choline-dependent phenotype [123].  
The demonstrated role of choline in pneumococcal physiology and virulence can mainly 
be attributed to choline functioning as a specific attachment site in the cell wall for a versatile 
family of noncovalently bound choline binding proteins (CBPs) (Fig.I.8 and I.13) [20,124] that, 
besides their contribution to virulence (section 5.2) play diverse and crucial roles in bacterial 
physiology including the cell wall hydrolases (see below a more detailed description of cell wall 
hydrolases biological roles and importance in pathogenesis). Also, the trimethylamino group of 
choline residues carry a net positive charge at physiological pH and the absence of these 
molecules may cause profound and multiple biochemical and structural disturbances at the 
pneumococcal surface. Choline also interacts directly with the platelet activating factor 
receptors of host cells promoting pneumococci adherence [125].  
 
3.2. BACTERIAL CELL WALL HYDROLASES  
 
For bacterial cell growth, the cell wall must be continuously restructured. PG synthesis 
requires degrading preexistent cell wall for the attachment of new constituent molecules, 
without compromising its structural integrity [105]. This requires the action of cell wall 
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hydrolases (CWHs), which are enzymes that specifically cleave covalent bonds of the cell wall. 
When this unregulated hydrolyzing activity weakens the cell wall making the cell unstable and 
sensitive to osmotic pressure, these enzymes eventually cause the lysis and death of the 
bacteria and, as such, are designated lysins, autolysins or lytic enzymes [20,105]. 
Consequently, the term autolysin may not include all cell wall hydrolases.  
These enzymes show substrate specificity, related to their interaction with the insoluble 
cell wall substrate, and bond specificity, which determines the site of action. Based on the 
bond specificity, that is, the type of bond hydrolyzed, CWHs are classified as: (i) glycosidases, 
including β-N-acetylmuramidases (or lysozymes) and β-N-acetylglucosaminidases, which 
hydrolyze the β-1,4 glycosidic bonds between GlcNAc and MurNAc residues of the glycan 
strains (lysozymes, between MurNAc and GlcNAc and glucosaminidases, between GlcNAc and 
MurNAc), and transglycosylases that cleave the same bond that lysozymes but by a different 
reaction mechanism (ii) amidases, that cleave the amide bond between the MurNAc on the 
glycan strands and the first amino acid L–alanine of the peptides of the cell wall and (iii) 
endopeptidases, that hydrolyze with different specificities within the peptide chains of the 
peptidoglycan [20].  
The bacterial CWHs identified and ubiquitously present in S. pneumoniae include an 
amidase LytA, N-acetylmuramoyl-L-alanine amidase [98,126,127], and two glycosidases, LytC, a 
β-N-acetylmuramidase (lysozyme) [128], and LytB, a β-N-acetylglucosaminidase (Fig.I.10) 
[129,130]. In addition, phosphorylcholine esterase Pce (or CbpE), which does not target the 
peptidoglycan but removes phoshorylcholine residues from TAs remodelling the distribution of 
these residues, is also a pneumococcal CWH (Fig.I.10) [131-133]. Moreover, an endopetidase 
function seems to be associated with the recently identified cell wall hydrolase CbpD [134].     
Besides their role in synthesis and repair of the cell wall, bacterial CWHs, due to their 
hydrolyzing activity, participate in a variety of fundamental biological functions. LytA is 
encoded by the lytA gene and it is a 318 amino acid protein with a predicted molecular mass of 
36.5 kDa [20]. Early studies focusing on its function reported a contribution to the separation 
of daughter cells at the end of cell division [135-137]. In the absence of LytA activity, 
pneumococcus grows normally but forms small chains (6 to 8 cells in length) [136]. However, 
LytA’s key function is being the major pneumococcal autolysin [129,135,136], representing the 
first example of a bacterial autolytic gene that was cloned and expressed heterologously 
[138,139]. As a potent lytic enzyme [129], it has significant roles in several processes such as 
self-induced lysis (autolysis) in the stationary phase of growth [135-137,140], competence 
development during genetic transformation [141,142] and in the irreversible bacteriolytic 
effects of β-lactam antibiotics [135-137,140,143]. It should be noted that the property of bile 
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or deoxycholate (DOC) solubility, used to differentiate pneumococci from other streptococci, is 






Figure I.10. Schematic representation of the pneumococcal cell wall and the bonds cleaved by the different CWHs 
LytA, LytB, LytC and Pce. Only two layers of the PG are represented. The bond between peptides (in this case 
tetrapeptides) is symbolized by two amino acids. G, N-acetylglucosamine; M, N-acetylmuramic acid.  
 
 
Interestingly, a mutant lacking lytA (M31) displays another autolytic activity in the 
stationary phase which has been ascribed to LytC [128,129]. This enzyme shows higher activity 
when incubated at 30ºC but still lower compared to that of LytA at 37ºC (LytA’s optimum 
temperature) [128,129]. A minor lytic function in the response to β-lactam antibiotics might 
also be attributed to the lysozyme [143]. 
Although LytB has glucosaminidase activity, its in vitro degradation rate of choline-
containing cell walls is rather low, in remarkable contrast to LytA and also very distinct from 
LytC [129]. Consequently, it is considered a nonautolytic hydrolase of pneumococcus. This was 
unequivocally demonstrated when inactivation of the lytB gene did not affect total cell wall 
hydrolytic activity in the stationary phase of growth and, most importantly, no lysis was 
observed at either 30ºC or 37ºC in the absence of both LytC and LytA activities [129]. 
Nevertheless, LytB has a central role in the physical separation of daughter cells, the final 
event of the cell division cycle [129,130]. Indeed, inactivation of the lytB gene in M31 led to 
the formation of long chains with more than 100 cells [129,130]. This enzyme was found to be 
localized at the cell poles on the pneumococcal surface which might be indicative of this 
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critical role [129]. Also concordant, transcription of lytB, similar to lytA, is high during the 
exponential phase of growth and decays as the culture enters the stationary phase [20].     
 
3.2.1. AUTOLYSIN LytA CELLULAR LOCALIZATION 
   
As mentioned before, all pneumococcal cell wall hydrolases are CBPs [124,144], therefore 
located at the cell surface [128,129,132,145] and dependent on choline binding for activity. 
Indeed, in fractionation assays, LytA was detected in the cell walls [127] and also appears 
associated with the membrane [146,147]. The surface exposed protein accounts for the 
majority of LytA in cells although, an appreciable amount occurs in the cytoplasmic fraction 
[146-148]. This is consistent with the reported interaction with both WTA [121,149] and cell 
membrane-linked LTA [146]. It should be noted that in intact cells, though LTAs are attached to 
the cell membrane, they are not entirely physically separated from the peptidoglycan as they 
can branch into it and therefore become embedded within the structure. Thus, LytA is 
considered to be cell wall localized.      
Accordingly, when ethanolamine was used instead of choline in the growth medium, LytA 
was totally cytoplasmic [146]. Additionally, as a cell surface exposed protein and due to its 
noncovalent binding to choline, LytA can be released from the cell surface by 2% choline 
[146,149,150]. Even though in a few studies the effectiveness of this process was questioned 
[151,152], it was also demonstrated in parallel assays that the efficiency of removal of another 
CBP by the same method was dependent on the strain, varying considerable between different 
capsular types [151]. More importantly, LytA has been located in an external position, 
predominantly target to the equatorial growing regions of pneumococci (septum at the 
midcell) being present also at the cell poles (Fig.I.11A) [145]. It was also bound to the outer 
periplasmic face of the inner cytoplasmic membrane when synthesized in E. coli (Fig.I.11B) 
[90,145]. It can be inferred that in both homologous and heterologous systems, the activity of 
the enzyme must be regulated, although the nature of the control system in E. coli remains 
fully unknown. In S. pneumoniae, the activity of the enzyme is controlled even in two extreme 
situations such as the hyperproduction of LytA (from inside) [137] or by the addition of the 
enzyme to the culture medium (from outside) [140] however, in both cases, culture lysis takes 
place shortly after cells enter the stationary phase in contrast with the normal lysis observed 
late in stationary phase.  
In order to reach the peptidoglycan, LytA must be translocated to the outside of the cell. 
Surface proteins of Gram-positive bacteria, including cell wall hydrolases are usually targeted 
for secretion from the bacterial cytoplasm by N-terminal signal sequences [60,153,154]. The 
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signal sequence allows export across the cytoplasmic membrane by the general secretion Sec 
pathway, a ubiquitous and essential transport system in every bacterium [155]. This system is 
well characterized in E. coli, consisting basically of a membrane-spanning translocase channel 
SecYEG (composed of the membrane integral proteins SecY, SecE and SecG) and SecA, that 
binds to cytoplasmic precursor proteins destined for export and delivers them to the 
translocase (through its ability to bind both membrane phospholipids and the translocase 
itself) and is also an ATPase that provides energy for translocation. Through repeated cycles of 
ATP binding and hydrolysis, SecA undergoes conformational changes that drive stepwise 
export of a precursor protein through the translocase and across the membrane. During or 
immediately after transport, the signal sequence is cleaved off from the precursor by a signal 
peptidase and the resulting mature exported protein then folds into its final conformation 
[156,157]. It was very recently described that some Gram-positive bacteria, including 
Streptococcus species, have additionally an accessory Sec pathway with an accessory SecA 
protein called SecA2 [154,158-160]. Like SecA, this protein also has an ATPase activity but is 
generally not essential for cell viability [156,158,161,162]. Besides the systems that seem to 
only encompass SecA2, others also contain an accessory SecY2 like in Streptococcus gordonii, 
Streptococcus parasanguinis and Streptococcus agalactiae [156,160,161,163]. This 
streptococcal SecA2/SecY2 system includes as well at least three accessory secretion proteins 
[156,160]. Interestingly, the secA2 locus in S. pneumoniae exhibits the same conserved genes 









Figure I.11. Immunochemical localization of the pneumococcal amidase in intact cells of S. pneumoniae and in 
ultrathin sections of E. coli. S. pneumoniae strain M51 grown in medium containing choline (A) or ultrathin sections 
of E. coli (B) were labelled with anti-amidase serum. Bars represent 0.5 μm. From [145]. 
 
 
In remarkable contrast to all other CWHs (LytB, LytC and Pce) identified in pneumococcus 
[20,128,129] and the large majority of CBPs [124], LytA does not have a signal peptide (Fig.I.12) 
[145]. Other sequence signals, besides the canonical signal peptide, or motifs associated with a 
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surface localization, including the cell wall anchoring motif LPXTG [165], were not found. In 
Staphylococcus aureus a holin-like protein that increases CWH activity was suggested to also 
assist their transport [166] however, such a protein has not been found in S. pneumoniae. 
Additionally, a zinc metalloprotease, ZmpB, was proposed to control translocation of LytA to 
the surface possibly by proteolytic release of LytA from the intracellular complex with protein 
CinA [167]. Nevertheless, this assumption was not reproducible by an independent study. 
Strain contamination was suggested since the mutant strain used before was not identified as 
S. pneumoniae and differed from its parent strain in several aspects [168]. Consequently, the 
mechanism of transport of LytA through the membrane to reach the peptidoglycan substrate 
remains an open question.  
 
3.3. LYTIC ENZYMES PHAGE-BACTERIAL INTERRELATIONSHIP 
3.3.1. DOMAIN ORGANIZATION 
 
The lysins that phages encode to release their progeny from infected cells through 
degradation of the bacterial peptidoglycan are also cell wall hydrolyzing enzymes [56]. Two 
different classes of lytic enzymes have been found in pneumococcal phages. All of the reported 
lysogenic phages (HB-3, MM1, EJ-1, VO1 and SV1) as well as the lytic phages Dp-1 and ω-2 
possess amidases [24,25,36,169-171], whereas phages belonging to the Cp family encode 
lysozymes [24,172,173]. 
The phage lytic enzymes found so far in the pneumococcal system are strikingly related to 
the lytic enzyme LytA of the bacterium [18,20]. All these enzymes can only hydrolyze cell walls 
that contain choline in their teichoic acids, with the unique known exception of the lysozyme 
Cpl-7 from the pneumococcal phage Cp-7 [18,98,121,149,169,173]. The first experimental 
evidence showing that a pneumococcal phage lysin depended on the presence of choline for 
activity (in vivo and in vitro) came from the characterization of the Cpl-1 lysin encoded by the 
phage Cp-1 [172]. Comparative analysis between this phage lysozyme and the host amidase 
LytA revealed extensive sequence similarities in the C-terminal regions of both proteins, 
whereas the respective N-terminal regions were completely different [174]. As both enzymes 
shared the choline absolute requirement for activity [118,149,172], it was suggested that the 
pneumococcal autolysin and the lytic enzymes of its phages have two independently functional 
domains, the C-terminal domain (choline binding domain, CBD) involved in the specific binding 
to the choline residues contained in the cell wall of pneumococci (i.e. substrate recognition), 
whereas the N-terminal conferring the specificity for the catalytic activity (Fig.I.12) [174,175].  
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Further experimental support for this hypothesis was achieved with additional research 
on several new phage lytic enzymes [18,169,173,176]. The remarkably high nucleotide identity 
among these phage enzymes and to the host LytA reflected the common features shared 
between them, with the maximum value of identity of 87% when comparing lytA and hbl from 
HB-3 temperate phage (and 90% between amino acid sequences), both encoding a choline-
dependent amidase activity [169,176]. Based on this nucleotide identity, lytA was and can still 
be used as a probe in hybridization experiments to detect lytic genes in phages [15,169]. In 
addition, the lysozyme encoded by the pneumococcal phage Cp-7 contains an N-terminal 
domain similar to that of the Cpl-1 lysozyme but a completely different C-terminal domain 
from that of the rest of the enzymes (Fig.I.12) [173]. As a result this enzyme was shown to 
maintain the lysozyme activity but, as mentioned before, does not require binding to choline 
for degrading pneumococcal cell walls [92,173].  
Moreover, the construction of functional chimeric lytic enzymes [175,177-180], as well as 
the independent functional expression of the two domains [177,181,182] allowed to further 
establish the role of each of these domains. For instance, the C-terminal domain of the 
pneumococcal amidase when independently cloned and produced in E. coli is able to bind 
choline but is unable to hydrolyze cell walls [177]. Fusion proteins generated using individual 
functional modules of bacterial and phage origins (chimeras) were able to hydrolyze 
pneumococcal cell walls with the activity characteristic of their catalytic modules [175,179]. 
This observation suggested that several module combinations are possible in vivo through 
recombination between phage and bacterial genes since they show high identity 
[175,179,183]. Indeed, the characterization of Cpl-7 [173] and amidase Pal from phage Dp-1 
[171] corroborate this assumption. In the case of Dp-1, the N-terminal region is highly similar 
to the lysins of Streptococcus mitis phage SM1 [184] and Lactococcus lactis phage BK5-T [185] 
whereas the C-terminal region is similar to the pneumococcal choline binding domain 
(Fig.I.12). Thus, the lysin is a natural chimera of intergeneric origin possibly resulting from 
recombination of phage genes from these species [171].  
Studies focused on the choline interaction revealed that, despite the absence of autolysis 
by pneumococci grown in ethanolamine [98,118,121] due to the lack of specific ligands from 
the insoluble cell wall substrate, soluble choline- or ethanolamine-containing muropeptides of 
pneumococcus were hydrolyzed by LytA at similar rates [186]. Furthermore, cell walls isolated 
from choline-independent pneumococcal mutants grown in the absence of any aminoalcohol, 
and lacking either choline or ethanolamine in the TAs, are resistant to degradation by LytA 
[117,120]. It was also observed a complete and rapid hydrolysis when pneumococcal 
peptidoglycan lacking TAs was used as substrate [120]. This is consistent with the observation 
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that cell walls from Gram-negative bacteria such as E. coli, that do not contain either choline or 
TAs, are degraded by LytA when expressed concomitantly with the holin of Cp-1 or EJ-1 
[90,91]. Equally, the expression of entire phage lytic cassettes in E. coli and Pseudomonas 
putida (also a Gram-negative bacterium) revealed that pneumococcal phage lysins (amidases 
and lysozymes) are also able to hydrolyze the intact PG network of these bacteria [90,91]. 
Considering all these studies together, a plausible reason for this ability might be the lower 
structural complexity of the peptidoglycan from Gram-negative bacteria. Presence of TAs 
chains may actually block access of the host and phage lysins to the pneumococcal 
peptidoglycan substrate unless this inhibitory effect is somehow neutralized through an 






Figure I.12. Diagrammatic representation of the structure of S. pneumoniae cell wall hydrolases (host and phage) 
and of other choline binding proteins. LytA, LytC, LytB and Pce are bacterial CWHs and Hbl, Ejl, Mml, Pal, Cpl-1 and 
Cpl-7 are phage-encoded CWHs. PspA and PspC or CbpA are also choline binding proteins (CBPs) but without cell 
wall hydrolyzing activity. The domains containing the active centre of the enzymes are represented for amidase in 
green or purple (in the case of Pal), lysozyme (yellow), pink (glucosaminidase) or violet (phosphorylcholine esterase, 
Pce). The choline binding domain (blue) and the choline binding repeats are also shown. The C-terminal of Cpl-7 is 
coloured in orange. Signal peptides of LytB, LytC and Pce are depicted as small rectangles at the left in the structure. 





Considering the discussed common properties, lytic genes of phages infecting S. 
pneumoniae were cloned in the homologous system to explore the role of these lysins in 
bacterial-mediated lytic events [92]. Pneumococcal cultures are prone to lyse under certain 
physiological conditions without the involvement of a phage-encoded enzyme [135,136], thus 
a mutant deleted in the lytA gene (M31) was used. The expression of either lysozymes (Cpl-1 
and Cpl-7) or amidase (Hbl) in this background restored the bacterial wild-type phenotypes 
[92]. The transformed bacteria underwent extensive lysis in the stationary phase of growth or 
after deoxycholate addition, events ascribed to LytA [135,136,188], and grew as normal 
diplococci instead of forming short chains [92]. Although LytC autolytic activity was not 
inhibited, it contributes little to lysis under those experimental conditions [128,129], so the 
extensive lytic patterns observed could be essentially attributed to the phage enzymes [92]. 
On the other hand, expressing in E. coli the phage Cp-1 holin concomitant with LytA amidase, 
instead of the respective phage lysin, resulted in extensive cell lysis [91]. It then became clear 
that autolysin LytA and S. pneumoniae phage lysins could functionally replace one another.  
The subsequent characterization of the other choline-dependent pneumococcal cell wall 
hydrolases LytB, LytC and Pce revealed that these proteins also display a bimodular 
organization (Fig.I.12). Furthermore, the choline binding domain of the autolysin LytA is, like in 
phage lysins, constituted by six repeated motifs (known as choline binding repeats, CBRs) of 
20-21 amino acids and similar motifs have been detected in other CBPs (Fig.I.12) 
[20,30,170,173,177,178,189]. However, in LytB and LytC, the CBD was unusually found in the 
N-terminal region whereas the active site of the enzymes was localized in the C-terminal 
domain (Fig.I.12) [128,129]. Also, the number of CBRs varies among the CBPs with 10, 11 and 
15 present in Pce, LytC and LytB, respectively (Fig.I.12) [20,128]. Interestingly, LytB is able to 
bind to ethanolamine-grown cells (although the long chains remain uncut) [129], in sharp 
contrast with LytA [145,149]. Additionally, a comparison of the lytic enzymes from Gram-
positive bacteria and their phages did not indicate such a high degree of structural and 
functional similarity as that showed between LytA and S. pneumoniae phage lytic enzymes. 
Still, the modular organization with separate catalytic and cell wall binding domains (targeting 
proteins to the bacterial surface) is a general characteristic of Gram-positive bacteria cell wall 
hydrolases (phage-encoded and bacterial), in which the catalytic activity is almost always 
located in the N-terminal region while the C-terminal part contains the substrate recognition 
and binding domain [190-193]. Indeed, a relationship was reported, based solely on amino acid 
sequence identity, between three different lysins from Bacillus cereus phages, showing 




3.3.2. REGULATORY MECHANISMS 
 
Besides the strict requirement for choline in the teichoic acids to degrade the 
pneumococcal cell wall  [98,149,173], since specific attachment to choline localizes the lysin 
catalytic domain near the peptidoglycan substrate, another interesting property shared 
between pneumococcal phage-encoded enzymes and the host LytA is the intimate 
involvement of choline of TAs in the regulation of the lytic activity at the post-translational 
level [121,126,146,169,170,194,195].   
It is now known that the interaction with choline at the cell surface is crucial for autolysin 
activation [121,126,146,148,189]. In early studies, it was reported the puzzling observation 
that ethanolamine grown pneumococci not only contain LytA resistant cell walls but, in 
addition, the normal autolytic enzyme characteristic of choline-grown bacteria (with high 
catalytic activity, later named the C-form autolysin) is missing from such cells and is replaced 
by one with a low catalytic activity (E-form autolysin), suggesting a more important function 
for choline than just a binding ligand [121,148]. Indeed, choline (TA-bound) could mediate the 
“conversion” in vivo and in vitro of the low active E-form of LytA into the fully catalytically 
active C-form [121,126,146,148]. In addition, the low active E-form of the enzyme was 
detected only in the cytoplasmic fractions of choline-grown pneumococci whereas the 
prevalent C-form was present at the cell surface, since only at the surface are possible the 
interactions between the autolysin and TAs [146,148]. Concordantly, the single E-form present 
in cells grown with ethanolamine was found only in the cytoplasm when investigated in 
different cellular fractions [146]. These findings have been further corroborated by the 
elucidation of the biochemical role of CBRs in conversion, revealing that LytA depends on the 
binding of a minimum of 4 CBRs repeats on the C-terminal domain for enzymatic activity and 
the catalytic efficiency increases directly with the number of repeats involved in the choline 
interaction [30].  
Likewise, choline binding also seems to induce and stabilize the active conformation of all 
the phage lysins of S. pneumoniae studied so far. For instance, the phage lysin encoded by 
phage HB-3 can be converted to a more active form under conditions similar to those 
described for the pneumococcal autolysin [148,169]. Structural and thermodynamic 
characterization of Pal of phage Dp-1 revealed that choline interaction strongly stabilizes the 
cell wall binding module, and the conformational stabilization is transmitted to the catalytic 
region. These structural rearrangements triggered by choline may underlie the in vitro 
“conversion” of Pal from the low to the full activity form [196]. The specific recognition of 
choline by the lysin of phage Cp-1 was also demonstrated to enhance its catalytic activity and 
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the stability of the enzyme [181,195]. Finally, choline induces alterations in the Ejl encoded by 
phage EJ-1 [170] resembling those induced in the bacterial LytA, which have been related to 
increased catalytic efficiency [189]. 
Apart from the converting (activating) capability of the LTA [146], it was also proposed 
that the activity of LytA could be inhibited by the choline-containing lipoteichoic acid 
[126,146,194]. However, the inhibitory role of LTA and the mechanism underlining it are 
unclear. On one hand, Höltje and Tomasz reported that LytA activation is mediated only by the 
pneumococcal choline-containing cell wall teichoic acid because, under the experimental 
conditions used, LTA inhibits the autolysin activity in contrast to WTA [126,194]. On the other 
hand, subsequent studies argued that the LTA inhibitory effect reported previously was due to 
the formation of micelles by LTA in aqueous solution (as LTA contain lipid moieties) preventing 
the access to the substrate of the bound autolysin, since LTA stripped of its lipid moiety lost its 
capacity to inhibit the autolysin to the same extent that it lost its capacity to form the “micelle 
traps” [146]. Still, it was not discarded the possibility that in vivo the LTA could constrain 
autolysin activity. It was suggested that LTA might constitute a topological barrier, similar to 
the in vitro situation when the autolysin is bound to LTA-micelles and is thereby hindered from 
reaching the peptidoglycan substrate [146].  
In similar studies, free choline was shown to interfere with the interaction between 
choline-containing teichoic acids and LytA [127,146,149]. Indeed, high choline concentrations 
(2%) completely inhibit the enzyme in vitro [146,149]. Even in vivo, 2% choline in the culture 
medium leads to phenotypically autolysin-deficient pneumococci [146]. This inhibition was 
attributed to desorption of the enzyme from its substrate by choline [149]. Most likely, it 
occupies the same sites that allow the enzyme to recognize and interact with the teichoic acid-
bound choline [149], explaining the observed release by choline of LytA associated with both 
LTA and WTA [146,149]. Similarly, other choline binding proteins are also dissociated by 
choline [151].  
Curiously, free choline and lipoteichoic acid also inhibited the activity of the Cp-1 phage 
lysin Cpl-1 [172], tested in vitro essentially according to the method of Höltje and Tomasz 
[194]. Therefore, the activity of Cpl-1 might be hindered by LTA as proposed for LytA, although 
the physiological relevance of this putative regulation still remains an open question since 
pneumococcal phage lysins are generally believed to be cytoplasmic (thus, their activity would 
be physically hampered until holins set the time of lysis).  
Since the autolytic LytA enzyme plays important roles in complex physiological processes 
(such as cell wall enlargement and cell division) and its cell wall hydrolyzing activity is 
potentially lethal to the bacterial cell, it is understandable that a variety of control strategies 
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exist. Other than the direct interactions with TA-choline, the teichoic acid phosphorylcholine 
esterase could offer an additional potential regulatory mechanism through the removal of a 
critical set of phosphorylcholine residues from either the cell wall teichoic acid or from the 
lipoteichoic acid, which is also a substrate for the esterase [131]. The selective removal of a 
fraction of choline residues by this enzyme is likely to create autolysin resistant regions in the 
cell wall. In the same way, the potential inhibitory influence of lipoteichoic acid may be 
affected by the removal of phosphorylcholine residues [194]. As far as the expression of the 
lytA gene is concerned, characterization of the transcript of the autolysin did not reveal the 
presence of putative transcriptional or translation regulatory structures [197]. Although lytA is 
constitutively expressed during the exponential phase of growth [197,198], more recently a 
distinguishable transcriptional regulation of lytA was described during competence 
development with higher expression of the autolysin. lytA is located in a competence-induced 
operon being cotranscribed under competence conditions with recA [198-200]. 
Other levels of LytA regulation at the cell surface may include the energy status of the 
cytoplasmic membrane [90], paralleling what happens in other Gram-positive bacteria. It was 
described that the bacteriocin-induced lysis of some Lactococcus and Lactobacillus strains is a 
consequence of bacteriocin-induced depletion of cellular energy [201]. Moreover, it is known 
that pmf-dissipating agents are able to trigger lysis in Bacillus subtilis [202,203]. It is worth 
noting that, despite two main bacterial lysins (the amidase LytC and the putative 
endopeptidase LytE) having been implicated in cell lysis triggered by energy poisons, the major 
B. subtilis glucosaminidase LytD, also a secreted enzyme, appears not to participate in this 
response [204,205]. This set of data therefore suggests that whereas some enzymes respond 
to pmf-dissipating factors, others have their activity stimulated in different ways, still 
unknown, even within the same species. Whether the control of the pneumococcal autolysin 
activity depends on an energized membrane remains to be determined.  
 
4. LYSIS IN S. PNEUMONIAE 
 
Besides phage-mediated host lysis, S. pneumoniae also undergoes lysis mediated by its 
own autolysin LytA under several physiological circumstances [135,136,141], as mentioned 
earlier. For instance, it has been consistently observed the self-induced lysis (autolysis) in vitro 
in the stationary phase of growth [135-137,140]. Direct experimental evidence for the 
essential role of LytA in this autolytic event was provided by studies with autolysin defective 
pneumococci [135,136], where restoring the enzyme reverted the cells to the wild-type 
phenotype of stationary phase lysis [137,140]. Although autolysis has also been reported for 
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other bacterial species, the extensive lysis caused by LytA in this stage is a unique feature of S. 
pneumoniae. However, how and why autolysin control is relieved remains unknown. It was 
suggested that it could be an advantage for pneumococcal survival under prolonged periods of 
nutritional deprivation, serving the contents of the lysed cell as a nutrient source, since in a 
fully lytic culture it was observed that some viable cells remain for a considerable amount of 
time while in a lytA mutant derivative of the same strain there were no long-term survivors, 
even though there was no culture lysis in the stationary phase [206].              
Bacterial lysis mediated by LytA has also been implicated in competence to undergo 
genetic transformation [141,142]. Competence, the ability of cells to take up free DNA from 
the surrounding medium, is a transitory property in S. pneumoniae which develops suddenly 
during the early exponential phase of growth [141]. During the development of this process, 
release of transforming DNA was repeatedly observed [141,207]. It was proposed that the 
competence-induced liberation of DNA from the cytoplasm to the medium is mediated by 
LytA-dependent cell lysis (autolysis), since lytA mutants have significantly less amount of DNA 
available in the medium, and that it occurs in a subfraction of the actively growing bacterial 
population where the majority of cells acts as a recipient of the DNA from the medium [141]. 
Other more recent studies reported that competence-induced pneumococci lysed 
competence-deficient cells during cocultivation (allolysis) [142,208,209]. LytA of competent 
attackers is also important in this process and in noncompetent target cells LytA can as well be 
trans-activated by competent cells [142,152,208]. Even though, allolysis promotes DNA 
release, it was not ruled out that autolysis could operate simultaneously [142].  
Besides cell-regulated processes, it is known that β-lactams trigger pneumococcal LytA-
mediated lysis [135,136,140,210]. These compounds inhibit the transpeptidase activity of cell 
surface localized PBPs and consequently cell wall synthesis in growing cells resulting in arrest 
of bacterial growth (bacteriostatic response). Additionally, inhibition of PG synthesis also leads 
to uncontrolled activity of LytA which inevitable ends up in cell lysis (bacteriolytic response) 
[206,210]. The mechanisms connecting the interaction of β-lactam with its PBP target and LytA 
activation are not known despite clues about some factors involved exist. For instance, besides 
cell lysis, cell death is also induced by penicillin independently of LytA involving the putative 
Cid protein and this protein was implicated in triggering LytA activity [211]. A model for S. 
pneumoniae penicillin induced-lysis via Cid was speculated resembling the phage classical 
holin-endolysin mechanism of host lysis assumed for pneumococcal phages. Normally, the Cid 
protein would operate at the cytoplasmic membrane providing a mechanism of controlled 
transport of LytA to the pneumococcal cell wall, which guarantees negative regulation of its 
activity at the cell surface. When performing this physiological function, Cid would exist in low 
GENERAL INTRODUCTION 
32 
numbers per cell being the cid gene under precise control. However, a substantial antibiotic-
induced increase in the number of copies of this protein would be toxic for the bacterium. At a 
higher cell concentration, Cid would assume a holin-like function injuring the cytoplasmic 
membrane, probably by increased permeability, causing not only cell death due to loss of 
membrane integrity but allowing the release from the cytoplasm to the cell wall of large 
amounts or unregulated forms or even both of the autolytic enzyme [211]. However, the 
gene(s) responsible for the cid phenotype were not yet identified. Curiously, in subsequent 
studies it was demonstrated that the CidA protein of S. aureus is actually a phage holin-like 
protein that controls cell death and lysis forming membrane lesions [212]. Accordingly, CidA 
has a positive effect on cell wall hydrolase activity and results in an increased sensitivity to 
penicillin-induced killing [166]. Still, the mechanisms through which this membrane 
disturbance triggers the activity of bacterial cell wall hydrolases activity are unknown.      
Notably, bacterial lysis is associated with the S. pneumoniae pathogenic potential. Thus, 
its role, including in the context of biofilms, will be further discussed.  
 
5. LYSIS AND PNEUMOCOCCAL VIRULENCE  
5.1. PNEUMOCOCCAL VIRULENCE  
 
S. pneumoniae is usually found as a commensal organism in the human host colonizing 
asymptomatically the nasopharynx of healthy individuals [3,213,214]. Although multiple 
pneumococcal serotypes can be carried in the nasopharynx, some of the most common 
serotypes isolated from carriage are also those serotypes most commonly associated with 
invasive disease [2]. This, together with the observation that disease most likely occurs by a 
serotype that recently colonised the host [215] strongly suggests that carriage is the first step 
in the ability of the pneumococcus to cause infection. For dissemination from the nasopharynx 
to other parts of the host (e.g. middle ear, lung, brain), S. pneumoniae must cross tissue 
barriers and be able to adapt to different environments within the host. Despite the precise 
mechanisms being unclear, this transition into invasive pathogen is a complex process that 
involves several bacterial virulence determinants. Also, host factors clearly play a role in the 







5.2. IMPORTANT VIRULENCE FACTORS 
5.2.1. POLYSACCHARIDE CAPSULE  
 
The polysaccharide capsule, that covers the cell surface of the pneumococcus, is 
considered one of the most important factors in its ability to cause infection [20,217,218].  In 
fact, nonencapsulated strains are rarely isolated from patients and have greatly reduced 
virulence (being considered mostly avirulent) compared to the respective encapsulated 
counterparts [3,217,219]. The capsule is important during invasive infection, presumably 
because it confers protection to the bacterium from phagocytosis by blocking the opsonization 
directed against cell surface antigens [20,217,218,220]. Despite the diversity of the capsular 
polysaccharides (more than 90 different capsular serotypes are known so far [6-9]), all perform 
this same primary function even though different capsular types differ in their resistance to 
phagocytosis [220]. As a highly immunogenic material, it elicits a large immune response and 
as a consequence of compromised phagocytic clearance, the increase in these responses 
causes even more tissue damage at the infection site, which may facilitate further invasion 
[218].  
Furthermore, studies have shown that the capsule is not only important in disease but for 
colonization as well [221,222]. Due to the presence of a capsule, pneumococcus is able to 
escape from entrapment in the mucus thus, is more likely to transit to the epithelial surface 
where stable colonization occurs [221]. It also appears that the capsule interferes with the 
formation of biofilms, the preferred growth modality of S. pneumoniae during colonization 
[223]. 
 
5.2.2. SURFACE PROTEINS 
 
The bacterial surface also plays a major role during pneumococcal disease, as it 
represents the interface on which the cell interacts with the host. Many pneumococcal 
virulence factors are indeed located in the cell surface including choline binding proteins 
(Fig.I.13). For example, choline binding protein A, CbpA (also known as SpsA, Streptococcus 
pneumoniae secretory IgA binding protein, and PspC, pneumococcal surface protein C), the 
most abundant choline binding protein [224], has been shown to be involved in adherence to 
endothelial cells and lung epithelium [224,225], which is probably related to its observed role 
in colonization [224,226,227] and invasion of the lung tissue in vivo [226,228].  
Likewise, mutants lacking PspA (pneumococcal surface protein A), another cell surface 
exposed CBP, are attenuated in animal models [229]. In invasive infections, it was proposed 
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that the protein exerts its virulence function by interfering with complement-dependent host 
defense mechanisms. By inhibiting complement deposition and activation on the bacterial 
surface, it reduces the effectiveness of clearance [230,231]. On the other hand, PspA might act 
by a very different mechanism in mucosal carriage, where complement concentrations are 
especially low [232]. It has been suggested that S. pneumoniae may use PspA to overcome the 
iron limitation at mucosal surfaces, since it binds human apolactoferrin (the metal-depleted 
form of lactoferrin) [233,234], an iron chelating protein which can deplete this metal and 
restrict bacterial growth protecting the host from bacterial infections by prevention of 
colonization [235]. Besides its bacteriostatic activity, apolactoferrin is also bactericidal against 
S. pneumoniae [236,237]. Interestingly, PspA binding to apolactoferrin was found to offer as 







5.2.3. PNEUMOLYSIN  
 
The pneumolysin (Ply) is the major pneumococcal toxin functioning outside the bacterial 
cell [3]. It is present in almost all isolates that cause infection [238]. This toxin is believed to 
have multiple functions in virulence as it possesses both cytotoxic and proinflammatory 
properties [3]. Pneumolysin binds to cholesterol in host cell membranes inducing lysis and 
apoptosis by forming transmembrane pores [3,217,238]. This allows the access of the 
pneumococcus to tissues where it proliferates and initiates inflammatory responses [238]. For 
instance, by disrupting the blood-brain barrier, this toxin may play a crucial role in 
bacteraemia. In fact, absence of Ply function delayed bacteraemia in animal models [239]. At 
sublytic concentrations, Ply also has several effects namely it stimulates the production of 
inflammatory cytokines such as tumour necrosis factor-α and interleukin-1β [240], decreases 
Figure I.13. Some of the major pneumococcal virulence factors. 
Those include the polysaccharide capsule, pneumococcal 
surface proteins including choline binding proteins such as LytA, 
cell wall fragments and pneumolysin (Ply). The CBPs LytB and 
LytC are also represented even though their roles in 
pathogenesis are not yet fully understood. Lysis by LytA releases 




the bactericidal activity and migration of neutrophils [241] and activates the classical 
complement pathway [242] thereby causing inflammation tissue damage. 
 
5.2.4. CELL WALL HYDROLASES  
 
The cell wall hydrolases LytB, LytC and Pce (Fig.I.13) were recently associated to 
pneumococcal pathogenesis although their roles are still poorly understood [130,132,243]. 
Despite these proteins having no effect on virulence in a model for pneumococcus-induced 
sepsis, loss of function of these proteins in rat models reduced significantly colonization of the 
nasopharynx [243]. For LytC and Pce, this can be attributable to the observed reduced 
adherence to nasopharyngeal cells at 30ºC [243] since the temperature in the nasopharynx is 
usually lower than the normal body temperature of 37ºC. Interestingly, LytC is a minor lysin in 
vitro with higher activity at 30ºC [128] and this is also consistent with a potential role on 
colonization. On the other hand, LytB is fundamental for pneumococcal cell separation 
[129,130] and it has been proposed that bacterial chain formation limits the dissemination of 
the bacteria during colonization and infection and the increased target size of pneumococcal 
chains may increase the efficiency of phagocytosis in eliminating the bacteria [20,123,130].  
 
5.3. BACTERIAL LYSIS  
 
Lysis by LytA of pneumococci has been strongly implicated in pneumococcal pathogenesis 
[226,239,244,245]. Indeed, S. pneumoniae strains without functional LytA showed in vivo 
reduced virulence relative to that of the wild-type strain [244,245] and mice immunized with 
purified autolysin survived significantly longer than nonimmunized mice after exposure to a S. 
pneumoniae virulent strain [244]. Additionally, it has been shown that the absence of LytA 
alters the course of pneumococcal disease [239], but it were also reported minor differences in 
mice survival time upon infection with pneumococcal strains lacking LytA activity relative to 
the wild-type strains [135].  
One of the direct implications is the release upon lysis of cell wall components, including 
peptidoglycan fragments and teichoic acids, that were demonstrated to elicit strong 
inflammatory responses during infection [3,246-248]. Lysis-induced inflammation seems to 
contribute to tissue injury [249], which may thereby increase permeability of host barriers and 
contribute significantly to the severity of the infection. In fact, in an animal model of S. 
pneumoniae meningitis, treatment with a nonbacteriolytic antibiotic resulted in the release of 
smaller amounts of teichoic acids [250] and in a decrease of mortality [251].       
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It has also been suggested that LytA-induced lysis influences pneumococcal pathogenesis 
by releasing intracellular virulence factors [3]. In vitro, lysis induces the release of pneumolysin 
in the stationary phase and during competence development (Fig.I.13) [208,244,252]. A 
functional link between lysis and pneumolysin was also established in vivo based on the 
observations that mutants deficient in production of both Ply and LytA were no less virulent 
than strains carrying either Ply or LytA alone [245], and the level of protection in mice 
immunized with autolysin or pneumolysin were shown to be similar with no detectable 
additional protection occurring in animals immunized with both proteins [253]. However, the 
interplay between LytA and pneumolysin is controversial. Even though it was thought that the 
extracellular presence of Ply was only due to autolysin-induced lysis, significant amounts of Ply 
were observed to be released from pneumococci during log-phase growth when lysis is not 
evident [252]. The lysis requirement for this process was questioned when the pattern of Ply 
release during exponential phase in the absence of LytA or in the presence of 2% choline (that 
suppresses lysis) was shown to be similar to that of the wild-type strain or in growth in normal 
choline concentrations [252]. Accordingly, under some infection conditions, mutations in 
pneumolysin and autolysin had different effects on virulence [252]. In addition, in a 
subsequent study it was shown a cell wall localization for Ply [254]. Nevertheless, although the 
exclusive lysis-dependent release of Ply has been disbelieved [252,254], in those studies when 
cell lysis does occur a large quantity of Ply is made available extracelullarly in culture 
supernatants [252,254]. In agreement, reduced release of Ply in vivo and in vitro was detected 
upon the use of nonbacteriolytic antibiotics in comparison to a bacteriolytic antibiotic [255]. 
More recently, it was proposed that bacterial fragments generated during autolysis 
prevent the phagocyte-mediated elimination of live pneumococci, a property frequently 
associated with the pneumococcal capsule [256]. Although less studied, LytA-induced lysis 
could also influence virulence by providing DNA for genetic exchange. Indeed, in vitro DNA 
release was observed both in competence and in stationary phase [207,208,257]. It is possible 
that through this process bacteria could acquire properties more favorable to persistence in 
the host during colonization or that play a role in infection or in antibiotic resistance [257,258]. 
 
5.4. LYSIS IN PNEUMOCOCCAL BIOFILMS 
5.4.1. PNEUMOCOCCAL BIOFILMS 
 
In most environments, bacteria form surface-associated organized communities of 
aggregated cells embedded in an extracellular polymeric substance (EPS) matrix, called 
biofilms [259-261]. These complex structures are known to comprise one species or multiple 
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species existing in a mixed community [262,263]. Biofilm growth starts when single planktonic 
cells attach to a surface that normally is conditioned to enhance attachment. In early 
formation, those individual cells strongly adhere and proliferate into dense cell groups and, as 
this occurs, they become surrounded by the extracellular matrix. During subsequent 
maturation, parts of the biofilm can disperse and migrate. In addition, the biofilm can continue 
to develop into a heterogeneous population of cells that are metabolically, physiologically and 
genetically distinct from one another [263]. Dispersion events can result in bacterial 
dissemination and colonization of new niches [264].  
Due to its remarkable difference from planktonic growth, biofilm development allows 
bacteria to survive in hostile environments [259,261,265]. In the human host, biofilm 
formation is clearly an important microbial survival strategy. Since the EPS matrix is difficult to 
permeate, they are inherently less susceptible to antimicrobial agents, even if the individual 
cells are highly susceptible, and resist attack and killing by the host immune system [259,266]. 
Several other factors and mechanisms to evade elimination are intrinsic to this bacterial 
lifestyle [263]. For instance, some cells in biofilms are able to exist in a metabolically dormant 
state (growth-limited bacteria) which may confer protection against many drugs that target 
actively growing bacterial cells [267].  
It has been estimated that biofilms are involved in 60% of all human bacterial infections 
and that they are essential for many infections to occur [259,268]. Indeed, biofilm formation in 
vivo was demonstrated for numerous bacterial pathogens, such as Pseudomonas aeruginosa in 
cystic fibrosis-related lung infections, Haemophilus influenzae in chronic otitis media, 
Staphylococcus aureus in chronic rhinosinusitis and Escherichia coli in urinary tract infections 
[259,261]. The presence of these structures at the site of infection associates them with these 
disorders. Furthermore, in some of the infections, biofilm formation is actually an absolute 
requirement [259,261].  
In S. pneumoniae, biofilm formation has also recently been shown in vitro and in vivo 
[223,269-274]. In fact, pneumococcal biofilms were demonstrated to be locally present in 
infected tissues of individuals with chronic rhinosinusitis [272] and chronic otitis media [273]. 
Moreover, in a chinchilla model of otitis pneumococci were shown to form in vivo biofilm 
communities, further supporting the hypothesis that this type of growth plays an important 
role in pneumococcal infection [275]. Despite not having found an association between the 
ability to form biofilms in vitro and the capacity to colonize the nasopharynx, cause pneumonia 
and enter the bloodstream (invasive infections) in a mouse model [276], another study 
established that in the nasopharyngeal colonization, biofilms are likely to contribute to this 
process since biofilm defects in vitro normally impaired colonization in vivo [223]. Additionally, 
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it was observed that the pattern of pneumococcal gene expression, including virulence factors, 
in in vitro biofilms was highly similar to the one of bacteria in tissue infections (brain and 
lungs), while the expression pattern in liquid growth resembled that of bacteria infecting the 
blood [271]. Furthermore, pneumococci grown in a biofilm were more effective in inducing 
tissue infection (meningitis and pneumonia) differing from cells from liquid culture that were 
more effective in causing blood infection. These findings reveal that during tissue infection 
pneumococci are most probable in a biofilm-like state and therefore, strongly suggest that the 
ability to form biofilms is important in these cases [271]. Despite this, little is still known about 
the molecular mechanisms governing pneumococcal biofilm development.  
Concerning the involvement of proteins in S. pneumoniae biofilm formation, in a recent 
work a proteomic analysis over the course of biofilm growth revealed a differential production 
of proteins [269]. Also, a remarkable increase in the number of detectable proteins was 
observed in biofilm relatively to liquid growth and it was suggested that such dramatic changes 
could be partly explained by transition/adaptation to the complex sessile mode of growth 
[269]. Protein identification revealed that proteins involved in attachment, bacterial resistance 
and virulence were more abundant under biofilm growth conditions [269]. This seemed 
related with the referred upregulation of pneumococcal virulence genes in tissue infection 
(associated with biofilm growth) [271]. In addition, in a quest for the role of choline binding 
proteins, mutants in LytA as well as in LytC and LytB, showed a decreased capacity to form 
biofilms in vitro, whereas no such reduction was observed, for instance, in Pce mutants [270]. 
Nevertheless, the role of the autolysin LytA, and of the other proteins, in establishing robust 
biofilms remains to be determined.  
 
5.4.2. ROLE OF LYSIS 
 
The EPS matrix, constituting a major part of the biofilm, is typically produced by the 
bacteria themselves within the biofilm [277]. It is a complex mixture of macromolecules that in 
general includes polysaccharides, proteins and DNA [263,266]. In S. pneumoniae, increasing 
evidence suggests that extracellular polysaccharides indeed form part of the biofilm matrix, 
whether the biofilm is formed by strains containing a polysaccharide capsule or by 
nonencapsulated strains [274,278]. Proteins and extracellular DNA (eDNA) were found as well 
as integral parts of the pneumococcal biofilm matrix [270,274,278].  
The matrix eDNA, initially presumed to be a residual material, is  actually essential in the 
biofilm mode of life serving as a nutrient source [277], allowing horizontal gene transfer 
between cells (facilitated by the closest proximity within the biofilm) [279], and even 
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mediating antibiotic resistance [280]. Remarkably, it has become increasingly clear that eDNA 
is also a critical component of the biofilm structure [281-286]. It is in fact required for biofilm 
formation in several species including Gram-positive bacteria [281-286]. For example, in 
Listeria monocytogenes and Bacillus cereus it was reported that eDNA can promote the initial 
surface attachment imperative for further biofilm growth [282,286]. Furthermore, in 
Staphlylococcus aureus and L. monocytogenes, for instance, eDNA was found to be not only 
responsible for early biofilm formation but also for cell interconnection maintaining 
established biofilms, mainly based on the observation that DNase I treatment caused 
significant dispersal of the preformed structures [284,286,287]. However, in other studies, 
developed biofilms seem to be far less susceptible to DNase I treatment, as in the case of 
Staphylococcus epidermidis and Pseudomonas aeruginosa, even though DNA is important for 
initial establishment of the biofilm [281,284,288]. Interestingly, it was observed that eDNA is 
present as a fibrous network in Enterococcus faecalis [283] and a grid-like structure was visible 
for P. aeruginosa [289], which is linked to the structural stability conferred by this compound 
[281,283].  
In S. pneumoniae, the presence of eDNA was also found to influence biofilm formation. 
When pneumococci were grown in the presence of DNase I, the development of this structure 
was indeed greatly impaired, while culture growth was not affected [270]. Moreover, a 
significant inhibitory effect on biofilm formation was observed adding DNase I after 6 h of 
growth [270]. Nevertheless, in another study, it was reported the absence of any effect of 
DNase I whether before or after biofilm development [223] and these discrepancies are not 
yet understood. Despite this, an additional independent analysis, corroborated the first 
findings as it was shown that DNase I treatment significantly reduced biofilm biomass [278], 
further implicating eDNA in the establishment of pneumococcal biofilms.  
Concerning the source of eDNA for the biofilm, it has been suggested for some bacteria 
that active secretion mechanisms may exist [281,282]. Even though the possibility of such 
mechanisms was not excluded, growing evidence especially in Gram-positive bacteria, support 
the hypothesis that eDNA is mainly released from cells through lysis [283,287-293]. In E. 
faecalis, impairments in biofilm formation occurred in the absence of the autolysin Atn due to 
defects in DNA release [283]. Likewise, in S. epidermidis biofilms, most of the eDNA promoting 
biofilm formation is made available by the autolysin AtlE, probably through lysis of a 
subpopulation of the bacteria [288]. Similar findings were also shown during biofilm 
development in S. aureus involving the holin-like protein Cid, which as mentioned before 
influences the autolytic activity in this species [287,291,292], and in Streptococcus gordonii the 
release of eDNA by the major autolysin was suggested to be spatially or temporally regulated 
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for optimal development of stable biofilms [290]. There might be a parallel system in S. 
pneumoniae. As a matter of fact, the major pneumococcal autolysin LytA was shown to 
influence biofilm formation [270] and in pneumococcal liquid cultures, it was demonstrated 
that DNA is released into the medium through LytA-induced lysis, whether in the stationary 
phase or by a fraction of the bacterial population in competence induction [141,142,207]. 
Thus, within the biofilm limited lytic events mediated by LytA could promote eDNA release 
favoring its formation, highlighting the need to test this hypothesis.     
 
5.5. ASSOCIATION BETWEEN PNEUMOCOCCAL PHAGES AND VIRULENCE 
 
Dissemination of genetic information among bacteria is facilitated by phages and it is also 
well documented that some lysogenic phages bear virulence-related genes [12,294]. Toxins are 
the best recognized examples of virulence factors encoded by phages in several bacterial 
pathogens, with even more severe consequences upon prophage induction [12]. However, it 
has become clear that prophages have a broader contribution to their host virulence. For 
instance, some phages also encode regulatory factors that increase expression of virulence 
genes not encoded by the phage [295], while others encode enzymes that alter bacterial 
components related to virulence [296].  
The abundance of lysogeny among S. pneumoniae strains associated with human 
infections [15,25,36,42-44] has raised the possibility that phages may influence bacterial 
virulence. However, this putative phage participation remains elusive since sequence analysis 
of the pneumococcal genomes failed to reveal any gene potentially involved in host 
pathogenesis [20,24]. Even though an improved adherence of pneumococci to pharyngeal cells 
in vitro was reported as specifically associated with the MM1 prophage, it remains unknown 
whether it provides an advantage in colonization [297]. 
Autolytic events have been strongly implicated in S. pneumoniae virulence mostly by 
massive release of proinflammatory cell wall fragments and intracellular factors [3,217]. 
Additionally, although no direct evidence exists, it seems that controlled bacteria-mediated 
lysis may influence positively the formation of pneumococcal biofilms [270], the importance of 
which has been increasingly recognized in vivo in both colonization and infection 
[223,272,273]. Since it is now clear that all pneumococcal phages encode their own lysins, 
prophage induction (occurring in both substantial and spontaneous fashion) may contribute to 
virulence through lysis. In this context, it is important to study the precise mechanisms 
involved in phage-mediated lysis as well as the impact of this process on S. pneumoniae, 
especially within biofilms of lysogens where the lysis phenomenon is not yet understood. 
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It is known that S. pneumoniae phages depend on the phage-encoded functions of holin 
and lysin to accomplish lysis and release of their progeny [20,24,25,36,90,91], where the phage 
lysin has been shown to hydrolyze the pneumococcal cell wall whereas holin compromises the 
cytoplasmic membrane integrity [90,91]. On the other hand, the major pneumococcal 
autolysin LytA is localized inactive in the cell wall [126,127,145,146,194] and, in some Gram-
positive bacteria the activity of autolysins is apparently regulated at the bacterial surface 
through the membrane electrochemical gradient  [201-203]. Taking into account the powerful 
lytic activity of LytA [128,136], the membrane disruption caused by the holins may trigger the 
host autolysin that could also contribute actively to the release of the newly formed phage 
particles. 
Furthermore, experimental evidence demonstrating the peculiar high structural and 
functional similarity between pneumococcal autolysin and phage lysins has been gathered 
[20,92]. This is best exemplified by the constitutive expression of the phage lysins Cpl-1 or Hbl 
in S. pneumoniae M31 (deleted in the lytA gene), that reestablished the capacity of the cells to 
undergo autolysis in stationary phase [92]. It then seems that the phage lysins may be 
regulated by the same bacterial physiological mechanism that controls LytA activity. 
Additionally, it appears reasonable to hypothesize an extracytoplasmic targeting of the phage 
lysins since the cell wall located LytA also lacks an N-terminal secretory signal sequence [145]. 
Therefore, this invites speculation that the phage lysins might actually be activated by holin-
induced membrane deenergization at the end of the lytic cycle, in sharp contrast to the 
mechanism generally accepted in S. pneumoniae of the holin-dependent export of phage lysins 
to their peptidoglycan target [20,24,91,93]. Overall, a simple strategy for phage release can be 
envisaged: host lysis mediated by phages might be achieved by holin activation, through 
collapse of membrane energization, of both phage and bacterial lysins already positioned at 
the cell wall.   
From the host perspective, the eDNA constituent of the biofilm matrix [263,266] has been 
suggested not only to be required for the biofilm development of several bacteria [281-283], 
but also to influence this process in S. pneumoniae [270,278]. Furthermore, autolysins of some 
Gram-positive bacteria play a role in biofilm growth, probably by providing a source of eDNA 
[283,288,293,298] and it was observed that pneumococcal mutants in the autolysin LytA have 
a decreased capacity for establishing biofilms [270]. Thus, the implication of LytA in the 
formation of these multicellular structures could be explained by eDNA release upon regulated 
cell lysis. In this scenario, since lysogenic phages are normally spontaneously induced resulting 
in cell lysis [35,39-41], it can be hypothesized that prophage of a pneumococcal subpopulation 
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might also participate in eDNA release within the biofilm and consequently enhance its 
formation.      
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Most bacteriophages (phages) release their progeny through the action of holins that 
form lesions in the cytoplasmic membrane and lysins that degrade the bacterial peptidoglycan. 
Although the function of each protein is well established in phages infecting Streptococcus 
pneumoniae, the role - if any - of the powerful bacterial autolysin LytA in virion release is 
currently unknown. In this study, deletions of the bacterial and phage lysins were done in 
lysogenic S. pneumoniae strains, allowing the evaluation of the contribution of each lytic 
enzyme to phage release through the monitoring of bacterial-culture lysis and phage plaque 
assays. In addition, we assessed membrane integrity during phage-mediated lysis using flow 
cytometry to evaluate the regulatory role of holins over the lytic activities. Our data show that 
LytA is activated at the end of the lytic cycle and that its triggering results from holin-induced 
membrane permeabilization. In the absence of phage lysin, LytA is able to mediate bacterial 
lysis and phage release, although exclusive dependence on the autolysin results in reduced 
virion egress and altered kinetics that may impair phage fitness. Under normal conditions, 
activation of bacterial LytA, together with the phage lysin, leads to greater phage progeny 
release. Our findings demonstrate that S. pneumoniae phages use the ubiquitous host 




















Streptococcus pneumoniae (pneumococcus), a common and important human pathogen, 
is characterized by the high incidence of lysogeny in isolates associated with infection [1,2]. 
Pneumococcal bacteriophages (phages) share with the majority of bacteriophages infecting 
other bacterial species the holin-lysin system to lyse the host cell and release their progeny at 
the end of the lytic cycle. Genes encoding both holins and lysins (historically termed 
endolysins) are indeed found in the genomes of all known pneumococcal phages [3-6]. 
Supporting this mechanism, a lytic phenotype in the heterologous Escherichia coli system was 
achieved only by the simultaneous expression of the Ejh holin and the Ejl endolysin of 
pneumococcal phage EJ-1 [3]. When these proteins were independently expressed, cellular 
lysis was not perceived. Similar results were shown for pneumococcal phage Cp-1, not only in 
E. coli, but also in the pneumococcus itself [4]. 
Phage lysins destroy the pneumococcal peptidoglycan network due to their muralytic 
activity, whereas holins have been shown in S. pneumoniae to form nonspecific lesions [3], 
most likely upon a process of oligomerization in the cytoplasmic membrane, as observed for 
the E. coli phage λ [7-9]. It was generally proposed that holin lesions allow access of phage 
lysins to the cell wall [10,11], as the majority of phage lysins, including the pneumococcal 
endolysins, lack a typical N-terminal secretory signal sequence and transmembrane domains 
[3]. However, recent evidence also highlights the possibility for a holin-independent targeting 
of phage lysins to the cell wall, where holin lesions seem to be crucial for the activation of the 
already externalized phage lysins [12-14]. Regardless of the mechanism operating in S. 
pneumoniae to activate phage lysins, holin activity compromises membrane integrity. 
Pneumococcal cells present their own autolytic activity, mainly due to the presence of a 
powerful bacterial cell wall hydrolase, LytA (an N-acetylmuramoyl-L-alanine amidase), 
responsible for bacterial lysis under certain physiological conditions [15]. Although other 
bacterial species also encode peptidoglycan hydrolases, the extensive lysis after entering 
stationary phase caused by LytA is a unique feature of S. pneumoniae. Interestingly, LytA is 
translocated across the cytoplasmic membrane to the cell wall, where it remains inactive, in 
spite of the absence of a canonical N-terminal sequence signal [16]. In the cell wall, autolysin 
activities are tightly regulated by mechanisms that seem to be related to the energized state of 
the cell membrane. In fact, depolarizing agents are able to trigger autolysis in Bacillus subtilis 
[17,18], and bacteriocin-induced depletion of membrane potential triggers autolysis of some 
species of the genera Lactococcus and Lactobacillus, closely related to streptococci [19]. It is 
therefore possible that the holin-inflicted perturbations of the S. pneumoniae cytoplasmic 
CHAPTER II 
61 
membrane upon the induction of the lytic cycle may trigger not only the lytic activity of the 
phage lysin, but also that of inactive LytA located in the cell wall. Accordingly, LytA could also 
participate in the release of phage particles at the end of the infectious cycle, especially 
considering its powerful autolytic activity. Previous studies have suggested a role for the host 
autolytic enzyme in the release of phage progeny [20,21], but in fact, the evidence is unclear 
and dubious, considering that the existence of phage-encoded lysins was unknown or very 
poorly understood and some of the experimental conditions used to show a role of LytA could 
have also affected the activity of the phage lysin [20]. 
To clarify the possible role of the bacterial autolysin in host lysis, we used the S. 
pneumoniae strain SVMC28, lysogenic for the SV1 prophage [1], which contains a typical holin-
lysin cassette, and a different host strain lysogenized with the same SV1 phage. Our results 
show that LytA is activated by the holin-induced membrane disruption, just like the phage 
endolysin. In the absence of the endolysin, LytA is capable of mediating host lysis, releasing 
functional phage particles able to complete their life cycle. Still, sole dependence on LytA 
results in an altered pattern of phage release that may reduce phage fitness. Importantly, we 
also show that, together with the endolysin, the concurrent LytA activation is critical for 
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3. MATERIAL AND METHODS 
 
Bacterial strains, plasmids, and growth conditions 
 
The bacterial strains and plasmids used in this study are listed in Table II.1. S. pneumoniae 
strains SVMC28 and R36A were obtained from the Rockefeller University collection (A. 
Tomasz). R36AΔlytA was kindly provided by S. Filipe. SVMC28 is a clinical isolate lysogenic for 
phage SV1. All S. pneumoniae strains were grown in a casein-based semisynthetic medium 
(C+Y) at 37°C without aeration [22] or in tryptic soy agar (Oxoid, Basingstoke, England) 
supplemented with 5% (v/v) sterile sheep blood and incubated at 37°C in 5% CO2. 
Pneumococcal mutant strains were grown in the presence of 2 µg/ml erythromycin or 4 µg/ml 
chloramphenicol (Sigma, Steinheim, Germany), or both, as appropriate. E. coli strains were 
usually grown in LB medium (Difco, MD). When required, the medium was supplemented with 
100 µg/ml ampicillin (Sigma, Steinheim, Germany), 1 mg/ml erythromycin, or 20 µg/ml 
chloramphenicol for plasmid selection. M9 minimal medium agar containing thiamine (1 mM; 





Chloramphenicol and erythromycin MICs were determined by Etest following the 
manufacturer’s guidelines (AB Biodisk, Solna, Sweden). Susceptibility to novobiocin was tested 
with impregnated paper discs (Oxoid, Hampshire, England). PCR to detect the cat gene, which 
amplifies a 338-bp fragment internal to the gene, in the SVMC28 strain was performed using 




All routine DNA manipulations were performed according to standard methods [24]. The 
PCR primers are listed in Table II.2. Chromosomal DNA from S. pneumoniae and phage DNA 
were isolated similarly to previously described procedures [25-27]. Plasmids were prepared 
using either the High Pure plasmid isolation system or the Genopure plasmid Midi system 
(Roche, Mannheim, Germany), and PCR products and endonuclease digests were purified using 
the High Pure PCR product purification system (Roche, Mannheim, Germany). The enzymes 
used in the manipulation of DNA were purchased from MBI Fermentas (Vilnius, Lithuania). All 
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oligonucleotides were obtained from the Invitrogen Co. (Paisley, Scotland). Nucleotide 
sequences were analyzed using VECTOR NTI Deluxe (Invitrogen, Barcelona, Spain) software.  
 
Construction of pneumococcal mutants by insertional deletion of lytA and svl 
 
The mutant strain SVMC28ΔlytA, in which the lytA gene was deleted and replaced by the 
erm(B) gene, was constructed essentially as described previously [28]. First, lytAup (529 bp), 
the sequence encoding the upstream fragment of lytA, was amplified with the primers AFLYTA 
and ARLYTA from SVMC28 chromosomal DNA. The PCR product was digested with EcoRI and 
BamHI and inserted into the plasmid pGEM-3Z to generate pZ1. Next, lytAdw (509 bp), the 
sequence encoding the downstream fragment of lytA, was amplified from chromosomal DNA 
of SVMC28 using the primers BFLYTA and BRLYTA, and the PCR product was inserted as an 
XmiI-PaeI fragment into pZ1, generating pZ2. Lastly, the BamHI/ClaI fragment (2051 bp) from 
pJDC9, which contained the Ermr cassette [erm(B) gene] [29], was cloned into the BamHI/XmiI-
digested plasmid pZ2, yielding pZ3. Plasmid pZ3 contained the erm(B) marker flanked by the 
upstream and downstream regions of lytA and was used as a template for PCR with AFLYTA 
and BRLYTA to produce an aLTA fragment. After transformation of SVMC28 with aLTA, the 
deletion of lytA in the erythromycin-resistant SVMC28ΔlytA mutant was confirmed by PCR 
amplification and subsequent sequencing with primers DINF-D4 and ORF1-R3, external to 
AFLYTA and BRLYTA (supplementary data, Fig.II.S1A). An identical strategy was used to 
construct the mutant SVMC28Δsvl, in which svl was replaced by the cat gene. svlup (583 bp) 
and svldw (477 bp) were PCR amplified from SV1 phage DNA using the primer pairs AFLYS1-
ARLYS1 and BFLYS1-BRLYS1. svldw contained 185 bp of svl. A CAT fragment (1,053 bp), 
containing the Cmr marker (cat), was amplified from pEVP3 with BM18H and PEVP3-1R and 
cloned into pZ5 as a BamHI-XmiI fragment. aLS1 was produced with AFLYS1 and BRLYS1 from 
pZ6, and the resulting PCR product was used to transform the pneumococcal strain SVMC28. 
The deletion of svl in the chloramphenicol-resistant SVMC28Δsvl mutant was confirmed by PCR 
amplification and sequencing with primers 28HA37-R5 and 28HA37-X1, external to AFLYS1 and 
BRLYS1 (Fig.II.S1B). To construct the double-deletion mutant SVMC28ΔsvlΔlytA, the PCR 
fragment aLTA was used to transform SVMC28Δsvl. The chloramphenicol- and erythromycin-
resistant strain SVMC28ΔsvlΔlytA was confirmed to carry deletions of the lytA and svl genes by 
the procedures described above (Fig.II.S1). For all PCRs, except those used as templates in 
sequencing reactions, the High Fidelity PCR Enzyme Mix kit (MBI Fermentas, Vilnius, Lithuania) 
was used. The amplicons (DNA products amplified by PCR) are described in Table II.1. 
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Transformation of S. pneumoniae and selection of transformants 
 
Transformation of pneumococcal cells was carried out as described previously [28]. 
Transformants were selected on tryptic soy agar supplemented with 5% (v/v) sheep blood and 
chloramphenicol (4 µg/ml) and/or erythromycin (2 µg/ml). 
 
Analysis of phage excision 
 
The pulsed-field gel electrophoresis (PFGE) procedure for the visualization of 
extrachromosomal phage DNA was adapted from the method of Ramirez et al. [1], except that 
cells were harvested after a 2-h period of mitomycin C (MitC) (Sigma, Steinheim, Germany) 
treatment. The electrophoresis conditions were 6 V/cm, ramping of the pulse between 1 and 2 
s, and a total running time of 16 h. The buffer was maintained at 14°C during the run. 
 
Construction of lysogenized strains 
 
The lysogenized strains were constructed using the laboratory strain R36A. SV1, obtained 
from wild-type SVMC28, was used to lysogenize strains R36A and R36AΔlytA, resulting in 
strains R36AP and R36APΔlytA (Table II.1). To obtain lysogenic strains defective in the phage 
lysin, R36A and R36AΔlytA were infected with SV1Δsvl extract from SVMC28Δsvl. The resulting 
lysogens were named R36APΔsvl and R36APΔlytAΔsvl, respectively (Table II.1). Phage infection 
was performed by phage plaque assays (see below). Agar was picked at the edges of plaques. 
The presence of both wild-type and mutant phages was tested for by PCR with primers for SV1 
[AFLYS1 and ARLYS1 (Table II.2)]. MitC-induced lysis was performed on selected PCR-positive 
colonies. We considered that response to MitC was indicative of phage excision and 
consequently of successful prior lysogeny. The released phages were able to infect and lyse 
cells of the wild-type R36A strain, producing phage plaques and confirming that the strains 




Overnight cultures of wild-type, mutant, and lysogenized strains in C+Y supplemented 
with the appropriate antibiotics were diluted 1:100 in fresh medium (without antibiotics), and 
the cultures were grown until the optical density at 600 nm (OD600nm) reached approximately 
0.2 to 0.25. MitC was then added to a final concentration of 0.1 µg/ml to induce the lytic cycle 
[30]. Incubation was continued, and growth was monitored by the OD. Cultures treated with 
CHAPTER II 
65 
deoxycholate (DOC) [0.04% (w/v)] and nisin (1 µg/ml) (Sigma, Steinheim, Germany) were 
grown to an OD600nm of 0.4 and 0.2 to 0.25, respectively. All assays were carried out at least in 
duplicate. Lysis was expressed directly as the OD600nm drop or as the percentage decrease in 
the OD600nm relative to its maximal value (the OD value prior to lysis). The degree of lysis at 
each time point was calculated from the following equation: lysis extent (percentage) = 100 – 
(percentage of maximal OD). 
 
Phage plaque assays 
 
Plaque assays were performed as described elsewhere [31] with the following 
modifications: C+Y medium with 170 U catalase/ml agar was used, top agar was not added, 
and phage were applied in 10 µl aliquots directly on the soft agar (0.35%) with the indicator 
strain. Incubation was performed at 30°C. Lysogenic phages were induced with MitC. At 
specific times (between 40 and 180 min) after MitC treatment, cultures were filtered through a 
0.45 µm-pore-size membrane, and the supernatant was stored at 4°C for a maximum of 24 h 
until it was used. To lysogenize the strains, cultures were filtered after total lysis (180 min). To 
eliminate the possibility that lysis of the indicator strain was caused by the bacterial products 
(e.g., bacteriocins) and not caused by phage infection, a fractionation of the culture medium 
was performed. Cultures treated for 180 min with MitC were prefiltered through a 0.45 µm-
pore-size membrane, followed by filtering them with a 100 kDa mass-cutoff polyethersulfone 
membrane (Vivaspin 20 concentrator; Sartorius Stedim Biotech, Goettingen, Germany), which 
retained the SV1 phage but not proteins that could cause bacterial lysis, such as LytA, Svl, 
holins, and bacteriocins (mass < 100 kDa). Both the filtrate containing proteins of < 100 kDa 
and that containing the phage particles were used. Phage plaques were observed with a Leica 



























, erythromycin resistance; Cm
r
, chloramphenicol resistance; Amp
r
, ampicillin resistance; Nov
r
, novobiocin resistance. 
b 
Strain construction by a cross carried out by using transformation is indicated as recipient X DNA donor. Primes used to amplify DNA fragments by PCR are indicated in parentheses.
Strain, plasmid 
or DNA construct 
Relevant characteristics
a





S. pneumoniae     
    SVMC28 Lysogenic for phage SV1; parental strain 
susceptible to Ery and Cm  
Expression of LytA and Svl  [1] 
    SVMC28 lytA SVMC28 lytA::erm(B); Ery
r
   Expression of Svl, absence of LytA expression SVMC28 X aLTA  
    SVMC28 svl SVMC28 svl::cat; Cm
r  
 Expression of LytA, absence of Svl expression SVMC28 X aLS1 




  Absence of LytA and Svl expression  SVMC28 svl  X aLTA  
    CP1500 Nov
r
 Donor of point markers, control in transformation assays  [32] 
    R36A Laboratory strain; nonlysogenic; susceptible to 
Ery and Cm 
Recipient for phage infection Rockefeller University Collection 
    R36A lytA R36AlytA::(pJDC9)::lytA; Ery
r
 Recipient for phage infection S. Filipe 
    R36AP R36A lysogenic for phage SV1 Expression of LytA and Svl R36A infected with SV1  
    R36AP lytA R36A lytA lysogenic for phage SV1; Ery
r
 Expression of Svl, absence of LytA expression R36A lytA infected with SV1  
    R36APΔsvl R36A lysogenic for phage SV1 svl::cat; Cm
r
 Expression of LytA, absence of Svl expression R36A infected with SV1 with svl deleted 






Absence of LytA and Svl expression R36A lytA infected with SV1 with svl 
deleted 
E. coli     
    DH5α lacZ∆M15 Recipient for pZ1-pZ3 Invitrogen 
    JM109 F´lacI
q
Z∆M15 Recipient for pZ4-pZ6  
Plasmids    
    pGEM-3Z lacZα; Amp
r                                                                                                                                                                      
 Cloning vector  
    pZ1     pGEM-3Z::lytAup; Amp
r
 Cloning vector lytAup (AFLYTA, ARLYTA) 
    pZ2 pZ1::lytAdw; Amp
r
 Cloning vector lytAdw (BFLYTA, BRLYTA) 




 Template for PCR product aLTA  
    pZ4  pGEM-3Z::svlup; Amp
r
 Cloning vector svlup (AFLYS1, ARLYS1) 
    pZ5 pZ4::svldw; Amp
r
 Cloning vector svldw (BFLYS1, BRLYS1) 




 Template for PCR product aLS1  CAT (BM18H, PEVP3-1R) 
    pEVP3 Cm
r
 Source of cat gene; template for PCR product CAT  [33] 
    pJDC9 Ery
r
 Source of erm(B) gene  [29] 
 
Amplicons    
    aLTA lytAup::erm(B)::lytAdw For insertion-deletion replacement for lytA aLTA (AFLYTA, BRLYTA) 





Table II.2 - PCR primers used in this study. 
Primer Sequence (5´ 3´)
a
 Recognition site 
CATd  TTAGGYTATTGGGATAAGTTA  - 
CATr CATGRTAACCATCACAWACCAG - 
AFLYTA  AGCGAATTCGGCAGGATATAAGGGTGTTATC  EcoRI 
ARLYTA   ATAGGATCCATTCTACTCCTTATCAATTAAAAC  BamHI 
BFLYTA   GCAGTCGACTAATGGAATGTCTTTCAAATC  XmiI 
BRLYTA CAATAGCATGCGATATTCCTTTCACCTTTTTCC  PaeI 
DINF-D4 GCAAAAGATCCTTCCTCTAGTTTC  - 
ORF1-R3 CTTCACCATCAGCTCCCAAC - 
AFLYS1  AGCGAATTCAGGGGTTCTCTTACTGATGATC  EcoRI 
ARLYS1 ATAGGATCCTCCCTATCGTCCTTTCCATGC  BamHI 
BFLYS1 GCAGTCGACTGAAGACAGGCTGGGTCAAGTAC  XmiI 
BRLYS1 CAATAGCATGCGCTATTTCCCAAGGTGCTGG  PaeI 
BM18H  ATAGGATCCGGGTTCCGAGGCTCAACGTCAA  BamHI 
PEVP3-1R  CGAGGTCGACGGTATCGATAAGCT  XmiI 
28HA37-X1  TCAGGTTACTTGAAAAGGCAATAG  - 
28HA37-R5 CAACGTCGCCGTTCTGTTGAATC - 
a 




Flow cytometry analysis of cultures treated with MitC was performed. As a control for cell 
death, the cultures were treated with nisin and DOC. All compounds used were filtered 
through a 0.22 µm-pore-size membrane before flow cytometry measurement. In these assays, 
selective overnight cultures of wild-type SVMC28 and the derived mutants strains were diluted 
1:100 in fresh 0.22 µm-filtered C+Y and grown to the appropriate OD600nm. Cells were collected 
immediately after exposure and at 20-min intervals during a 2-h period and then diluted in 
sterile-filtered 0.85% NaCl to a concentration of ~1x10
6 cells/ml. Cell viability was assessed by 
using the Live/Dead BacLight bacterial viability kit (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s instructions. Briefly, 1.5 µl of Syto 9 (green fluorescent nucleic acid stain; 3.34 
mM) at a final concentration of 5 µM and 1.5 µl of propidium iodide (PI) (red fluorescent 
nucleic acid stain; 2 mM) at a final concentration of 3 µM were added to each 1-ml diluted 
sample of cells. PI stock solution was diluted to 2 mM in sterile-filtered distilled H2O 
immediately prior to staining. The samples were then incubated at room temperature in the 
dark for 20 min and analyzed on a Partec CyFlow space flow cytometer (Partec GmbH, 
Münster, Germany) with 488-nm excitation from a blue solid-state laser at 50 mW. Forward 
scatter (FSC), side scatter (SSC), and two fluorescence signals were measured. Green 
fluorescence, indicating the population of live cells (nonpermeabilized cytoplasmic 
membranes) was detected in the FL1 channel, and red fluorescence, indicating the population 
of dead cells (permeabilized cytoplasmic membranes), was detected in the FL3 channel. 
Optical filters were set up so that FL1 measured at 520 nm and FL3 measured above 610 nm. 
The sample analysis rate was kept below 1000 events/s. The trigger was set for the FSC 
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channel, and the combination of FSC and SSC was used to discriminate bacteria from the 
background. Twelve thousand events were collected for each sample taken. Data were 
collected and analyzed using FloMax software (Partec GmbH, Münster, Germany). Assays were 
carried out at least in duplicate. 
Cell viability was also assessed by fluorescence microscopy to confirm staining by the 
different strains after MitC treatment. Syto 9/PI-labeled cell suspensions were microscopically 
analyzed 40, 80, and 120 min after MitC addition with a Zeiss Axiovert 200 M microscope (Carl 
Zeiss, Germany) equipped with a 100-W halogen lamp, the appropriate excitation and 
emission filters for Syto 9 and PI [excitation wavelengths, 450 to 490 nm (Syto 9) and 540 to 
552 nm (PI); emission wavelengths, 515 to 565 nm (Syto 9) and > 590 nm (PI)], a Plan 
Apochromat 63X/1.4 objective lens, and a CoolSnap HQ charge-coupled device camera (Roper 
Scientific Photometrics, Tucson, AZ). Fluorescence photographs were acquired with 




Differences in the mean values of the lysis extent between strains were analyzed by a 
Student t test. For all comparisons, a P value of < 0.05 was considered to represent statistical 
significance; 95% confidence intervals for the average of the OD measurements from different 
experiments were calculated based on the Student t distribution. 
 
Nucleotide sequence accession number 
 
The DNA sequence of the 1.719 kb SV1 lytic cassette has been assigned GenBank 

















The prophage SV1 lytic cassette and construction of the lysin mutants 
 
Strain SVMC28, an S. pneumoniae clinical isolate lysogenic for the inducible phage SV1, 
was selected for study [1]. The SV1 lytic cassette is localized downstream of the structural 
cluster and adjacent to the attP site in the SV1 genome, similarly to other pneumococcal lytic 
cassettes, and shows a high nucleotide sequence identity to the pneumococcal phage MM1 
[5]. In addition, it exhibits a typical three-component organization in which the two open 
reading frames encoding putative holins (Svh1 and Svh2) precede the endolysin gene, which 
encodes a putative amidase (Svl). Attempts to clone svh1 and svh2 open reading frames in E. 
coli resulted in loss of viability, strongly indicating that these proteins correspond to holins 
(data not shown). 
In order to construct S. pneumoniae mutants without bacterial and phage lytic activities, 
the lytA and svl genes were eliminated by insertion-deletion in the clinical isolate SVMC28 
(Table II.1 and supplementary data, Fig.II.S1). Elimination of the lytic genes did not alter the 
growth rates of the mutants. In fact, all strains displayed growth curves indistinguishable from 
those of the parental strain, indicating that the modifications introduced had no significant 
impact on pneumococcal physiology. As expected, the lytA-deficient strains SVMC28ΔlytA and 
SVMC28ΔsvlΔlytA were greatly resistant to autolysis in stationary phase (data not shown) and 
when treated with nisin or DOC (see Fig.II.3). In these cases, only 30% to 45% lysis occurred 
280 min after nisin or DOC addition, which was far less than that exhibited by the wild-type 
strain SVMC28 (close to 95%). The phage lysin played no role in the response to these stimuli, 
since SVMC28ΔlytA and SVMC28ΔsvlΔlytA showed similar lytic phenotypes. Thus, residual lysis 
was probably caused by other pneumococcal autolysins, such as LytC, which is also responsible 
for lysis in stationary phase but with a lower activity than LytA at 37°C [34,35]. The elimination 
of svl in the SVMC28Δsvl mutant did not alter the lytic response upon nisin and DOC 
treatment, which was characterized by the same lysis rate as the wild-type strain (see Fig.II.3), 
confirming that LytA is fully functional in this mutant strain. 
 
Phenotypic evaluation of phage-induced lysis 
 
To investigate the possible role of the autolysin LytA in phage release in S. pneumoniae, 
we started by comparing the lytic phenotypes of the parental and mutant strains after 
induction of the SV1 lytic cycle with MitC. As indicated in Fig.II.1A, SVMC28ΔlytA cultures 
showed pronounced lysis 80 min after MitC addition, in contrast to the control untreated 
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cultures. This is consistent with the known role of phage lysins in bacterial cell wall 
degradation to allow the release of new phage particles. Remarkably, in the mutant lacking 
endolysin (SVMC28Δsvl), lysis was unequivocally detected after treatment with MitC, clearly 
demonstrating that LytA is activated after prophage induction.  
Analysis of the MitC-treated double mutant SVMC28ΔsvlΔlytA, which lacks LytA and Svl, 
revealed negligible lysis with a maximum of 35% lysis at 180 min (Fig.II.1A), which may reflect 
the activity of LytC [35]. A PFGE analysis of the total DNA showed no considerable changes in 
prophage excision compared to the wild-type in SVMC28Δsvl and SVMC28ΔsvlΔlytA mutant 
strains, with all MitC-treated cultures showing free phage DNA (~33 kb), which was not 
detected in the untreated control cultures (Fig.II.1B). This was also observed for the lytA-
deficient mutant SVMC28ΔlytA (data not shown). The extra fragments visualized below the 
chromosome are concatemers of the phage genome, as already demonstrated for SV1 [1]. 
These observations clearly demonstrate that, similarly to the wild-type, in all mutant strains, 
the phage successfully initiated the lytic cycle with DNA excision and replication, indicating 
that the observed lysis after MitC addition was phage mediated. 
To test whether this newly discovered role of LytA was independent of the bacterial 
genetic context, we characterized the lysis of similar mutants generated in the R36A 
background by lysogenizing the laboratory strains R36A and R36AΔlytA with phages SV1 and 
SV1 with svl deleted (SV1Δsvl) (Table II.1). As depicted in Fig.II.1C, MitC induction of phage 
excision in the endolysin-deficient R36APΔsvl strain resulted in pronounced lysis, confirming 
the activation of LytA. Thus, independently of the host genetic background, LytA mediates 
phage-induced lysis of the host cell in the absence of the endolysin. 
It is noteworthy that the lysis rates of the Δsvl mutant were similar to those of the ΔlytA 
mutant in both SVMC28 and R36A backgrounds (Fig.II.1A and C), indicating that the exclusive 
presence of the autolysin LytA in the absence of any phage lytic enzyme is sufficient for an 
accentuated decrease in OD at the end of the lytic cycle. However, the bacterial autolysin 
appears not to influence the lysis rate or the lysis extent promoted by Svl, since these 
parameters were similar between the SVMC28 and R36AP strains (containing both enzymes) 
and the respective ΔlytA mutants, in which just the Svl activity is present (Fig.II.1A and C). 
Nevertheless, for R36A in the absence of LytA (strain R36APΔlytA), the lysis timing was 
delayed. Thus, in contrast to the experiment performed in the SVMC28 genetic background, in 
































Figure II.1. Participation of bacterial and phage lysins in pneumococcal phage-induced lysis. (A) Lysis profiles of 
SVMC28 strains. Wild-type SVMC28 and the derived mutants were grown to an OD600nm of 0.2 to 0.25, and 0.1 
µg/ml of MitC was added to induce phage excision (0 min). (B) PFGE analysis of extrachromosomal phage DNA 
induced with MitC. Total DNA was isolated from cultures of SVMC28, SVMC28Δsvl, and SVMC28ΔsvlΔlytA treated 
with MitC or left untreated (control). The preparations were separated by PFGE. The white arrow indicates the 
bacterial chromosome (about 2.2 Mb), while the black arrow indicates phage DNA. Similar PFGE profiles were 
obtained for SVMC28ΔlytA (data not shown). Mrλ, lambda ladder PFGE marker (New England Biolabs, Beverly, MA). 
(C) Lysis profiles of lysogenized R36A strains. R36AP, R36APΔlytA, R36APΔsvl, and R36APΔlytAΔsvl were grown to an 
OD600nm of 0.2 to 0.25, and 0.1 µg/ml of MitC was added to induce phage excision (0 min). In panels A and C, the 
arrows represent the times at which lysis started: 80 min after MitC addition for SVMC28, SVMC28ΔlytA, and R36AP 
(black arrows) and 100 min for SVMC28Δsvl, R36APΔsvl, and R36APΔlytA (white arrows). The untreated SVMC28 
and R36AP cultures are representative of the growth curves of all untreated strains. The results are averages of a 
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In both genetic backgrounds, exclusive reliance on LytA for lysis resulted in a 20-min delay 
relative to when both phage and host lysins were present (Fig.II.1A and C). This delay was not a 
reflection of a difference in growth rates, as the doubling time of the Δsvl mutants was 
comparable to those of the SVMC28 and R36AP strains. In addition, a substantial reduction of 
the total lysis percentage in the Δsvl mutants relative to the strains carrying both bacterial and 
phage lysins was also observed [at 180 min, SVMC28Δsvl and SVMC28, P < 10-4 (Fig.II.1A) and 
R36APΔsvl and R36AP, P < 10-4 (Fig.II.1C)]. 
Collectively, these results suggest that in the absence of phage endolysin, although LytA is 
able to mediate bacterial lysis, already assembled phage particles may be retained inside the 
bacterial host for a longer time, and that relying exclusively on the host autolysin could have 
an important impact on the quantity of phage particles released. 
 
Phenotypic assessment of phage release 
 
Although the different lytic phenotypes provide clues about the changes in the phage 
particles released, the measurement of phage production was essential to determine if a 
significant difference in the release of phage progeny was observed. A phage plaque assay, 
using strain R36A as an indicator, was therefore performed using the supernatant of the MitC-
induced strains SVMC28 and R36AP and the corresponding mutants at different time points. 
When the R36A lysogens (with phage already adapted to infect R36A) were used, the plating 
efficiency was improved relative to the phage obtained directly from SVMC28, providing 
excellent conditions to explore the differences attributed to LytA in virion release. 
In the absence of endolysin, phage plaques were clearly observed, indicating that LytA by 
itself allows the release of functional phages capable of completing their life cycle (Fig.II.2A). 
However, in accord with the delayed lysis timing, phage plaques obtained for R36APΔsvl were 
observed only from 100 min onward, whereas for R36AP, phage plaques were already visible 
80 min after MitC addition, when culture lysis was detected (Fig.II.2A). In agreement with the 
reduced lysis mediated exclusively by LytA relative to that observed in the presence of both 
host and phage lysins, the number of phage released when only LytA was present was also 
significantly diminished (at 180 min, P < 10-5) (Fig.II.2D). Thus, these results support previous 
observations and confirm that lysis strictly dependent on LytA may severely impair phage 








Figure II.2. Participation of bacterial and phage lysins in phage release. (A) Phage release patterns. The culture 
media of R36AP, R36APΔsvl, R36APΔlytA, and R36APΔlytAΔsvl treated with MitC were filtered (0.45 µm) at 20-min 
intervals after the start of lysis in the R36AP strain, and the supernatants were used directly in phage plaque assays 
of the indicator strain R36A. The time after MitC addition is indicated. The results are representative of three 
independent experiments. (B) Phage plaque assay using indicator strains differing only in the presence or absence 
of LytA. The supernatant of the culture medium of R36AP was collected 180 min after MitC treatment and used on 
indicator strains R36A and R36AΔlytA. The results are representative of three independent experiments.                 
(C) Indicator lawn lysis is due to phage induction. As a control, R36A indicator lawns were exposed to C+Y medium 
with MitC at the same concentration used for phage induction. For R36APΔlytAΔsvl, the supernatant collected 180 
min post-MitC addition produced no phage plaques. The supernatant of an R36AP culture treated for 180 min with 
MitC was filtered through a 100 kDa-cutoff membrane to retain phages while eliminating small proteins. The < 100 
kDa filtrate showed no phage plaques, unlike the retained fraction (> 100 kDa filtrate; 10
-1
 dilution), demonstrating 
that the plaques were due to phage and were not due to the action of bacterial and phage lysins, holins, or 
bacteriocins (mass < 100 kDa), which can cause cell lysis. (D) Comparison of the numbers of PFU per ml detected 
upon phage induction. The numbers of PFU per ml were determined for strains R36AP, R36APΔsvl, and R36APΔlytA 
after 180 min of MitC treatment on indicator lawns of strains R36A and R36AΔlytA, as indicated. Averages and 95% 
confidence intervals are indicated. For R36A in the indicator lawn, the comparisons were between supernatants 
obtained from R36APΔlytA and R36AP (P < 10
-4
), R36APΔsvl and R36APΔlytA (P < 10
-3
), and R36APΔsvl and R36AP   
(P < 10
-5
). When the R36AP supernatant was plated on indicator lawns of strains R36A and R36AΔlytA, P was < 10
-9
. 
Magnification (A to C), x6.3 or x8.0. 
 
 
Surprisingly, the bacterial-lawn clearance due to infection with supernatant from 
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R36APΔlytA and R36AP prevented a direct comparison of the phage plaques obtained at most 
of the time points studied. Nevertheless, at 180 min, when the two lytic processes reached 
indistinguishable and approximately stable lysis extents (Fig.II.1C), the bacterial lawn clearance 
due to infection with R36APΔlytA supernatant was much less pronounced than that due to 
infection with R36AP supernatant (Fig.II.2A), resulting from fewer phage being released           
(P < 10-4) (Fig.II.2D). Similarly, for the SVMC28 genetic background, in the absence of LytA, the 
bacterial clearance due to phage infection was always less marked at any given time than that 
observed for the wild-type (data not shown). This was also unexpected, since the lysis of 
SVMC28ΔlytA and the wild-type was characterized by the same overall extent, timing, and rate 
(Fig.II.1A). Thus, one would expect that the numbers of phage released would be equivalent at 
any given point of the lytic process for those strains.  
Thus, these data reveal a negative impact on phage release in the absence of LytA, 
indicating that the bacterial autolysin, together with the phage endolysin, maximizes progeny 
release, contributing substantially to this process. In fact, another set of experiments further 
established this role. When the same phage preparation obtained after total lysis of MitC-
treated R36AP was used to infect strains R36A and R36AΔlytA as indicators (differing only in 
the presence of a functional LytA), fewer phage plaques were obtained for R36AΔlytA (P < 10-9) 
(Fig.II.2B and D), demonstrating the importance of the presence of the host lysin for plaque 
formation and supporting its role in phage release. 
 
Membrane permeabilization and cell lysis 
 
It has been shown for some bacteria that holins strictly control the lysis timing by 
disrupting the bacterial cytoplasmic membrane, which results in the triggering of the endolysin 
activity [7,10,12,14,36]. In S. pneumoniae, phage endolysins depend on holin activity for 
efficient peptidoglycan degradation [3,4], but whether the timing of lysis, and thus the 
endolysin activity, is controlled by holins has yet to be determined. Given the observation that 
LytA is able to mediate phage-induced lysis, we tested if the permeabilization and consequent 
depolarization of the cytoplasmic membrane caused by the holins [7,9] is responsible for the 
activation of both lysins. 
To address this issue, a real-time flow cytometry analysis of bacterial viability based on 
membrane integrity was performed after phage induction. In this assay, using a Live/Dead Bac-
Light bacterial viability kit (Invitrogen, Carlsbad, CA), cells with damaged membranes (the dead 
population) allow the uptake of PI, fluorescing red (FL3 channel), whereas undamaged cells 
(the live population) internalize only the Syto 9 dye, fluorescing green (FL1 channel). The first 
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step consisted of setting gates that differentiated between the two populations. As a control 
for cell death, we used the antimicrobial agent nisin, which, by inserting into the cytoplasmic 
membrane, causes irreparable membrane damage and triggers pneumococcal LytA activity 
(Fig.II.3A) [37]. After 10 min, before complete lysis occurred in the wild-type culture, the 
untreated and the nisin-treated cells formed two well-defined and distinct populations 
(Fig.II.3B). Therefore, the gates representing damaged (R2) and undamaged (R3) cells were 
constructed using a 1:1 mixture of untreated and nisin-treated cells. Gating with R2 and R3 
revealed that 99% of the untreated cells remained intact compared with less than 0.2% of the 
nisin-treated cells (Fig.II.3B). To assess the robustness of the constructed gates, we used the 
detergent DOC, a well-known trigger of LytA activity [15,38], which is assumed to have 
membrane-permeabilizing properties. In this experiment, the LytA-lacking mutant 
SVMC28ΔsvlΔlytA was used to avoid immediate lysis (Fig.II.3C and D). The untreated cells fit 
entirely into gate R3, and immediately after DOC addition, the cells were distributed almost 
exclusively in gate R2 (Fig.II.3D). Similar results were obtained with strain SVMC28ΔlytA (data 
not shown). Therefore, the chosen gates allowed complete differentiation of damaged cell 
populations due to other membrane perturbations, in addition to those induced by nisin. 
The validated gates were then applied to determine the proportions of viable and 
permeabilized populations in wild-type and mutant cultures treated with MitC. Depending on 
the strain analyzed, different fluorescence patterns emerged. For the double mutant 
SVMC28ΔsvlΔlytA, a shift of the bacterial population toward increased red fluorescence 
intensity (R3 to R2) was observed, indicating that the cells were becoming permeabilized with 
increasing time after phage induction (Fig.II.4). In fact, after 120 min of phage induction, 
almost all cells were within the R2 gate. This feature was not observed for the wild-type strain 
(Fig.II.4) or the SVMC28ΔlytA strain (Fig.II.S2). At 80 min, membrane integrity was already 
compromised in a significant fraction of the SVMC28ΔsvlΔlytA bacterial population, precisely 
when lysis was evident in the wild-type (Fig.II.1A). In contrast, in both the SVMC28ΔlytA and 
wild-type strains, the majority of the population detected was viable, with the holin-damaged 
fraction corresponding to about 7% (Fig.II.4 and S2). This can be attributed to rapid lysis upon 
holin membrane permeabilization. The compartment of damaged cells that had not yet lysed 
was therefore very sparsely populated due to the extremely fast lysis triggered by holin 
activity. These data provide definite evidence that holin-induced membrane lesions trigger the 
lytic activity of the phage endolysin. 
 





Figure II.3. Kinetics of nisin- and DOC-triggered lysis of wild-type S. pneumoniae SVMC28 and mutants and 
corresponding flow cytometry analysis. (A) Kinetics of nisin-triggered lysis. Nisin at a final concentration of 1 µg/ml 
was added to cultures at an OD600nm of 0.2 to 0.25, and the OD was monitored. The arrows indicate the times at 
which nisin-treated cultures were harvested for flow cytometry analysis (10 min). (B) Flow cytometry analysis of 
wild-type SVMC28 and SVMC28ΔsvlΔlytA after nisin treatment. Exponentially growing cells were treated with nisin 
or left untreated (panel A), stained with a mixture of Syto 9 and PI, and analyzed on a flow cytometer. Similar 
analysis patterns were obtained for SVMC28ΔlytA and SVMC28Δsvl (data not shown). Gates R2 and R3 
differentiated between damaged and undamaged cell populations, respectively, and were designed over gate R1, 
which included the total stained population. The results are representative of a minimum of two independent 
experiments. (C) Kinetics of DOC-triggered lysis. DOC at a final concentration of 0.04% (w/v) was added at time zero 
to cultures in mid-exponential phase (OD600nm=0.4), and the turbidity was monitored. (D) Flow cytometry analysis of 
SVMC28ΔsvlΔlytA exposed to DOC. Exponentially growing cells were treated with DOC at 0.04% (w/v). Culture 
samples were collected at 0, 40, and 80 min after DOC addition (panel C), stained with a mixture of Syto 9 and PI, 
and analyzed on a flow cytometer. As a control, the same cells were left untreated. Gate definitions were as for 
panel A. The results are representative of a minimum of two independent experiments. In panels A and C, the 
results presented for each strain correspond to the mean value of at least two independent assays, and 95% 
confidence intervals are indicated. 
 
We then went on to analyze by flow cytometry the mutant SVMC28Δsvl after MitC 
treatment to test the hypothesis that LytA may also be activated by the same holin lesions that 
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Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10498    10498    -     87 .48 18 .76   26 .57   80 .04 7.28     10 .12   79 .26
R2 R1 11077    10076    -     95 .98 7.25     11 .45   92 .77 72 .73   97 .01   74 .80
R3 R1 134     126     -     1.20 17 .49   21 .83   76 .70 19 .31   28 .21   103.24
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9
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Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10353    10353    -     86 .28 23 .72   34 .26   80 .78 9.80     13 .30   7 .22
R2 R1 10933    9911    -     95 .73 7.43     13 .21   112.18 85 .48   116.71  76 .75
R3 R1 304     263     -     2.54 24 .72   32 .66   87 .34 24 .23   41 .51   113.34
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9







































































File:  0  m in  120 00p AR T IG O .F C S    D a te :  0 4-05-200 7  T im e : 17 :0 8:49     P a rtic les:  120 00   Acq .-T im e:  12 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10179   10179    -     84 .83 32 .35   46 .31   78 .67 13 .62   18 .46   76 .91
R2 R1 10015    8862    -     87 .06 7.27     15 .80   125.20 89 .16   124.79  79 .42
R3 R1 1232    1119    -     10 .99 34 .62   47 .36   80 .26 31 .58   56 .24   101.05
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9







































































File:  d up lo  v iva s 120 00p 2.F C S    D ate:  1 4-09-20 07  T im e:  1 6:44:2 1    P artic les :  12 000 Acq .-T im e:  17 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y M an-y C V-y %
R1 <None> 11221   11221    -     93 .51 32 .67   4 .41   84 .55 13 .68   18 .46   77 .10
R2 R1 455     316     -     2.82 7.94     .04   102.06 39 .68   50 .18   4 .52




































































































































































































































































































































































































































































































































































































Time after DOC addition
untreated 0 min
40 min 80 min
File:  n is in  1 2000 pAR TIGO.FC S    D ate:  04-04 -2 007  T im e:  1 5:21 :0 7    P artic le s:  1 2000    Acq .-T im e : 63  s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10295    10295    -     85 .79 8.89     12 .62   90 .27 5.92     7.48     74 .11
R2 R1 11037    10006    -     97 .19 1.54     2.29     96 .41 40 .71   52 .14   78 .59
R3 R1 30       16       -     0.16 8.10     11 .17   69 .62 8.41     11 .37   80 .36
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9






































































































































File:  n is in  1 2000 pAR TIGO .FC S    D ate:  29-03 -2 007  T im e:  1 7:40 :1 5    P artic le s:  1 2000    Acq .-T im e : 11  s
















































































































Region Gate Ungated C oun t C oun t/m l % Gat d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10718    10718    -     89 .32 27 .78   35 .88   68 .5 12 .42  15 .26   62 .42
R2 R1 11757    10678    -     99 .63 6.98     9.31     67 .9 82 .12  103.15  65 .10
R3 R1 59       18       -     0.17 20 .80   69 .30   116.01 8.77  25 .1    137.75
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9






































































File:  v iv as 120 00p AR TIG O.F C S    D a te : 29 -0 3-200 7  T im e:  14:3 4:39    P a rtic les:  120 00   Acq .-T im e:  1 8 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10146    10146    -     84 .55 63 .53   78 .56   61 .53 28 .16   33 .00   56 .00
R2 R1 313     121     -     1.19 20 .97  32 .10   81 .59 79 .17   99 . 9   73 .91
R3 R1 10992    10001    -     98 .57 92 .91   115.04  61 .92 41 .99   58 .45   80 .56
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9







































































File:  v iv as 120 00p AR TIG O.F C S    D a te : 04 -0 4-200 7  T im e:  16:0 0:28    P a rtic les:  120 00   Acq -T im e:  1 7 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11199    11199    -     93 .33 33 .49   44 .27   68 .57 19 .64   23 .87   6 .63
R2 R1 88      48       -     0.43 0 .71   13 .51   62 .66 30 .17   33 .35   49 .53





























































































































































































































































































































































































































































































































































































































































































































pattern resembled that of the wild-type strain, with a large population of intact cells (gate R3) 
and a smaller fraction of damaged cells (gate R2) at every time point after MitC phage 
induction (Fig.II.4). Contrary to the large reservoir of dead bacteria observed in 
SVMC28ΔsvlΔlytA, the fraction of damaged cells was substantially smaller in SVMC28Δsvl, as 
the population driven into the R2 gate by the holins underwent lysis, becoming undetectable 
by flow cytometry. Thus, membrane permeabilization caused by the holins is responsible for 
triggering LytA activity. However, in SVMC28Δsvl, a larger population of membrane-damaged 
cells (gate R2) was clearly visible from 80 min onward, in contrast to the residual fraction 
observed in the wild-type (Fig.II.4). This observation is in agreement with the previously 
observed lysis delay mediated by LytA in the absence of endolysin. In this case, as the time 
between holin action and LytA-induced lysis was more prolonged, a greater percentage of 
holin-permeabilized but still unlysed cells was detected than with the wild-type. Besides the 
well-defined population of membrane-permeabilized cells, exclusively distributed in the R2 
gate, there was also a population located between the R2 and R3 gates. This mixed population 
was also observed in SVMC28ΔsvlΔlytA, and since it was increasingly found in R2, it may 
correspond to chains containing both damaged and undamaged cells, where the number of 
damaged cells increased with time. This was indeed confirmed by fluorescence microscopy. As 
shown in Fig.II.5, the number of PI-stained cells within the chains increased with time after SV1 
induction. For instance, at 80 min, when the total population was almost evenly distributed 
between R2 and R3 (Fig.II.4), approximately half of most chains in fact consisted of damaged, 
PI-stained cells (Fig.II.5C). In addition, these observations also confirm the increased 
permeabilization perceived from flow cytometry analysis. In line with these data, in the 
SVMC28Δsvl flow cytometry profile, more chains were observed with a mixture of damaged 
and undamaged cells than in the wild-type (Fig.II.4). This persistence of chains, which are not 
promptly dispersed by cell lysis, is caused by the delayed LytA-induced lysis of holin-damaged 
cells. 





Figure II.4. Effect of phage holin activity on S. pneumoniae cell membrane permeabilization. Cultures of SVMC28, 
SVMC28ΔsvlΔlytA, and SVMC28Δsvl were treated with MitC and tested for membrane permeabilization at various 
times by flow cytometry analysis using a mixture of Syto 9 and PI staining (Live/Dead BacLight bacterial viability kit; 
Invitrogen, Carlsbad, CA). Experimentally defined gates R2 and R3 were used to differentiate between damaged and 
undamaged cell populations and were designed over gate R1, which included the total stained population (Fig.II.3). 
The left column shows a shift in the Syto 9/PI staining pattern through time after phage induction of strain 
SVMC28ΔsvlΔlytA, which lacks both the phage endolysin and the S. pneumoniae autolysin, LytA. In the presence of 
lytic enzymes (middle and right columns), a different scenario was observed, with only a few damaged cells 
detected. The data are from a representative experiment of a minimum of three independent experiments. 
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File:  1 20 m in  1 200 0p-4.FC S    D a te : 24 -1 0-200 7  T im e:  12:5 8:34    Pa rticles:  120 00   Ac q.-T im e:  4 0 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11803    11803    -     98 .36 6.98     8.58     68 .86 3.86     5.02     71 .74
R2 R1 1277    1271    -     10 .77 1.12     2.44     130.89 13 .85   15 .75   52 .58
R3 R1 10067    10004    -     84 .76 7.72     9.43     66 .48 3.14     4.63     101.86
S peed : 1 .0
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  13.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9






































































File  1 20 m in  1 200 0p.FC S    D a te : 26 -1 0-200 7  T im e:  12:4 5:22    Pa rticles:  120 00   Ac q.-T im e:  1 5 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 1147    11478    -     95 .65 5.94     7.04     61 .55 4.28     5.40     65 .71
R2 R1 730     700     -     6.10 1.05     2.31     120.78 12 .44   14 .07   49 .92





































































File:  1 20 m in  1 200 0p .FC S    D a te : 26 -1 0-200 7  T im e:  18:3 5:18    P a rtic les:  120 00   Ac q .-T im e:  1 8 s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11013    11013    -     91 .78 24 .38   33 .38   80 .56 11 .87   14 .90   71 .10
R2 R1 9311    8773    -     79 .66 7.34     13 .93   108.88 44 .08   59 .05   80 .29








File:  1 00 m in  1 200 0p.FC S    D a te : 26 -1 0-200 7  T im e:  12:2 6:17    Pa rticles:  120 00   Ac q.-T im e:  1 4 s
















































































































Region Gate Ungated C oun t C oun t/m l % t d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10742    10742    -     89 .52 7.16     8.48     61 .57 5.54     6.67     62 .21
R2 R1 983     761     -     7.08 1.75     3.35     105.31 15 .08   16 .97   48 .79








File:  1 00 m in  1 200 0p-2.FC S    D a te : 24 -1 0-200 7  T im e:  12 4 1:40    Pa rticles:  120 00   Ac q.-T im e:  1 4 s
















































































































Region Gate Ungated C oun t C oun t/m l % d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11722    11722    -     97 .68 7.93     9.91     71 .32 4.30     5.49     68 .99
R2 R1 1554    1528    -     13 .04 2.02     3.51     99 .56 15 .69   17 .43   47 .10
R3 R1 10179    9984    -     85 .17 8.28     10 .11   67 .91 4.18     6.24     98 .49
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9






File:  8 0 m in  12 000 p-2a.FC S    D a te : 24 -1 0-200 7  T im e:  12:2 6:12    Pa rticles:  120 00   Ac q.-T im e:  1 5 s
















































































































Region Gate Ungated C oun t C oun t/m l % t d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10634    10634    -     88 .62 9.85     12 .09   66 .73 5.07     6.27     65 .39
R2 R1 2879    2237    -     21 .04 3.74     6.12     92 .13 23 .81   26 .48   47 .92
R3 R1 8803    8265    -     77 .72 12 .70   15 .19   62 .95 7.60     11 .25   88 .21
S peed : 1 .0
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9







File:  8 0 m in  12 000 p-4.FC S   D ate:  26-10 -2 007   T im e:  12:09 :5 4    P artic le s:  1 200 0   Acq .-T im e : 15  s
















































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % t d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10686    10686    -     89 .05 7.98     9.59     63 .82 5.74     6.87     61 .15
R2 R1 798     579     -     5.42 1.76     3.40     104.90 15 .86   17 .67   47 .53








File:  8 0 m in  12 000 p-2.FC S    D ate:  26-10 -2 007   T im e:  17:49 :3 5    P artic le s:  1 200 0 Acq .-T im e : 12  s
















































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11287    11287    -     94 .06 32 .81   4 .51   77 .91 13 .10   16 .85   73 .13
R2 R1 5009    4656    -     41 .25 9.62     18 .83   104.19 48 .68   62 .15   72 .51





































































File:  6 0 m in  12 000 p-3.FC S    D ate:  26-10 -2 007   T im e:  11:51 :0 3    P artic le s:  1 200 0   Acq .-T im e : 15  s













































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % t d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11151    11151    -     92 .92 10 .20   13 .30   80 .84 7.80     9.23     60 .88
R2 R1 422     279     -     2.50 1.94     3.71     98 .67 17 .17   18 .82   41 .72





































































File:  4 0 m in  12 000 p .FC S    D ate:  26-10 -2 007   T im e:  1 7:13 :5 0    P artic le s:  1 200 0   Acq .-T im e : 17  s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11311    11311    -     94 .26 24 .47   37 .01   93 .27 17 .67   23 .71   79 .08
R2 R1 393     311     -     2.75 6.44     12 .12   98 .32 32 .26   40 .18   69 .75








File:  6 0 m in  12 000 p-3.FC S   D ate:  24-10 -2 007   T im e:  12:10 :2 3    P artic le s:  1 200 0   Acq .-T im e : 17  s
















































































































Region Gate Ungated C oun t C oun t/m l % t d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11016    11016    -     91 .80 11 .48   14 .81   76 .20 6.50     7.94     65 .28
R2 R1 1292    969     -     8.80 4.83     7.68     84 .72 26 .08   29 .06   47 .91
R3 R1 10447    9949    -     90 .31 16 .27   20 .03   70 .37 7.39     11 .34   97 .29
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9




































































































































File:  4 0 m in  12 000 p-3.FC S    D ate:  24-10 -2 007   T im e:  11:50 :1 6    P artic le s:  1 200 0   Acq .-T im e : 29  s
















































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10897    10897    -     90 .81 16 .60   24 .02   86 .09 9.36     11 .93   73 .02
R2 R1 52       36       -     0.33 3.05     5.68     88 .59 20 .02   22 .44   44 .42
R3 R1 1119    10664    -     97 .86 31 .58   42 .47   80 .74 7.75     11 .34   90 .32
S peed : 0 .5
E nable P arameter Gain Log L-L U-L
FS C  220.0 log3 80 .0 999.9
S SC  213.0 log3 10 .0 999.9
S SC  2 h  217.0 log3 10 .0 999.9
FL1  260.0 log4 10 .0 999.9
















File:  6 0 m in  12 000 p-2.FC S    D ate:  26-10 -2 007   T im e:  17:34 :1 8    P artic le s:  1 200 0   Acq .-T im e : 7  s






















































Region Gate Ungated C oun t C oun t/m l % t d GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11209    11209    -     93 .41 31 .90   44 .41   83 .26 15 .49   20 .12   75 .27
R2 R1 1385    1200    -     10 .71 6.54     13 .33   116.09 35 .39   43 .90   77 .45









































File: 100 min 12000p.FCS   Date: 26-10-2007  T ime : 18:09:05    Particle s: 12000   Acq.-T ime : 10 s
















































































































par te c PA S
Reg ion Gate Ungated C ount C ount/m l %Gated GMn-x Mean-x C V -x% GMn-y Mean-y C V -y%
R1 <None> 11151   11151   -    92 .92 29 .18    39 .83    79 .02 12 .24    15 .59    72 .27
R2 R1 8218     7702     -    69 .07 8.06    15 .99    109.51 46 .64    62 .11    78 .56







File:  4 0 m in  12 000 p .FC S    D ate:  26-10 -2 007   T im e:  1 1:33 :1 2    P artic le s:  1 200 0   Acq .-T im e : 10  s
















































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11463    11463    -     95 .53 17 .89   26 .10   90 .84 14 .35   18 .41   76 .64
R2 R1 58       35       -     0.31 2.54     6.93     152.17 17 .02   23 .89   98 .39












Figure II.5. Fluorescence microscopy analysis of Syto 9/PI-stained strain SVMC28ΔsvlΔlytA after MitC phage 
induction. SVMC28ΔsvlΔlytA culture samples were collected at 40, 80, and 120 min after the addition of 0.1 µg/ml 
MitC, stained with a mixture of Syto 9 and PI, and visualized on a fluorescence microscope (magnification, x630). As 
a control, the same cells were not treated with MitC. Different fluorescence patterns were clearly detected. (A) The 
untreated control corresponds mostly to bacteria exclusively stained with Syto 9. (B) After 40 min of phage 
induction, PI stained a few cells (dead cells), although the majority of cells stained only with Syto 9, indicative of 
intact membranes. (C) Eighty minutes after phage induction, almost half of the cells were stained with PI, with 
chains containing a mixture of PI- and Syto 9-stained cells. (D) After 120 min of phage induction, PI stained almost 
every cell. The chains showed few bacteria stained only with Syto 9. Each panel is from a representative experiment 
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The holin-lysin strategy to release phage progeny through host lysis is the most 
widespread system in nature [39] and appears to be present in every S. pneumoniae phage [3-
5]. In this system, phage endolysins ultimately destroy the host envelope, allowing the escape 
of fully assembled virions, and therefore, this phage-encoded function is essential [3,4,11]. 
However, the presence in S. pneumoniae of the powerful autolytic amidase LytA, which both 
structurally and functionally closely resembles pneumococcal phage endolysins [1,40-43], 
raises the possibility that it could play an important role in phage-mediated lysis. Since holins, 
the other protein components of phage holin-lysin systems, form lesions in the host 
membrane [3,7,9] and membrane depolarization leads to autolysis in B. subtilis [17], it is 
tempting to hypothesize that cell wall-resident LytA could be activated by the holin-induced 
lesions. Although it has been suggested that the pneumococcal autolytic enzyme LytA 
contributes to phage release, convincing evidence has never been provided [20,21]. In the 
earlier reports, some experimental conditions used to analyze the role of LytA (e.g., culture 
transfer after Dp-1 infection to medium containing ethanolamine instead of choline) inhibit 
autolysin activity, as indicated by the authors [20], but also inhibit the activity of phage lysins, 
which depend on choline for proper function in the majority of phages, including Dp-1. Thus, 
the inhibition of phage release could be attributed to inhibition of the Dp-1 endolysin activity. 
On the other hand, LytA was essential for lysis of strain R6 at a low multiplicity of infection (<1) 
of the virulent phage Dp-1, since no lytic phenotype was observed in the derived lytA-deficient 
strain, regardless of an evident role of the endolysin at a high multiplicity of infection (>1) in 
the strain lacking LytA [20,21]. Given those inconsistencies, we set out to clarify the role of the 
bacterial autolysin in host lysis and release of newly assembled phage particles, using SV1, a 
lysogenic pneumococcal phage that carries a typical lytic cassette encoding putative holin (Svh) 
and lysin (Svl) activities. 
The data presented here reveal unambiguously that LytA is activated during 
pneumococcal phage-mediated lysis. In the absence of endolysin, this extremely powerful 
autolysin is able to mediate extensive host lysis that actually results in the release of a large 
number of fully functional phage capable of infecting other hosts. Thus, pneumococcal phages 
are able to use the bacterial autolysin LytA to exit from the host cell, completing their life 
cycle, in contrast to all other phages relying on a holin-lysin system. In the overwhelming 
majority of phages studied so far, mutants in the genes encoding endolysins are absolutely 
incapable of host lysis, trapping the phage progeny within the host cell [39]. In T7 and T4 E. coli 
phages, artificial deletion of the endolysin did not prevent host lysis [44]. However, in these 
CHAPTER II 
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unusual cases, the phages evolved to use another protein with muralytic activity encoded in 
their genomes, whose native function is to assist in the initial stages of infection to allow entry 
of the phage genome into the host cytoplasm [44]. Dependence on lytic factors of cellular 
origin to disrupt the infected cell was indeed demonstrated only for phage PM2 of 
Pseudoalteromonas [45]. Still, this phage does not encode an endolysin in its genome to 
autonomously achieve bacterial-host lysis and uses a novel system different from the typical 
holin-lysin strategy for progeny release [45].  
If LytA is activated upon phage induction, leading to productive lysis in the absence of 
phage endolysins, what part does LytA play in the overall process under physiological 
conditions? From the lytic phenotypes, it seems that LytA activation does not contribute 
significantly to endolysin-mediated lysis (except perhaps for earlier lysis in the R36A bacterial 
background). Given these observations, we hypothesized that LytA activation is not crucial to 
accomplish efficient phage progeny release and is merely a side effect of the induction of the 
phage lytic system. However, the results from the phage plaque assays point to a different and 
more complex scenario. Phage release achieved by Svl endolysin is maximized by LytA, since 
the number of phage particles released is diminished in the absence of bacterial autolysin. This 
was observed both in lysogenic SVMC28 and lysogenized R36A strains. Interestingly, in the 
R36A genetic background, the absence of LytA (strain R36APΔlytA) also resulted in delayed 
lysis relative to that of the strain carrying both the phage and bacterial lysins. In conclusion, 
LytA activation after phage induction is not merely an inconsequential parallel process but 
seems to be essential for efficient phage progeny release.  
Although LytA acts cooperatively with phage lysin to optimize phage progeny release, we 
observed that dependence solely on LytA might result in impaired phage fitness. In fact, host 
autolysin-induced lytic phenotypes showed a delay in lysis timing and a reduction in the 
proportion of total lysis. This corresponded to a delay in the release of phage particles and a 
significant reduction in the overall phage yield relative to what happens in the presence of 
both autolysin and endolysin. While retained in host cells, fully assembled phages lose the 
opportunity to infect naïve hosts, with a detrimental effect on phage propagation. Indeed, 
previous reports have shown an intimate relationship between lysis timing and phage fitness 
[44,46]. In addition, as the holins permeabilize the cells before lysis occurs, the LytA-induced 
delay in lysis traps new phages inside an already dead cell without biosynthetic capacity and 
thus incapable of further particle assembly. This LytA-mediated suboptimal phage release 
provides a provocative explanation for the crucial role of endolysins. 
Another important conclusion from our data is that holin-induced lesions of the 
membrane not only activate phage endolysin, but also result in LytA activation. Thus, relying 
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simply on holin function, phages elegantly accomplish the activation of the entire lytic arsenal 
at their disposal. Although holin-induced LytA activation could somehow be predictable, this is 
a significant finding, as dissipation of the membrane proton motive force does not always 
trigger the autolysins. Indeed, in B. subtilis, the major autolysin does not respond to proton 
motive force-dissipating factors, despite other such enzymes being responsible for cell lysis 
following death from energy poisons [47-49]. Thus, our data raise the possibility that the 
energy status of the membrane is important in LytA regulation. However, the underlying 
signalling mechanism induced by depolarization to trigger the activity of LytA is not 
understood. Cell depolarization may induce structural and spatial changes in the membrane 
[17,50,51] leading to LytA activation, probably by altering the inhibitory interactions between 
LytA and cell wall components, such as lipoteichoic acids [16,52]. It must be emphasized that 
LytA activity is not always indicative of bacterial lysis, since the enzyme has been implicated in 
other physiological processes, such as peptidoglycan synthesis and turnover and daughter cell 
separation [15,53]. Given its potentially lethal activity, however, LytA is tightly regulated to 
ensure the maintenance of cell integrity. We may therefore speculate that these physiological 
functions of LytA involve small and controlled local changes in membrane architecture 
activating LytA in a controllable fashion. In contrast, extensive depolarization, such as that 
imposed by holins, with major changes in the cell membrane and consequently in the cell wall 
architecture, may lead to massive and uncontrolled LytA activation, resulting in cell lysis. In 
fact, LytA-induced lysis upon the addition of β-lactams is related to the inhibition of 
peptidoglycan synthesis [54], which could also induce major changes in cell wall structure. 
Since LytA resides in the cell wall, our observation that LytA is activated by holin lesions 
leads us to speculate on an alternative regulatory mechanism of phage endolysins. 
Pneumococcal phage lysins are structurally and functionally similar to the bacterial cell wall 
hydrolase LytA [1,40-42]. Indeed, the constitutive expression of the pneumococcal phage lysin 
Hbl or Cpl-1 in S. pneumoniae M31, a mutant with the lytA gene deleted, restored the ability of 
the strain to undergo lysis in stationary phase and after exposure to DOC, two cellular 
responses that are dependent upon LytA activity [43]. In spite of the absence of a canonical N-
terminal sequence signal, LytA is translocated across the cytoplasmic membrane [16]. Thus, 
pneumococcal phage lysins could also be transported by the same unknown pathway that 
targets LytA to the cell wall and could be subjected to the same type of physiological control. 
Although the canonical model of holin-lysin systems indicates that holins provide access of 
cytoplasmic lysins to the cell wall through holes generated in the cytoplasmic membrane, in 
pneumococci, holins could function simply to activate these secreted endolysins through 
membrane depolarization, similarly to LytA activation, rather than allowing their egress. 
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Taken together, our data provide the first evidence of the involvement of bacterial lysins 
in the progeny release of endolysin-equipped phages. Pneumococcal phage dependency on 
the host autolysin for optimal progeny release underscores the complex relationship between 
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7. SUPPLEMENTARY DATA 
 







Figure II.S1. Construction of S. pneumoniae mutant strains in lytA and svl genes by insertion-deletion. (A) 
Organization of the lytA genetic region of S. pneumoniae in SVMC28 and mutant strains SVMC28ΔlytA and 
SVMC28ΔsvlΔlytA. The upstream and downstream regions of lytA (white and bright grey, respectively) were used 
to construct the amplicon aLTA, represented in dark grey (Table II.1). Transformation with aLTA, containing the 
erm(B) gene, results in the deletion of lytA gene by resistance marker replacement. This was confirmed by PCR 
with the indicated primers (arrows below the maps, Table II.2). (B) Genetic organization of the lytic cassette of 
phage SV1 in SVMC28 and mutant strains SVMC28Δsvl and SVMC28ΔsvlΔlytA. The upstream and downstream 
regions of svl, used to construct aLS1 amplicon (dark grey, Table II.1), are also shown in white and bright grey, 
respectively. Deletion of svl gene resulted from transformation with aLS1 amplicon containing the cat gene. This 
was confirmed by PCR with the indicated primers (arrows below the maps, Table II.2). Pattern arrows indicate the 

















































Figure II.S2. Effect of phage holin activity on SVMC28ΔlytA cell membrane permeabilization. Strain SVMC28ΔlytA, 
which lacks the S. pneumoniae autolysin LytA, was treated with MitC and tested for membrane permeabilization at 
various times by flow cytometry analysis using a mixture of Syto 9 and PI staining. Experimentally defined gates R2 
and R3 were used to differentiate between damaged and undamaged cell populations and were designed over gate 
R1, which included the total stained population. In the absence of LytA, only a few damaged cells were detected, 
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Streptococcus pneumoniae bacteriophages (phages) have typical holin-lysin cassettes to 
accomplish host lysis. The widespread holin-lysin system generally relies on the holin to disrupt 
the cytoplasmic membrane allowing access of the endolysin to the peptidoglycan. Such 
strategy is assumed to operate in pneumococcus based on the extended membrane 
permeabilization by holins and the lack of lysin export signals. We investigated the precise lytic 
mechanism of pneumococcal phages by constructing lysogens without holin activity. 
Upon holin deficient phage induction, lysin was produced and continuously targeted to 
the cell wall, acting as an exolysin. In spite of lacking a signal sequence, our data suggest that 
its export involves the host Sec pathway. At the bacterial surface, the phage lysin remains 
bound to choline in an inactive form, but is readily activated by the collapse of the cytoplasmic 
membrane electrochemical gradient achieved by the holins. In addition, activation of the 
externalized bacterial autolysin LytA, which also participates in phage-mediated lysis, is equally 
related to perturbations of the membrane proton motive force. 
We conclude that in pneumococcal phages the lysin reaches the peptidoglycan through a 
holin-independent pathway and that holin-triggered lesions on the membrane activate phage 




















The holin-lysin system is the main strategy adopted by bacteriophages to achieve lysis of 
their bacterial hosts at the end of the vegetative cycle in order to release their progeny [1]. The 
phage lysin is a protein characterized by having peptidoglycan degrading activity [1]. On the 
other hand, holins are proteins with transmembrane domains that cause lesions in the host 
cytoplasmic membrane [2]. According to the phage λ model for the holin-lysin system, during 
the infective cycle, enzymatically active endolysin accumulates in the cytoplasm, as it lacks an 
intrinsic secretory signal sequence, and holin accumulates in the cytoplasmic membrane 
without compromising its integrity [1]. At a defined time, holins disrupt the membrane 
allowing endolysins to gain access to the peptidoglycan target. Therefore, holins regulate lysin 
function hence determining the precise timing of bacterial lysis [2]. 
Although the holin-lysin paradigm was long though universal recent evidence questioning 
the absolute holin requirement for lysin export to the cell envelope has emerged. It was first 
reported that the Lys44 lysin from oenococcal temperate phage fOg44 carries a typical 
cleavable N-terminal signal sequence [3]. Lys44 is translocated to the extracytoplasmic 
environment by the host Sec machinery involving proteolytic removal of its signal peptide [3]. 
Later it was demonstrated that the Escherichia coli phages P1 and 21 lysins have an atypical 
signal sequence (SAR, signal-arrest-release) in the N-terminal domain that mediates the 
translocation of the enzyme without cleavage [4-6]. These lysins are exported by the host Sec 
system and accumulate in the periplasm as enzymatically inactive proteins anchored to the 
membrane by their N-terminal SAR. Surprisingly, those phages with secretory lysins also 
encode a holin that depolarizes the cell membrane releasing the SAR domain and thus 
generating the active, soluble form of the enzyme in the periplasm [4-8]. In the case of Lys44, 
subsequent studies revealed that lysin activity requires a sudden dissipation of the proton 
motive force (pmf), an event undertaken by the fOg44 holin [9]. A role for the energized 
membrane in regulating lysin activity was suggested [9], resembling the E. coli phages P1 and 
21. It has been recognized that other phage exolysins, mostly of Gram-negative hosts, possess 
secretion signals and, therefore, are likely to be exported also independently of holin activity 
[1,10-12]. 
In Streptococcus pneumoniae, all phages studied so far have typical holin-lysin cassettes in 
their genomes [13-17]. We recently observed that, in addition to the phage lysin, holins trigger 
the cell wall hydrolase LytA, the major pneumococcal autolysin, with a significant contribution 
to phage progeny release [18]. Even though the regulatory mechanism of LytA is not 
understood, the activation by holins indicates that compromising membrane integrity is 
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sufficient for activation of LytA, which remains inactive in the cell wall, presumably attached to 
the choline residues of the cell membrane-linked lipoteichoic acids (LTAs) [19-23]. 
Sequence comparison and functional studies revealed that pneumococcal phage lysins are 
extremely similar to LytA [13,24-27]. Nucleotide sequences share as much as 87% identity, as 
demonstrated for the Hbl lysin of the HB-3 phage [27]. Additionally, both phage and bacterial 
lysins exhibit a bimodular structure with an N-terminal catalytic domain and a C-terminal 
choline binding domain [13,24]. Module shuffling between these lysins of different origins was 
demonstrated to result in chimeric proteins that maintain the enzymatic function [13,28]. 
Moreover, constitutive expression of pneumococcal phage lysins Hbl or Cpl-1 in S. pneumoniae 
strain M31 (lacking LytA), restored the ability of this strain to undergo lysis in stationary phase 
and after exposure to deoxycholate (DOC), two cellular responses that are dependent on LytA 
activity [26]. Thus, S. pneumoniae phage lysins may share with LytA the same cellular 
localization and physiological control mechanisms.  
The increasingly recognition of phages with holin-independent export mechanisms of the 
phage lysin, together with the previously reported cell wall localization of LytA [19-23] and our 
observation that holins trigger LytA activity [18], led us to hypothesize that pneumococcal 
phage lysins, although lacking known secretion signals [13], could be targeted to the cell wall 
without requiring holins. In this case, holins would function to activate the already secreted 
lysins, in contrast to the canonical lysin-holin system believed to function in S. pneumoniae 
phages [13,15,16,29].  
To test this, we investigated the cellular localization and targeting of the pneumococcal 
phage lysin in the absence of holin function. The activation of the lysin was also tested using 
compounds that mimic the permeabilizing and pmf-dissipating membrane effects of holins. 
We found that the phage lysin does not accumulate in the cytoplasm but is continuously 
exported to the cell wall during phage assembly. Despite lacking a recognizable leader peptide 
or other known Gram-positive cell wall targeting motifs, our data point to the involvement of 
the host Sec pathway in lysin export. These findings show that in S. pneumoniae the transport 
of phage lysin to the cell wall compartment is not holin-mediated and that holin function 
results in the activation of both the secreted phage lysin and the bacterial autolysin by 





HOLIN-INDEPENDENT TARGETING OF PHAGE LYSINS 
94 
3. MATERIAL AND METHODS 
 
Bacterial strains, growth conditions and sodium azide sensitivity assay 
 
Streptococcus pneumoniae strains used in this study (Table III.1) are derivatives of strain 
SVMC28 (capsular type 23F, sequence type 36), which is a clinical isolate lysogenic for phage 
SV1 obtained from the Rockefeller University collection (A. Tomasz). All S. pneumoniae strains 
were grown in a casein-based semisynthetic medium (C+Y) at 37ºC without aeration [30] or in 
tryptic soy agar (TSA) (Oxoid, Hampshire, England) supplemented with 5% sterile sheep blood 
incubated at 37ºC in a 5% CO2 atmosphere. Pneumococcal mutant strains were grown in the 
presence of 200 μg/ml kanamycin (Kn), 100 μg/ml streptomycin (Sm), 4 μg/ml 
chloramphenicol (Cm) and/or 2 μg/ml erythromycin (Ery)  (Sigma, Steinheim, Germany), as 
appropriate.  
To evaluate the sensitivity of the wild-type and ΔholΔlytA strains to sodium azide (NaN3), 
cultures were grown to an optical density at 600 nm (OD600nm) of 0.2 (approximately 10
8 
CFU/ml) and appropriate dilutions were plated on blood-supplemented TSA plates containing 




All routine DNA manipulations were performed according to standard methods [31]. PCR 
primers are listed in Table III.1. Chromosomal DNA from S. pneumoniae and phage DNA were 
isolated similarly to already described procedures [32,33]. PCR reactions for the purpose of 
constructing mutant strains were carried out with High fidelity PCR enzyme Mix kit (MBI 
Fermentas, Vilnius, Lithuania). PCR products were purified using the High Pure PCR product 
purification system (Roche, Mannheim, Germany). All oligonucleotides were obtained from 
Invitrogen Co. (Paisley, Scotland). Nucleotide sequences were analyzed using VECTOR NTI 




Prior to the construction of mutant strains, S. pneumoniae wild-type strain SVMC28 was 
tested for growth in the presence of Kn and Sm by seeding in TSA supplemented with the 
antibiotics at the appropriate concentration (200 μg/ml and 100 μg/ml, respectively). The Kn 
sensitivity and Sm resistance background in SVMC28 allowed the usage of janus (kan-rpsL+) 
cassette [34], in a two-step transformation procedure for holin elimination.  
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First, strains harboring a substitution of the hol genes (svh1 and svh2) by the kan-rpsL+ 
cassette were constructed following the procedure previously described [34]. A PCR fragment 
containing the region immediately upstream of svh1 was amplified from SV1 phage DNA with 
primers AF_H and AR_H_C, and the kan-rpsL+ cassette was amplified from a PCR fragment 
containing the cassette (kindly provided by D. Morrison) with the Kan5 and DAM351 primers 
(Table III.1). Following purification, the two fragments were mixed and connected to generate 
fragment A by PCR with primers AF_H and DAM351. A fragment downstream of svh2 gene 
(containing just 11 bp of svh2) was then amplified from SV1 DNA with the BF_H_C/BR_H 
primer pair (Table III.1), purified and mixed with fragment A for assembly into a unique 
product through PCR amplification with primers AF_H and BR_H. Strains SVMC28 hol::kan-
rpsL+ and  SVMC28 hol::kan-rpsL+ lytA were obtained following transformation of strains 
SVMC28 and SVMC28 lytA respectively, with the final purified PCR product by selection for  
Knr transformants (Table III.1). 
Next, the kan-rpsL+ cassette was deleted as follows. The PCR fragment containing the 
region immediately upstream of svh1 was amplified with primers AF_H and AR_H_C2 and the 
fragment downstream of svh2 (with 11 bp of svh2) was amplified with primers BF_H and BR_H. 
Fragments assembly into a unique product was achieved with the AF_H and BR_H primer pair 
(Table III.1). Strains SVMC28 hol and  SVMC28 hol lytA (without the entire cassette) were 
obtained following transformation of strains SVMC28 hol::kan-rpsL+ and  SVMC28 hol::kan-
rpsL+ lytA respectively, with the final purified PCR product generating Kns Smr transformants 
selected with Sm (Table III.1). All strains harboring a deletion in lytA, were also selected for 
chloramphenicol resistance. Besides drug selection, mutants resulting from each 
transformation were further confirmed by PCR with primers AF_H and BR_H. Subsequent DNA 
sequencing confirmed holins deletion and the integrity of phage lysin svl gene.    
An identical strategy was used to construct the mutant strain SVMC28Δhol svl (Table 
III.1). The PCR fragment containing the region immediately upstream of svh1 and the kan-rpsL+ 
cassette were amplified and connected as before (fragment A). A fragment downstream of svl 
gene (containing 185 bp of svl) was amplified from SV1 DNA with the 2BFSVL_C/2BR_SVL 
primer pair (Table III.1), and assembled with fragment A with primers AF_H and 2BR_SVL. 
Transformation of SVMC28 with the final PCR product and selection for Knr transformants 
resulted in strain SVMC28 hol svl::kan-rpsL+. The kan-rpsL+ cassette was then deleted as 
follows. The region immediately upstream of svh1 and the region downstream of svl (with 185 
bp of svl) were amplified with primers pairs AF_H/AR_H_C3 and 2BFSVL/2BRSVL, respectively 
(Table III.1). Fragments assembly into a unique product was generated with AF_H and 2BRSVL 
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(Table III.1). Strain SVMC28 hol svl (without the entire cassette) was obtained following 
transformation of strain SVMC28 hol svl::kan-rpsL+ with the final purified PCR product by 
selection  for Smr transformants (Table III.1). Additionally to drug selection, mutants resulting 
from each transformation were further confirmed by PCR with primers AF_H and 2BRSVL. 
Subsequent DNA sequencing confirmed holins and svl deletion.    
Transformation of pneumococci was carried out as described [18]. Lysis upon DOC 
addition and after culture growth until late stationary phase confirmed the presence of LytA 
activity in SVMC28 hol and SVMC28 hol svl. In strain SVMC28 hol lytA, a nonlytic 




For induction of lysis, cultures were grown overnight at 37ºC in C+Y supplemented with 
the appropriate antibiotics, diluted 1:100 in fresh medium (without antibiotics) and kept at 
37ºC for the rest of the incubation period. Kinetics of lysis was monitored by measuring 
OD600nm. In experiments of induction of the phage lytic cycle, mitomycin C (MitC) (Sigma, 
Steinheim, Germany) was added when cultures reached approximately OD600nm 0.2-0.25 to a 
final concentration of 0.1 g/ml [35]. In membrane permeabilization assays, MitC-induced 
cultures were treated with DOC [0.04% (w/v)] (Sigma, Steinheim, Germany) at different time 
points. MitC-untreated controls were also treated with DOC at the same time points. In 
membrane pmf-dissipating assays, N,N´-dicyclohexylcarbodiimide (DCCD) (Sigma, Steinheim, 
Germany), an ATP synthase inhibitor [36], was added after 60 min of MitC addition at a final 
concentration of 100 μM. Whenever cultures were not MitC-induced, DCCD was added 60 min 
after the culture reached OD600nm 0.2-0.25, when MitC is added in treated cultures. In Sec- 
dependent export assays, after 20 min of MitC induction, cultures were treated with NaN3, a 
widely used SecA inhibitor, at a final concentration of 5 mM [37-40]. DCCD was added to 
cultures at 60 min and DOC at 200 min. As control for NaN3 effect on viability, DCCD was not 
used. For cultures not treated with NaN3, DCCD was added 60 min after MitC addition. All 




Flow cytometry analysis of cultures treated with MitC and DCCD was performed. As a 
control for cell death, cultures were treated with DOC. Cultures were treated with MitC or 
DCCD as described in the lysis assays section and cells were collected after exposure at defined 
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intervals and then diluted in sterile-filtered 0.85% NaCl to a concentration of ~ 1x10
6cells/ml. 
Cell viability was assessed by using the Live/Dead BacLight bacterial viability kit (Invitrogen, 
Carlbad, USA) as previously described [18]. Samples were analyzed on a Partec CyFlow space 
flow cytometer (Partec GmbH, Münster, Germany) with 488 nm excitation from a blue solid-
state laser at 50 mW. Green fluorescence (Syto 9), indicating the population of cells without 
permeabilized cytoplasmic membranes, was detected in the FL1 channel and red fluorescence 
(PI), indicating the population of cells with permeabilized cytoplasmic membranes, was 
detected in the FL3 channel. Optical filters were set up such that FL1 measured at 520 nm and 
FL3 measured above 610 nm. The sample analysis rate was kept below 1000 events/s. Twelve 
thousand events were collected for each sample taken. Data were collected and analyzed by 
using FloMax software (Partec GmbH, Münster, Germany). Assays were carried out at least in 
duplicate. 
 
Preparation of bacterial proteins 
 
Cells were grown at an OD600nm of 0.2-0.25 and then induced with MitC or left untreated. 
Sample aliquots (7 ml) were taken from liquid cultures at the indicated time points after MitC 
treatment. In the case of untreated cultures, the samples were collected at the same time 
points after the culture reached OD600nm 0.2-0.25. Cells were harvested by centrifugation (3200 
g, 4ºC, 10 min), washed once with 0.5 volumes of PBS 1x (PBS 10x pH 7.2, Gibco, Invitrogen, 
Paisley, Scotland) and ressuspended in 200 μl Tris 50 mM pH 7.5 (this cell pellet fraction was 
designated P). For choline wash, PBS washed cells were gently ressuspended in 200 μl choline 
chloride 2% (w/v) (Sigma, Steinheim, Germany) prepared in PBS 1x and incubated 30 min at 
4ºC without agitation. Bacteria were collected by centrifugation (3200 g, 4ºC, 15 min) and the 
supernatant was filtered through a 0.2 μm-low-binding-protein membrane (DISMIC-03CP, 
Toyo Roshikaisha, Ltd., Japan) to ensure the removal of all bacteria. This choline wash fraction 
was designated Scholine. As control, cells were incubated in the same conditions with PBS 1x or 
NaCl 2% (w/v) and the wash fractions were designated SPBS and SNaCl, respectively. The pellet 
was then washed once with 0.5 volumes of PBS 1x and ressuspended in 200 μl Tris 50 mM pH 
7.5. If cells were previously washed with choline, this cell pellet fraction was called Pcholine; if 
cells were subjected to control PBS wash, the fraction was called PPBS.  
In Sec-dependent export assays, cells grown at an OD600nm of 0.2-0.25 were induced with 
MitC and 20 min after induction, cultures were treated with NaN3 at final concentration of 5 
mM. Cells treated only with MitC were used as control for NaN3 effect. As before, sample 
aliquots (7 ml) were taken from liquid cultures at the indicated time points after MitC 
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treatment. Cell pellets (P) and choline wash fraction (Scholine) were prepared as described 
above. 
 
SDS-PAGE and immunoblotting  
 
Polyclonal antibody (pAb) against pneumococcal autolysin LytA was kindly provided by P. 
Garcia [41], monoclonal antibody (mAb) 144,H-3 that recognizes streptococcal elongation 
factor Ts was provided by J. Kolberg [42] and pAb antibody to CodY was a gift of A. Sonenshein 
[43]. mAb against pneumococcal pneumolysin (Ply) was purchased from Statens Serum 
Institute (Copenhagen, Denmark). For SDS-PAGE electrophoresis, samples (5 or 10 μl of total 
cells and 45 μl of cell washes) were boiled for 5 min with sample buffer containing 10% β-
mercaptoethanol at a final concentration of 1x. Samples were electrophoresed in 5% 
acrylamide stacking and 12% separating gels and proteins were electrotransferred to 0.20 μm 
nitrocellulose membranes (Whatman GmbH, Dassel, Germany). Protein molecular mass 
marker Precision Plus Protein Standard was used (Bio-rad, California, USA). For 
immunodetection, anti-LytA (rabbit), anti-Ply (mouse), anti-Cody (rabbit) and 144,H-3 anti- 
L7/L12 and Ts (mouse) antibodies were used at a dilution of 1:10000, 1:1000, 1:10000 and 
1:5000, respectively. mAb 144,H3 was used as hybridoma supernatant fluid. Secondary 
antibodies anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase (Santa Cruz 
Biotechnology Inc., California, USA) were diluted 1:5000. After incubation, blocking and 
washing procedures, blots were developed using the Pierce ECL western blotting substrate 
(Thermo Fisher Scientific Inc., Rockford, USA), according to the manufacturer’s instructions, 
and exposed to Amersham Hyperfilm ECL (GE Healthcare, Buckinghamshire, UK). 
 
 




, kanamycin resistance; Sm
r
, streptomycin resistance; Cm
r
, chloramphenicol resistance; Ery
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, erythromycin resistance; Nov
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, novobiocin resistance. 
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Information given in the order sequence; gene; and SV1 lytic cassette GenBank accession number. 
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    CP1500 Nov
r
; donor of point markers, control in transformation assays [44] 
Primers
b
   
    AF_H CTTAACCAAGCCTTACGAATGAC; upstream of svh1; FJ765451 This study 
    AR_H_C CATTATCCATTAAAAATCAAACGGCTCCTATTCTTTAGGTTCTCCCG (underlined sequence corresponding to 
kan cassette; complementary to primer Kan5); upstream of svh1 and downstream of AF_H; FJ765451 
This study 
    Kan5 CCGTTTGATTTTTAATGGATAATG [34] 
    DAM351 CTAGGGCCCCTTTCCTTATGCTTTTGGAC [34] 
    BF_H_C GCATAAGGAAAGGGGGCCTAGGGAAAGGACGATAGGGAATGG (underlined sequence corresponding to 
rpsL; complementary to primer DAM351); downstream of svh2; FJ765451 
This study 
    BR_H CTTGCTTAAACTGTTCACGGC;  downstream of svh2 and downstream of BF_H_C; FJ765451 This study 
    AR_H_C2 CCATTCCCTATCGTCCTTTCCCTCCTATTCTTTAGGTTCTCCCG (underlined sequence corresponding to 
region downstream of svh2; complementary to primer BF_H); upstream of svh1 and downstream of 
AF_H; FJ765451  
This study 
    BF_H GGAAAGGACGATAGGGAATGG; downstream of svh2 and upstream of BR_H;  FJ765451   This study 
    2BFSVL_C GCATAAGGAAAGGGGCCCTAGTGAAGACAGGCTGGGTCAAGTAC (underlined sequence corresponding to 
rpsL; complementary to primer DAM351); downstream of svl; FJ765451  
This study 
    2BRSVL GCTATTTCCCAAGGTGCTGG; downstream of svl and downstream of 2BFSVL_C; FJ765451 This study 
    AR_H_C3 GTACTTGACCCAGCCTGTCTTCACTCCTATTCTTTAGGTTCTCCCG (underlined sequence corresponding to 
region downstream of svl; complementary to primer 2BFSVL); upstream of svh1 and downstream of 
AF_H; FJ765451 
This study 
    2BFSVL TGAAGACAGGCTGGGTCAAGTAC; downstream of svl and upstream of 2BRSVL; FJ765451 This study 
9
9




Phage lysin and bacterial autolysin are not able to cause phage-mediated lysis in the absence 
of holin function 
 
In order to study how the phage holin-lysin mechanism operates in S. pneumoniae, we 
constructed holin-deficient Δhol lysogens. We reasoned that exploring both the cellular 
localization of the phage lysin and its triggering signals in a context without holin activity would 
offer insights into how holin and lysin functions integrate to achieve bacterial host lysis.  
The holin mutants were generated in pneumococcal strain SVMC28, lysogenic for phage 
SV1 (Table III.1). The lytic cassette of SV1 was previously characterized (Genbank accession 
number FJ65451) and contains two genes, svh1 and svh2, just upstream of the svl gene 
encoding the lysin Svl [18], which potentially encode two small proteins of 140 and 110 amino 
acids with a predicted molecular mass of 15.8 kDa and 11.9 kDa, respectively. The putative 
Svh1 and Svh2 proteins show high amino acid sequence identity (81.1% to 98.6%) to the two 
predicted holins from the S. pneumoniae lysogenic phages MM1 [17], VO1 [45] and 23782 [46]. 
Analysis of the predicted structure of the potential Svh holins using SOSUI 
(http://www.expasy.org) also reveals three and one potential hydrophobic transmembrane 
regions for Svh1 and Svh2 (with a N-out, C-in topology), a characteristic of class I and III holins 
[2,47], respectively. Moreover, as previously reported, attempts to clone svh1 and svh2 in E. 
coli resulted in loss of viability [18]. Therefore, the characteristics of the putative Svh proteins 
suggest that these proteins correspond to the holins of phage SV1.  
To eliminate holin activity, both svh1 and svh2 genes were deleted. All mutant strains 
displayed growth rates similar to the wild-type strain regardless of genetic manipulations. As 
expected, lytA-deficient strain ΔholΔlytA was resistant to autolysis in stationary phase 
(Fig.III.1A) and when treated with DOC (Fig III.2A2), two cellular responses dependent upon 
LytA. In contrast, Δhol and ΔholΔsvl show lysis in stationary phase (Fig.III.1A) and in response 
to DOC (data not shown) as expected from a fully functional autolysin. 
As holins permeabilize the pneumococcal membrane triggering the activity of both phage 
and bacterial lysins [14,18], the elimination of holin activity would be expected to prevent 
activation of both lysins. This was confirmed by inducing the SV1 lytic cycle with MitC in the 
Δhol mutants (Δhol, ΔholΔlytA and ΔholΔsvl). As anticipated, in the absence of holins, phage 
induction and a full course of phage infectious cycle did not culminate in host lysis at the 
expected time, despite the presence of LytA and Svl (Fig.III.1A). In fact, no lysis was observed in 
the Δhol mutants even two hours after its onset in the holin-carrying strains Δsvl and ΔlytA, a 
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time when lysis already reached its full extent in these strains with functional holins (Fig.III.1A). 
Cultures eventually lysed but only after a long MitC exposure, which is possibly related to the 
autolytic process occurring in late stationary phase [48] exacerbated by the accumulation of 
intracellular phages and phage proteins that have been shown in phage λ to continue to build 
up when holins fail to determine the moment of lysis [1,49].  
To further verify the abolishment of holin activity we tested the membrane integrity by 
flow cytometry after phage induction. In this assay, cells with permeabilized membranes allow 
the uptake of PI, fluorescing in the FL3 channel, while cells with nonpermeabilized membranes 
internalize only Syto 9, fluorescing in FL1. The gates representing permeabilized (R2) and 
nonpermeabilized cells (R3) were constructed as previously described [18]. In both ΔholΔsvl 
and ΔholΔlytA strains, MitC-treated cells are always found in gate R3 (Fig.III.1B), whether cells 
are analyzed before (40 min), at the onset (80 min) or at the end (120 min) of the lytic process 
observed in the Δsvl and ΔlytA strains possessing functional holins (Fig.III.1A). Indeed, at 120 
min only a small fraction of the cells are found in gate R2, with approximately 96% of cells 
maintaining membrane integrity. Similar results were obtained for the strain lacking holin 
activity but retaining both lytic functions (supplementary data, Fig.III.S1). In contrast, a strain 
with intact holin function but ΔsvlΔlytA becomes increasingly permeabilized after phage 
induction and at 120 min cells were found mostly in gate R2 (Fig.III.1B), as previously reported 
[18]. Collectively, the absence of membrane permeabilization and lysis demonstrates the 
successful elimination of holin activity and confirms that holins are required to activate lysins.  
 
Premature phage lysin-mediated lysis is induced by DOC that mimics holin function  
 
To further explore the pneumococcal holin-lysin mechanism, we examined lysin 
production throughout the lytic cycle before holin action. Since phage lysins are activated 
through membrane permeabilization caused by holins and the permeabilizing properties of 
DOC were previously confirmed by flow cytometry [18], DOC addition should result in phage 
lysin activation similarly to LytA. DOC was then added at several time points after phage 
induction to the ΔholΔlytA strain containing a functional phage lysin. In the absence of 
autolysin activity, lysis promoted by DOC should be related to phage lysin concentration.  
As can be seen in Fig.III.2A1, the addition of DOC to MitC-treated ΔholΔlytA cultures 
resulted in a gradual increase of lysis with time reaching a substantial percentage from 60 min 
onwards (over 75%). In contrast, only modest DOC-mediated lysis is observed at any time point 
in MitC-untreated cultures, with only 30% lysis at 60 min (Fig.III.2A2).  




Figure III.1. Effect of holin deletion in pneumococcal phage-induced lysis. (A) Absence of lysis in mutants lacking 
holins. SVMC28 derived mutants lacking holins with or without functional LytA and Svl were grown until OD600nm= 
0.2-0.25 and 0.1 g/ml of MitC was added to induce phage excision (t=0 min). As control for lysis, mutants carrying 
holins but deleted in LytA or Svl were also induced (dotted lines). Results are an average of a minimum of three 
independent experiments. Error bars represent 95% confidence intervals. (B) Maintenance of membrane integrity. 
Exponentially growing cells were treated with MitC (as indicated in panel A), collected after 40, 80 and 120 min and 
tested for membrane permeabilization by flow cytometry following staining with a mixture of Syto 9 and propidium 
iodide (PI) (Live/Dead BacLight bacterial viability kit, Invitrogen, Carlbad, USA). Similar analysis patterns were 
obtained for SVMC28Δhol (supplementary data, Fig.III.S1). As control for holin-induced permeabilization, strain 
SVMC28ΔsvlΔlytA was also studied and the results were similar to those already described [18]. Gate R2 
corresponds to the membrane damaged population, while gate R3 corresponds to the population with intact 
membrane. Both gates were designed over gate R1, which includes the total stained population. Results are 
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10992    10992    -     91 .60 23 .00   30 .95   70 .53 30 .94   38 .89   65 .57
R2 R1 159     103     -     0.94 4.34     7.41     113.54 13 .41   16 .83   78 .01
R3 R1 11595    10812    -     98 .36 53 .66   70 .25   67 .76 9.76     15 .26   85 .75
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par te c PAS
Region Gate Ungated C oun t C oun /ml % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10858    10858    -     90 .48 24 .97   33 .14   66 .32 38 .00   46 .60   58 .13
R2 R1 63       34       -     0.31 3.58    5.24     90 .86 10 .20  12 .79  78 .92
R3 R1 11686    10762    -     99 .12 72 .53   94 .80   64 .39 7.63     11 .11   79 .19
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 9953    9953    -     82 .94 13 .25   17 .71   80 .03 16 .38   19 .64   65 .76
R2 R1 698     372     -     3.74 3.27     5.32     109.68 11 .32   12 .77   56 .76
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10888    10888    -     90 .73 16 .93   24 .21   81 .20 23 .90   30 .90   73 .15
R2 R1 263     156     -     1.43 2.62     4.14     106.91 10 .08   11 .3    53 .70
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y
R1 <None> 10938    10938    -     91 .15 23 .64   32 .01   70 .42 33 . 0   42 .25   61 .81
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par te c PAS
Region Ga e Ungated C oun t C oun t/m l Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10750    10750    -     89 .58 16 .04   21 .71   74 .41 19 .78   24 .47   65 .77
R2 R1 360     256     -    2 38 2.49     3.77     104.38 8.10     9.29     61 .28
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11047    11047    -     92 .06 11 .75   16 .46   85 .58 17 .72   21 .59   66 .82
R2 R1 294     208     -     1.88 2.35     4.28     152.84 9.01     11 .39   86 .11
R3 R1 11347    10676    -     96 .64 40 .32   53 .79   78 .29 3.92     7.45     110.71
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Region Gate Ungated C oun t C oun t/m l Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11208    11208    -  93 .40 13 .91   18 .82   81 .89 14 .85   18 .46   68 .42
R2 R1 7530    7167    -  63 .95 6.46     10 .25   106.31 18 .23   23 .24   75 .61
R3 R1 4276    3990    -     35 .60 24 .09   31 .26   76 .40 11 .98   19 .27   88 .86
File:  L ytAL ytP  80  m in  pa rte 2  ga te d  AR T IGO.F C S   D a te :  1 -1 2-20 0  T im : 17 :0 0:06    P a rtic les: 20 00   Acq .-T im e:  2 0 s


























































































































































Region Gate Ungated C oun t C oun /ml % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11109    11109    -     92 .58 14 .85   20 .34   82 .25 17 .49   21 .34   66 .62
R2 R1 5541    5119    -     46 .08 4.92     8. 1    120.04 16 .81   21 .40   74 .84














































Western blot was also performed with the ΔholΔlytA strain using an antibody anti-LytA 
that recognizes the phage lysin due to the high similarity between LytA and Svl (89.3% identity 
at the amino acid level). A band of approximately 36 kDa was detected corresponding to the 
predicted mass of Svl (36.53 kDa). In agreement with the observed lysis, immunoblotting 
analysis of the MitC-treated culture revealed a large amount of Svl at 60 min (Fig.III.2B). When 
the same cells were not treated with MitC, only a residual amount of Svl was detected. The 
considerable increase in the quantity of Svl upon MitC treatment is consistent with induction 
of the phage lytic cycle since MitC treatment has little influence on the synthesis of the 
bacterial proteins elongation factor Ts and pneumolysin Ply (Fig.III.2B). In the absence of MitC, 
phage induction can still occur spontaneously although at a lower rate [50,51] with the 
subsequent synthesis of Svl (Fig.III.2B). Accordingly, the Svl accumulated in these conditions 
may be responsible, possibly together with other bacterial lysins, for the residual lysis 
observed (Fig.III.2A2, ΔholΔlytA MitC-; see also Fig.III.S2). Taken together these data indicate a 
progressive synthesis of pneumococcal phage lysin across the lytic cycle until lysis. 
Comparing ΔholΔlytA and ΔlytA, which differ only in the presence of functional holins, the 
lysis pattern due to DOC is the same up to 60 min of MitC treatment (Fig.III.2A1 and A3). 
Importantly, in both strains a significant lysis percentage (observed at 60 min) occurs upon 
DOC treatment before the normal time of lysis defined by holin action at 80 min, 
demonstrating that phage lysin build up does not by itself lead to bacterial lysis. Regardless of 
a significant accumulation of Svl, lysis was blocked until DOC was added to permeabilize the 
membrane. Thus, in S. pneumoniae a mechanism regulating phage lysins is functioning to 
prevent premature bacterial lysis. 
 
Phage lysin is cell wall localized and the targeting is not dependent upon holin 
 
Since DOC permeabilizes the membrane lipid bilayer, the observed lysis mediated by the 
phage lysin could result from compromising the barrier function of the cytoplasmic membrane. 
Thus, the release of intracellularly accumulated lysins onto their peptidoglycan substrate 
cannot be excluded. We next designed experiments to determine the exact location of the 
phage lysin. It was shown that LytA contains a choline binding domain that attaches the 
protein to the cell surface namely to the choline residues in the peptidoglycan-bound teichoic 
acids and lipoteichoic acids [13,19,21,23]. It was also shown that a 2% choline solution could 
compete for the binding sites leading to the release of LytA from the bacterial surface [19,52]. 
Due to high functional and structural similarity between LytA and pneumococcal phage lysins, 
including Svl, the effect of choline on phage lysin attachment was examined. To avoid holin-
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mediated phage lysin escape that could lead to misinterpretation of its localization, lysogens 

























Figure III.2. Premature phage lysin-mediated lysis of S. pneumoniae is triggered by membrane permeabilization. 
(A1, 2 and 3) Kinetics of DOC-induced lysis after phage induction. SVMC28ΔlytA and SVMC28ΔholΔlytA strains were 
grown until OD600nm=0.2-0.25 and 0.1 µg/ml of MitC was added to induce phage excision (t=0 min). Cultures were 
treated with DOC [final concentration of 0.04% (w/v)] at 20-min intervals after phage induction until 120 min. 
OD600nm is indicated before (full symbols) and 20 min after DOC addition (open symbols) and DOC-triggered lysis is 
expressed as percentage of optical density drop (values are shown above the bars). As control, MitC-untreated 
SVMC28ΔholΔlytA was also treated with DOC. Results are an average of a minimum of three independent 
experiments. Error bars represent 95% confidence intervals. (B) Phage lysin synthesis and accumulation after phage 
induction. SVMC28ΔholΔlytA was treated with MitC (as indicated in panel A) or left untreated. After 60 min of MitC 
addition, cells were harvested by centrifugation. In the case of untreated cultures, equal amounts of cells were 
collected at 60 min after the culture reached OD600nm 0.2-0.25 (when MitC is added to the treated cultures). 
Samples were processed for SDS-PAGE and western blotting to check for phage lysin Svl production with anti-LytA 
antibody. 10 μl of each sample was run in each lane. Imunodetection of the pneumococcal proteins Ts (cytoplasmic 
elongation factor) and Ply (cell wall pneumolysin) was also performed with antibodies 144,H-3 and anti-Ply, 




































































































































































































When lysogens expressing Svl (ΔholΔlytA MitC+) were washed with 2% choline in PBS, 60 
min after phage induction with MitC, Svl was found in a significant amount in the choline wash 
(Scholine) whereas no phage lysin was released from the cells by washing with PBS only (SPBS) 
(Fig.III.3A) or 2% NaCl solution (SNaCl) (Fig.III.3B), ruling out lysin extraction due to the high ionic 
strength of the choline solution. This observation suggests that the phage lysin is located in the 
cell wall even in the absence of the holin. As a control, the cell wall localized LytA was also 
extracted by the choline solution and found solely in Scholine (strain ΔholΔsvl, Fig.III.3A and B). 
Moreover, cytoplasmic Ts was not detected in the choline, PBS and NaCl washes excluding 
contamination of the wash fractions with cells or components of the cytoplasm due to cell lysis 
and also guaranteeing that Svl present in Scholine results exclusively from the action of choline. 
Similar results were obtained with another known cytoplasmic protein, CodY, reported before 
to successfully control for cell lysis in S. pneumoniae [53]. Finally, Ply was used as another 
control for the choline wash. Ply was recently demonstrated to localize at the cell surface [53], 
but since it is not a choline binding protein it is not expected to be affected by choline. 
Although almost undetectable, Ply was present in the wash fractions (Scholine and SPBS), which is 
consistent with its noncovalent binding to the cell wall [53], but it is detected in equivalent 
amounts in both choline and PBS washes strongly supporting the specificity of the choline 
wash to remove only choline binding proteins such as Svl and LytA.  
Overall, it can be concluded from these findings that pneumococcal phage lysin localizes 
to the cell surface and is dependent on interactions with choline for cell wall association. 
Furthermore, as in the absence of holins the phage lysin is found in the cell wall, holins are not 
required for phage lysin transport across the S. pneumoniae cytoplasmic membrane.  
Choline washing was used to further explore the surface localization of phage lysin on 
intact cells across the lytic cycle. ΔholΔlytA lysogens were treated with MitC, samples of equal 
volume were collected at different time points and the presence of Svl was assayed in the 
pellet (P) and wash fractions (S). Western blot analysis of the phage lysin production during 
SV1 lytic cycle indicated that the protein was detectable in pelleted cells at all times (Fig.III.3C). 
The Svl detection when MitC is added (t=0 min) can be attributed to spontaneous events, as 
mentioned above. With increasing time, however, MitC phage induction leads to increasing 
concentrations of Svl until the moment of lysis at 80 min. To better evaluate this, cytoplasmic 
accumulation of Ts was also followed. Although an increase of Ts was expected, as phage 
induction by MitC arrests cell division but cells continue to elongate and increase in mass 
[25,54], we observed that this increase is not as marked as that of Svl. Svl expression at the 
end of the lytic cycle is 6.7-fold higher when normalized by Ts (Fig.III.3C). Analogous 
observations were extended to the wash fractions. Choline led to the elution of increasing 
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amounts of Svl with time (Fig.III.3C). This amount of Svl extracted by choline was proportional 
to the amount accumulated in the cells (Scholine vs P, Fig.III.3C upper and lower panel). Control 
PBS washes did not promote Svl removal. Again, Ts cytoplasmic control revealed no detectable 
cell lysis or cell contamination in any of the wash samples, with Ts being detectable only in the 
intact bacteria. The results were clearly indicative of continuous holin-independent targeting 
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Figure III.3. Holin-independent cell wall localization of pneumococcal phage lysins. (A and B) Choline is able to 
extract phage lysins from intact bacteria. SVMC28ΔholΔlytA was treated with MitC (as indicated in Fig.III.1A) for 
phage induction. After 60 min of MitC addition, equal amounts of cells were harvested by centrifugation. Cells that 
were directly ressuspended in Tris 50 mM pH 7.5 correspond to the cell pellet fraction, P. Cells that were choline 
washed originated the supernatant choline wash fraction Scholine and the cell pellet fraction Pcholine. Control samples 
that were PBS or NaCl washed, instead of choline, originated SPBS and PPBS or SNaCl. All fractions were tested by 
western blotting for Svl presence with anti-LytA antibody. LytA was used as control for choline wash, thus 
equivalent samples were also collected 60 min after MitC-untreated SVMC28ΔholΔsvl culture reached OD600nm 0.2-
0.25. To control any contamination of fractions and the specificity of the choline washes, all fractions were tested 
for pneumococcal cytoplasmic elongation factor Ts (antibody 144,H-3), cytoplasmic protein CodY (antibody anti-
CodY) and cell associated pneumolysin Ply (antibody anti-Ply) that is not expected to be removed by choline. (C) 
Time course of phage lysin synthesis and cell wall targeting. Equal aliquots were taken from MitC-treated 
SVMC28ΔholΔlytA culture at 0, 20, 40, 50, 60 and 80 min. Cells were harvested by centrifugation and directly 
ressuspended in Tris 50 mM pH 7.5 (cell pellet fraction, P) or choline washed to remove choline binding proteins 
(choline wash fraction, Scholine). As control, cells collected at 60 and 80 min were also washed with PBS only (SPBS). All 
fractions were tested by western blotting for Svl presence with anti-LytA antibody. P and S fractions were also 
tested for Ts (antibody 144,H-3) to control for the accumulation of cytoplasmic proteins throughout time and in the 
choline wash fraction to control for cytoplasmic contamination. The ratio between Svl and Ts expression in pelleted 
cells was determined and the Svl increase with time is represented. 10 μl (panel A) or 5 μl (panels B and C) of each P 
fraction and 45 μl of each S fraction were run in each lane. The mass of the molecular mass markers is indicated. 
Results are representative of a minimum of two independent experiments. 
 
 
Membrane pmf dissipation is essential and sufficient for triggering phage lysin and bacterial 
autolysin  
 
From the above results pneumococcal phage exolysins do not require the hole-forming 
capacity of holins for their delivery to the peptidoglycan. However, our data point to a strict 
holin requirement for lysin activity (this study, [18]). In this case, holins could function to 
collapse the cytoplasmic membrane electrochemical gradient, leading to the activation of the 
externalized lysin, in a similar fashion to the holins of exolysin-carrying phages [5,6,9,55].  
To test this hypothesis, we used the membrane pmf-dissipating agent N,N´-
dicyclohexylcarbodiimide (DCCD) that inhibits the ATP synthase depleting the proton gradient 
and thus, leading to the disruption of the pmf [36]. As shown in Fig.III.4A, addition of DCCD to 
ΔholΔlytA cultures 60 min after the phage induction with MitC triggered complete host lysis. In 
contrast, negligible lysis was observed with DCCD in the absence of phage lysin (ΔholΔlytA 
without MitC treatment, Fig.III.4A). These results indicate that, in the absence of holins, DCCD 
activates the phage lysin resulting in cell lysis. Likewise, incubation of the lysogen ΔholΔsvl 
(expressing LytA) with DCCD always triggered lysis independently of MitC treatment (Fig.III.4A). 
Thus, DCCD-induced pmf dissipation also activates the bacterial LytA, known to be holin- 
activated in phage release (this study, [18]).   
To confirm that the observed lysis was not the result of cytoplasmic membrane damage 
that allowed the phage lysin to reach the peptidoglycan, we analyzed the effect of DCCD on 
membrane permeabilization by flow cytometry. Strain ΔholΔlytA without MitC treatment was 
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used to avoid lysis due to the presence of the autolysin or the phage lysin. As before, cells with 
permeabilized membranes allow the uptake of PI and distribute within gate R2 whereas cells 
with intact membranes that internalize only Syto 9 are found in gate R3. The ΔholΔlytA cells 
collected at the moment of DCCD addition (t=0 min, corresponding to 60 min in the growth 
curve in panel A) are almost exclusively contained in R3, like the untreated control (Fig.III.4B). 
This demonstrates that exposure to DCCD does not instantaneously permeabilize membranes 
in agreement with DCCD’s mode of action, that dissipates the pmf but does not create 
membrane lesions. This is in contrast to DOC that has an immediate permeabilizing effect, as 
can be seen by the two well-defined populations concentrated evenly in both gates when a 
50% mixture of DOC and DCCD-treated cells (at t=0 min) was analyzed (Fig.III.4B). Even after 
140 min of DCCD exposure (corresponding to 200 min in the growth curve in panel A, when 
lysis is practically complete if either LytA or Svl are present), the distribution pattern is very 
distinctive from that of DOC-treated cells, with very few cells in gate R2. It is highly unlikely 
that this low percentage of cells that internalized PI and thus, may have permeabilized 
membranes, resulted in the extended lysis observed upon DCCD treatment of strains with 
functional lysins (see for instance strain ΔholΔlytA+MitC+DCCD, Fig.III.4A), considering that in 
lysis promoted by holins almost all ΔsvlΔlytA cells were found to be permeabilized by flow 
cytometry (Fig.III.1B, [18]). We conjecture that this small degree of permeabilization may be a 
consequence of an extended time under the effect of DCCD.  
Taken together, these data indicate that the pneumococcal phage lysin is already 
positioned in the cell wall at lysis onset as collapse of the membrane pmf cannot allow protein 
passage. We conclude that pneumococcal phage lysin is externalized by a holin-independent 





























































Figure III.4. Pneumococcal lysis mediated by phage lysin and bacterial autolysin LytA is triggered by membrane 
pmf dissipation. (A) Kinetics of DCCD-induced lysis with and without phage induction. SVMC28 derived mutants 
lacking holins and LytA or Svl were grown until OD600nm=0.2-0.25 and 0.1 g/ml of MitC was added to induce phage 
excision (t=0 min). After 60 min of MitC addition, the pmf-dissipating agent DCCD (100 μM) was added to the 
cultures (indicated by arrow).  When cultures were not MitC-induced, DCCD was added at 60 min after the cultures 
reached OD600nm 0.2-0.25 (when MitC is added to the treated cultures). As control for DCCD-induced lysis, cultures 
were induced with MitC but not treated with DCCD. Results are an average of a minimum of three independent 
experiments. Error bars represent 95% confidence intervals. (B) Minimal membrane permeabilization effect of pmf-
dissipating agent DCCD. SVMC28ΔholΔlytA cells were treated with DCCD 60 min after the cultures reached OD600nm 
0.2-0.25 (when MitC is added in other cultures). Cells were collected immediately after DCCD addition (t=0 min) and 
140 min after treatment, corresponding to 60 min and 200 min in the curves shown in panel A. Also a fraction of the 
same culture was left untreated. Again, t=0 min and t=140 min in the flow cytometry analysis corresponds to 60 min 
and 200 min after OD600nm 0.2-0.25, respectively. As control for massive membrane permeabilization, cells were also 
treated with DOC [0.04% (w/v)] 60 min after OD600nm 0.2-0.25. Cells were stained with a mixture of Syto 9 and 
propidium iodide and analyzed on a flow cytometer. For definition of gates R2 and R3 see Fig.III.1. Results are 
representative of a minimum of two independent experiments. 
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10722    10722    -     89 .35 25 .11   32 .49   65 .86 31 .01   37 .77   58 .59
R2 R1 4884    4463    -     41 .62 10 .81   13 .55   59 .69 40 .53   48 .56   53 .57
R3 R1 6545    6106    -     56 .95 109.44  145.44  64 .65 12 .72   19 .77   85 .97
File:  d ccd 140  g ated  AR T IG O  ME LH O R .F C S    D a te :  1 0-12-201 0  T im e : 19 :0 7:57     P a rtic les:  120 00   Acq .-T im e:  19 s


























































































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10639    10639    -     88 .66 12 .11   15 .80   73 .57 21 .38   25 .45   62 .02
R2 R1 2396    2013    -     18 .92 9.89     14 .77   87 .09 23 .15   27 .56   62 .01
R3 R1 9147    8514    -     80 .03 36 .32   45 .06   67 .69 19 .14   24 .91   70 .48
File:  v iv as 140  g ated  AR T IG O  M E LH O R .F C S    D a te :  13 -1 2-201 0  T im e:  18:4 7:45    P a rtic les:  120 00   Acq .-T im e:  1 6 s


























































































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11426    11426    -     95 .22 9.72     13 .61   92 .93 20 .02   24 .04   66 .81
R2 R1 87       49       -     0.43 5.25     8.69     102.73 14 .08   19 .49   97 .75
R3 R1 11622    11278    -     98 .70 27 .72   35 .63   78 .35 2.54     4.49     132.43
File:  v iv as_4  g ated  AR T IG O .fc s   D a te : 10 -1 2-201 0  T im e:  17:2 5:33    P a rtic les:  120 00   Acq .-T im e:   s


























































































































































par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% Mn-y Mean-y C V-y %
R1 <None> 11126    11126    -     92 .72 23 .54   31 .55   70 .00 41 .41   51 .78   63 .31
R2 R1 152     80       -     0.72 5.19     7.66     103.35 11 .85   14 .48   72 .80
R3 R1 11697    11013    -     98 .98 7 .19   92 .32   64 .28 11 .47   17 .27   83 .00
File:  d ccd  0 _2 pa rte  2  ga te d  AR T IG O .F C S    D a te :  13 -12-201 0  T im e : 18 :5 4:11     P a rtic les:  120 00   Acq .-T im e:  18 s


























































































































































Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11125    11125    -     92 .71 26 .53   35 .36   68 .03 33 .11   41 .38   61 .03
R2 R1 296     177     -     1.59 6.00     12 .51   132.24 19 .37   30 .89   100.22
R3 R1 11326    10832    -     97 .37 104.97  136.09  63 .00 14 .56   22 .14   82 .75
Time after DCCD treatment (ΔholΔlytA)
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Involvement of the Sec pathway in phage lysin targeting to the cell wall  
 
Phage lysin cell wall localization implies its translocation across the membrane. It is known 
that the Sec export pathway is highly conserved among bacteria [56], which led us to 
investigate if this host system was involved in the extracytoplasmic targeting of S. pneumoniae 
phage lysins. For that, we utilized sodium azide (NaN3), a widely used inhibitor of the SecA 
ATPase activity that was established to suppress protein translocation by the Sec pathway in 
both Gram-negative and Gram-positive bacteria [39,40] including Streptococcus gordonii [38] 
and Streptococcus parasanguinis [37], both closest related to S. pneumoniae. To ΔholΔlytA 
cultures, NaN3 was added (at a 5 mM concentration that allows cell growth) shortly after MitC 
induction of Svl expression. We then tested the effect of DCCD since it can only trigger lysis in 
strains with externalized lysins (see above).  
The addition of DCCD to MitC and NaN3-treated cultures did not result in cell lysis contrary 
to cultures treated only with MitC where DCCD activated the phage lysin (Fig.III.5A). However, 
when DOC is added to NaN3-treated cultures to permeabilize the membrane lysis occurred, 
indicating that phage lysins were synthesized and accumulated in the cells. This indicates that, 
in the absence of holin, NaN3 blocks the membrane translocation of the phage lysin. To further 
support this, we examined the NaN3 effect on the capacity of choline to extract Svl from the 
cell surface. SDS-PAGE analysis at selected time points of the choline washes of MitC-induced 
ΔholΔlytA cells treated with NaN3 showed that from 30 min onwards of NaN3 exposure (50 min 
after MitC treatment) the amount of Svl eluted with choline did not increase (Fig.III.5B). This is 
in contrast to the continuous increase of choline extractable Svl of MitC-induced ΔholΔlytA 
(Fig.III.3C). Control PBS washes were unable to extract Svl and the absence of a Ts positive 
signal revealed no detectable cell lysis or cell contamination in any of the wash samples 
(Fig.III.5B). The ratio of the amount of choline-washed Svl at each time point by the 
corresponding amount of Ts detected in the cell pellet (which represents a measure of the 
number of cells washed; shown in Fig.III.5B, upper panel), renders the decreased levels of 
extracytoplasmic Svl in NaN3-treated cells more perceptible, with 5.8-fold more Svl extracted 
in NaN3-untreated cells at 80 min after MitC treatment (Fig.III.5C). Therefore, the decrease in 






Figure III.5. Pneumococcal phage lysin export to the cell wall involves the Sec system.  (A) Inhibition of Sec-
mediated secretion prevents DCCD-induced lysis by phage lysin. SVMC28ΔholΔlytA cultures were treated with 0.1 
g/ml of MitC for phage excision at OD600nm=0.2-0.25 (t=0 min). To a fraction of the cultures 5 mM of NaN3 was 
added 20 min after induction, followed by 100 μM of DCCD at 60 min and 0.04% (w/v) of DOC at 200 min (indicated 
by arrows). In the other fraction, DCCD was omitted. As control for the effectiveness of DCCD-induced lysis, cultures 
were induced with MitC and treated only with DCCD after 60 min. Results are an average of a minimum of three 
independent experiments. Error bars represent 95% confidence intervals. (B) Phage lysin does not target to the cell 
wall when the Sec system is inhibited. SVMC28ΔholΔlytA was treated with MitC for phage induction (t=0 min) and 
with NaN3 after 20 min. Equal aliquots were taken from cultures at 0, 20, 40, 50, 60 and 80 min. Cells were 
harvested by centrifugation and directly ressuspended in Tris 50 mM pH 7.5 (cell pellet fraction, P) or choline 
washed to remove choline binding proteins (choline wash fraction, Scholine). As control, cells collected at 60 and 80 
min were also washed with PBS only (SPBS). All fractions were tested by western blotting for the presence of Svl with 
anti-LytA antibody. P and S fractions were also tested with Ts (antibody 144,H-3) to control for the accumulation of 
cytoplasmic proteins throughout time and in the choline wash fraction to control for cytoplasmic contamination. In 
each lane, 10 μl of each P fraction and 45 μl of each S fraction were run. The mass of the molecular mass markers is 
indicated. Results are representative of a minimum of two independent experiments. (C) Comparison of phage lysin 
extracted by choline in the presence or absence of a functional Sec system. The quantity of phage lysin washed with 
choline from the cell wall of MitC-induced ΔholΔlytA cells treated with NaN3 or left untreated was determined at 
each time point from the western blots shown in Fig.III.5B and 3C, respectively. The same was done for Ts present in 
the cell pellet under identical experimental conditions. The normalization of Svl-choline washed by the 
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Surprisingly, despite Svl accumulation in the cell pellet of NaN3-treated cells it was 
substantially less than in the absence of NaN3 (Fig.III.5B and 3C, upper panels). In contrast, Ts 
increased in a similar fashion independently of NaN3 treatment (Fig.III.5B and 3C, upper 
panels). In fact, a comparison between Svl and Ts in the cell pellet did not reveal an increase in 
Svl expression (data not shown), in contrast to the 6.7-fold increase discussed above 
(Fig.III.3C). The observed difference may reflect degradation of intracellular Svl unable to reach 
its final destination. Intracellular degradation of nonexported proteins was already described 
in previous studies with Listeria monocytogenes, in which MurA, transported by the accessory 
Sec system (SecA2), was not only absent from the cell wall in a secA2 mutant but also in all 
subcellular fractions [57,58]. Collectively, these results point to the involvement of the host 
















































All S. pneumoniae phages rely on the holin-lysin system to achieve host lysis and release 
the new phage particles at the end of the lytic cycle [13-15,17,18]. It was proposed that, 
similarly to the majority of phages, pneumococcal phage lysins accumulate in the cytoplasm 
(hence designated endolysins) and are released by holin-mediated membrane disruption 
[1,2,13,15,16,29]. Here we provide evidence that the lysin of pneumococcal phage SV1 is 
targeted to the cell wall without requiring holins to permeabilize the membrane. Given the 
high structural and functional similarities between Svl and all other known pneumococcal 
phage lysins (exemplified by 85% to 97% nucleotide identity with lysins from phages EJ-1, 
MM1, HB-3 and VO1), our data point to the existence of exolysins in the majority of S. 
pneumoniae phages. Lysin export independent of holins has already been demonstrated for 
phages P1 and 21 of the Gram-negative E. coli and for phage fOg44 of the Gram-positive 
Oenococcus oeni [3,5,6]. However, in all of these cases a signal sequence for protein sorting is 
present, clearly indicating an extracytoplasmic pool of lysins [3,5,6]. The unusual feature of 
pneumococcal phage lysins is the absence of any known signal element for membrane 
translocation [13]. Using PSORT v3.0 (http://www.expasy.org) to predict protein subcellular 
localization, neither sequence motifs associated with a specific localization site, nor 
transmembrane regions or cleavable N-terminal signal peptides were detected in Svl, as 
reported for all other lysins of pneumococcal phages studied so far [13].  
Phage lysins that target the cell wall of Gram-positive bacteria and that generally require 
holin-mediated access, frequently exhibit structural motifs for association with the cell surface 
(cell wall binding domains) that are responsible to direct the lytic enzymes to their substrate 
[59]. In S. pneumoniae phage lysins these also exist in the form of choline binding domains that 
recognize the choline residues [13,24] exclusively associated with the teichoic and lipoteichoic 
acids of the cell wall [13]. According to the exolysin model, where the pneumococcal phage 
lysin is continuously targeted throughout the lytic cycle, choline residues must also act as 
docking regions positioning and maintaining the enzyme already close to its substrate until the 
ideal lysis time. This is further strengthened by the presence of such domains in the bacterial 
cell wall hydrolase LytA [13,60], that is known to be localized and regulated in the 
pneumococcal cell envelope [19-23] (confirmed here by choline removal and treatment with 
pmf-dissipating agents). Building up an increasing amount of phage lysins at the surface, rather 
than targeting them to their site of action only at the end of the lytic cycle, may ensure a more 
rapid cell lysis once the lytic activity is triggered. It was further suggested that a thick 
peptidoglycan layer, characteristic of Gram-positive bacteria like S. pneumoniae, requires a 
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more extensive peptidoglycan degrading activity to promote lysis [3]. The accumulation of 
exolysins could thus represent an evolutionary advantage for pneumococcal phages.  
Since the bulk of protein export across the cytoplasmic membrane is carried out in 
bacteria by the Sec pathway [56], we further investigated the involvement of this system on 
pneumococcal phage lysin targeting. Despite the absence of any known signal sequences, 
experiments with the Sec inhibitor NaN3 suggest that Svl export occurs through the S. 
pneumoniae Sec pathway. In the presence of NaN3, membrane pmf disruption induced by 
DCCD could no longer promote phage lysin activation since the accumulation of Svl at the cell 
surface was prevented. Additionally, exported Svl (eluted with choline from the cell wall) was 
indistinguishable by SDS-PAGE from Svl found in total cells, indicating that phage lysin present 
in the cell wall did not suffer proteolytic cleavage relative to its cytoplasmic form. Thus, phage 
lysin transport does not involve protein processing, which generally implies the absence of 
signal sequences [56], in agreement with the in silico prediction. The mechanism of this 
unusual Sec-dependent protein translocation still remains to be elucidated. Absence of 
secretory sequences concomitant with extracytoplasmic localization and Sec-dependent 
export was only reported in the mycobacteriophage Ms6 lysin LysA [55]. However, in this case 
the export is assisted by a phage chaperone-like protein (Gp1) that is encoded in the unusual 
lytic operon of Ms6. In contrast, SV1 and other pneumococcal phages lytic cassettes are less 
complex, not encoding other known functions besides holins and lysins [13-15,17,18]. 
Additionally, the analysis of SV1 genome as well as of other pneumococcal phages sequences 
available did not reveal Gp1-related proteins, strongly suggesting that the transport of 
pneumococcal phage lysin does not involve chaperone-like phage functions. 
The results presented here may provide important clues for the still obscure transport 
mechanism of the bacterial autolysin. Similarly to Svl, bioinformatic predictions also indicate 
that LytA is deprived of motifs or signals that could position it outside the cytoplasm, although 
LytA was established early as a cell wall protein. Additionally, in common with the phage lysins, 
proteolytic cleavage of LytA was not detected ([20]; this work). We speculate that LytA may 
reach its final localization through the host Sec pathway that phages also seem to take 
advantage of to target their lysins. This hypothesis may be hard to address experimentally due 
to the ubiquitous expression of the autolysin (limiting experimental approaches blocking the 
Sec system) and the requirement of a functional Sec system for cell viability in many bacterial 
species [55,56]. Interestingly, this same mechanism may be also involved in the transport of 
few other peculiar choline binding proteins lacking specific targeting signals [61].  
It was recently described in the Gram-positive bacterium Listeria monocytogenes the 
involvement of the accessory Sec system, dependent on SecA2 (a paralogous of SecA of the 
CHAPTER III 
115 
canonical Sec pathway), in the export of several proteins without any obvious signals for 
bacterial surface targeting [58]. Nonetheless, the features of this subset of SecA2-exported 
proteins that target them for export by the SecA2 pathway remain unknown. It is remarkable 
that one of those peculiar L. monocytogenes proteins is the N-acetylmuramidase MurA that is, 
like the autolysin LytA and the pneumococcal phage lysins, a cell wall hydrolase [56]. 
Moreover, in this species, another murein hydrolase p60 is also exported through SecA2 but in 
this case it possesses a signal sequence [57,58]. Interestingly, SecA2 is also functional in 
Streptococcus species and a secA2 gene was detected in S. pneumoniae in a very high 
proportion of strains [37,38,56,62]. Thus, pneumococcal phage lysins, as well as LytA, could be 
secreted in a SecA2-dependent manner. It should be pointed out that very little is known 
about this type of transport in pneumococcus and in other streptococci the proteins reported 
to be exported via SecA2 are characterized by the presence of signal sequences [56,63]. Since 
SecA2 is an ATPase that provides energy for translocation like SecA, NaN3 should also result in 
its inhibition [38,56], rendering impossible the distinction between the two Sec pathways by 
this methodology. Further experiments are therefore needed to determine which Sec system 
is specifically involved.  
 In the context of phage exolysins, the previously demonstrated permeabilizing action of 
holins on the S. pneumoniae membrane [14,15,18,29] is not necessary to allow the passage of 
phage lysins from the cytoplasm onto the cell wall, as suggested before [13,15,16,29]. In fact, 
we showed that it is crucial to trigger the collapse of the membrane pmf that leads to lysins 
activation. We observed that a significant phage lysin secretion occurs before lysis is achieved, 
indicating that Sec-mediated export of the lysin is not sufficient for lysis. But when pmf is 
depleted before the normal lysis time (for instance by the addition of DCCD), complete lysis 
occurred through Svl activation. For the other described phages encoding exolysins, it was also 
argued that membrane pmf disruption achieved by the holins activate the exported lysins 
[5,6,9,55]. Still, regardless of the phage lysin cellular localization (cytoplasmic or 
extracytoplasmic) that determines the way the holins trigger their action (permeabilization or 
pmf collapse), in all holin-lysin systems it is the holins that signal the lysins when to play their 
part in the release of phage progeny.  
In phage 21, the secreted SAR lysin is associated with a pinholin that, as opposed to the 
large-hole-forming λ-like holins, forms channels not sufficiently large for lysins to pass through 
[1,6,64,65]. In fact, this pinholin is unable to complement the lysins of phage λ in promoting 
lysis [6]. Although we did not specifically evaluate the size of SV1 holin lesions, holins of other 
S. pneumoniae phages were shown to form holes large enough to allow lysin passage [15,29]. 
Additionally, inspection of the amino acid sequence of both SV1 holins did not reveal an N-
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terminal (transmembrane) SAR domain (rich in residues that are weakly hydrophobic), a 
feature described for the pinholin of phage 21 [8,65]. However, exolysins not associated with a 
pinholin have been described [6]. The holin of phage P1, which is paired with the SAR lysin Lyz, 
is in fact a canonical holin [6]. Curiously, the Gp4 holin of the exolysin-carrying 
mycobacteriophage Ms6 has in its primary sequence characteristics of pinholins, although it is 
able to promote the release of the cytoplasmic λ lysin but not of the Ms6 lysin [66].  
Continuous localization of the phage lysin to the cell wall requires that it be held in an 
inactive state, which we showed to be related to the energized membrane. However, it 
remains unknown how membrane pmf is converted into a suppressive modulator of Svl or how 
the inactive state is subverted by the dissipation of the cytoplasmic membrane 
electrochemical gradient. Since we observed that the bacterial LytA is also sensitive to the 
energy status of the membrane and given the dependence of LytA and phage lysins on choline 
binding for catalytic activity [13,60,67], pmf may influence the activities of both the phage lysin 
and bacterial autolysin in a similar way. It is accepted that the interaction with the membrane-
bound lipoteichoic acids regulates LytA activity [19,23] and it was even observed that LTA 
inhibited the activity of the Cpl-1 lysin of phage Cp-1 [68]. Furthermore, it was suggested that 
the membrane establishes a specific conformation of LTAs in Gram-positive bacteria since, for 
instance, variations of the ionic strength of the medium result in LTA conformational change 
[69]. Thus, loss of the membrane pmf promoted by the holins may induce structural and 
chemical rearrangements in the cell envelope that may result in the abolishment of the 
inhibitory activity of LTA over both lysins. The holin lesions could also release some activator 
factor from the membrane. However, preliminary results do not seem to support this 
hypothesis since no lysis was observed in ΔholΔsvl or ΔholΔlytA strains treated with MitC for 
80 min (allowing LytA or Svl expression) with the supernatant of ΔsvlΔlytA cells, carrying 
functional holins, treated with MitC for 140 min (at which time, lysis is completed in the wild-
type culture). The possibility that resulting pH changes may specifically influence lysin control 
should also be considered. Indeed, in Bacillus subtilis it was shown that the cell wall has a low 
local pH sustained by the membrane pmf and its abolishment results in cellular lysis [70]. 
Further experiments are required to clarify these issues. 
In conclusion, our data supports the inclusion of the majority of pneumococcal phages in 
the class of phages carrying exolysins, greatly increasing the number of phages with this lysis 
mechanism and indicating that these may be much more frequent than previously thought. In 
these phages, membrane pmf dissipation by the holins is necessary for lysin activation. In S. 
pneumoniae this is also sufficient to trigger the externalized major autolysin LytA that was 
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7. SUPPLEMENTARY DATA 
 




Figure III.S1. Effect of holin deletion on SVMC28Δhol membrane integrity. SVMC28Δhol strain (lacking holins but 
with functional LytA and Svl) was grown until OD600nm=0.2-0.25 and 0.1 g/ml of MitC was added to induce phage 
excision (t=0 min). Cells were collected after 40 and 120 min and tested for membrane permeabilization by flow 
cytometry following staining with a mixture of Syto 9 and propidium iodide (PI). Gate R2 corresponds to the 
membrane damaged population, while gate R3 corresponds to the population with intact membrane. Both gates 
were designed over gate R1, which includes the total stained population. At 120 min, the large majority of cells 







Figure III.S2. Kinetics of DOC-induced lysis after phage induction in SVMC28ΔsvlΔlytA strain. SVMC28ΔsvlΔlytA 
was grown until OD600nm=0.2-0.25 and 0.1 µg/ml of MitC was added to induce phage excision (t=0 min). Cultures 
were treated with DOC [final concentration of 0.04% (w/v)] at 20-min intervals after phage induction. OD600nm is 
indicated before (full symbols) and 20 min after DOC addition (open symbols) and DOC-triggered lysis is expressed 
as percentage of optical density drop (values are shown above the bars). The residual lysis observed in 
SVMC28ΔsvlΔlytA MitC
+
 may be attributed to other bacterial lysins. A rough comparison with SVMC28ΔholΔlytA 
MitC
-
 (Fig.III.2A2) seems to indicate that in this case the contribution of the phage lysin accumulated due to 
spontaneous phage induction to the residual lysis is only apparent from 80 min onwards. Analysis of a MitC-
untreated SVMC28ΔholΔsvlΔlytA mutant is needed to better evaluate this effect. Results are an average of a 
minimum of three independent experiments. Error bars represent 95% confidence intervals.  
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 10315    10315    -     85 .96 8.88     11 .52   75 .19 12 .98   15 .47   63 .05
R2 R1 634     429     -     4.16 2.56     3.40     85 .25 8.42     9.15     44 .68
R3 R1 10971    9723    -     94 .26 25 .77   32 .89   71 .79 4.35     6.64     82 .49
Time after MitC  addition (Δhol)
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par te c PAS
Region Gate Ungated C oun t C oun t/m l % Gated GMn-x Mean-x C V-x% GMn-y Mean-y C V-y %
R1 <None> 11289    11289    -     94 .08 16 .03   22 .52   77 .68 31 .86   41 .71   70 .77
R2 R1 57       45       -     0.40 2.97     3.75     79 .23 7.98     9.16     65 .42
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Streptococcus pneumoniae (pneumococcus) is able to form biofilms in vivo and previous 
studies propose that pneumococcal biofilms play a relevant role both in colonization and 
infection. Additionally, pneumococci recovered from human infections are characterized by a 
high prevalence of lysogenic bacteriophages (phages) residing quiescently in their host 
chromosome. We investigated a possible link between lysogeny and biofilm formation. 
Considering that extracellular DNA (eDNA) is a key factor in the biofilm matrix, we reasoned 
that prophage spontaneous activation with the consequent bacterial host lysis could provide a 
source of eDNA, enhancing pneumococcal biofilm development. Monitoring biofilm growth of 
lysogenic and nonlysogenic pneumococcal strains indicated that phage-infected bacteria are 
more proficient at forming biofilms that is their biofilms are characterized by a higher biomass 
and cell viability. The presence of phage particles throughout the lysogenic strains biofilm 
development implicated prophage spontaneous induction in this effect. Analysis of lysogens 
deficient for phage lysin and the bacterial major autolysin revealed that the absence of either 
lytic activity impaired biofilm development and the addition of DNA restored the ability of 
mutant strains to form robust biofilms. These findings establish that limited phage-mediated 
host lysis of a fraction of the bacterial population, due to spontaneous phage induction, 
constitutes an important source of eDNA for the S. pneumoniae biofilm matrix and that this 

















Biofilms, the most frequently encountered physiological form adopted by 
microorganisms, are surface-adapted communities that constitute a protected mode of 
bacterial growth allowing survival in hostile environments [1-4]. Recent studies demonstrated 
the potential of Streptococcus pneumoniae to produce biofilms in vivo [5,6]. Pneumococcal 
biofilms were indeed detected on affected tissues in patients with chronic rhinosinusitis [6], 
children with otitis media [5], as well as a chinchilla model of otitis [7]. The presence of these 
communities at the site of infection implicates them in these disorders, although their 
significance in the infection process is a matter of debate. Two recent studies have failed to 
find an association between the ability to form biofilms and whether the isolates had been 
recovered from asymptomatic carriers or caused invasive infections [8,9]. Moreover, a mouse 
model of invasive infection failed to show any association between the capacity to cause 
bacteremia and the ability of the strains to form robust biofilms [8]. Although these two 
studies question the role of biofilms in determining the invasive potential of pneumococci, the 
transcriptional profile of several known virulence-related genes in S. pneumoniae isolated from 
lungs and brains of infected mice is similar to that in biofilms formed in vitro, suggesting a 
possible biofilm-like state of S. pneumoniae associated with tissues [10]. In addition, a link was 
established between pneumococcal biofilm formation and the asymptomatic colonization of 
the nasopharynx [11], the most frequent state of pneumococci. Overall, these studies highlight 
the importance of studying S. pneumoniae biofilms, particularly of identifying the factors that 
influence the formation of these structures. 
Bacterial biofilms are encased within an extracellular matrix consisting of polysaccharides, 
proteins and nucleic acids [1]. Although polysaccharides and proteins are important 
components, the role of extracellular DNA (eDNA) as a critical element of the matrix is 
increasingly recognized, both in providing structural stability as well as protection against 
antimicrobial agents [12-15]. In Gram-positive bacteria, such as Enterococcus faecalis and 
Staphylococcus epidermidis, autolysins (bacterial murein hydrolases) were recently implicated 
in biofilm formation, apparently by mediating bacterial lysis with the consequent release of 
eDNA [12,16-18]. Pneumococcal cells are characterized by the presence of a major autolysin 
LytA, an N-acetylmuramoyl-L-alanine amidase, which is responsible for the unusual property of 
massive cellular lysis displayed in the stationary phase of liquid cultures [19]. Furthermore, cell 
lysis dependent on LytA was also detected upon competence development, which results in 
DNA release into the medium [20,21]. The observation that S. pneumoniae biofilm formation is 
influenced by the presence of eDNA [22,23] and that LytA mutants have a decreased capacity 
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to form biofilms [23], hints that LytA-induced pneumococcal lysis could be related to biofilm 
formation through the release of eDNA. 
In addition to autolytic events, cell lysis in S. pneumoniae can also be mediated by 
lysogenic phages, which have a high prevalence (76%) in isolates associated with infection 
[24,25]. During lysogeny, the prophage is integrated in the bacterial chromosome being 
replicated as part of the host genome. Upon induction, the repressed lysogenic state shifts to 
lytic growth with the production of viral particles and subsequent phage-mediated host lysis to 
release the phage progeny [24,26]. It was recognized early that free phages can be found in 
cultures of lysogenic bacteria in the absence of a known inducing agent, indicating that some 
prophages spontaneously enter the lytic cycle [27]. Spontaneous phage induction seems to be 
a common feature of lysogeny, being nonspecific of the phage or the bacterial host, although 
the factors that promote spontaneous induction, either in vitro or in vivo, are poorly 
understood. Recent studies showed that this natural phenomenon may contribute to 
pathogenicity in Salmonella [28], increasing the awareness of the potential importance of 
lysogeny in the context of infection. This spontaneous phage release occurs obviously at low 
levels, and the phage titer observed is orders of magnitude less than the one produced when 
the same bacteria are treated with an inducing agent [26,29,30]. 
Whether agent-induced or spontaneous, it was believed that phages of S. pneumoniae 
relied exclusively on their own lysins to hydrolyze host cell wall peptidoglycan and release the 
phage progeny [31]. Recently, it was shown that pneumococcal lysogenic phages achieve an 
optimal exit strategy by orchestrating the coordinated action of the phage-encoded lysin and 
the bacterial major autolysin LytA [32].  
Inevitably, prophage activation results, through bacterial lysis, in the release of the 
cellular components to the extracellular medium. Since eDNA is increasingly recognized as a 
critical element for biofilm formation, we hypothesized that spontaneous induction of 
lysogenic phages could have a positive effect on pneumococcal biofilms. To test this, we have 
evaluated biofilm formation and eDNA release of isogenic strains differing in carriage of a 
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3. MATERIAL AND METHODS 
 
Bacterial strains, culture conditions and DNA manipulations 
 
Bacterial strains SVMC28 and R36A were obtained from the Rockefeller University 
collection (A. Tomasz). R36A is a nonlysogenic, nonencapsulated strain [24]. SVMC28 is an 
encapsulated (serotype 23F) clinical isolate, lysogenic for phage SV1 encoding the Svl phage 
lysin [32]. R36AΔlytA was kindly provided by S. Filipe. SVMC28 derived mutants SVMC28Δsvl, 
SVMC28ΔlytA and SVMC28ΔsvlΔlytA belong to the Faculdade de Medicina de Lisboa collection. 
The SV1-lysogenized strains R36AP, R36APΔlytA, R36APΔsvl and R36APΔlytAΔsvl are also from 
the Faculdade de Medicina de Lisboa collection. All strains were described previously [32]. All 
S. pneumoniae strains were grown in a casein-based semisynthetic medium (C+Y) at 37ºC 
without aeration or in tryptic soy agar (TSA) (Oxoid, Hampshire, England) supplemented with 
5% (v/v) sterile sheep blood incubated at 37ºC in 5% CO2. For overnight cultures, 
pneumococcal mutant strains were grown in the presence of 2 µg/ml erythromycin or 4 µg/ml 
chloramphenicol (Sigma, Steinheim, Germany) or both, as appropriate. After selective growth, 
the culture was diluted 1:100 in fresh medium and grown until the appropriate optical density. 
Chromosomal DNA from S. pneumoniae strain R36A was isolated following previously 
described procedures [33]. Sperm salmon DNA was purchased from Invitrogen Co. (Carlsbad, 
California, USA).  
 
Biofilm biomass quantification  
 
Biofilm formation was determined by the ability of cells to grow adherent to 96-well flat-
bottom polystyrene microtiter plates (NuncTM, Roskilde, Denmark) in static conditions. Cells 
were grown in C+Y medium, with selective antibiotic when necessary, to an optical density 
measured at 600 nm (OD600nm) between 0.5 and 0.6 and then diluted 1:4 in fresh medium to a 
final volume of 200 µl per well. Microtiter plates were incubated at 37 ºC and biofilm mass was 
determined by staining with crystal violet [23] and measuring the OD595nm using a plate reader 
(Tecan Infinite M200 with i-controlTM software V1.40). The incubation times at which the 
biomass was quantified were selected based on preliminary experiments in order to monitor 
the dynamics of biofilm growth and dispersal. Shorter time intervals were selected when 
biofilm mass showed steeper variations. The incubation times at which biomass was quantified 
were 6 h, 12 h, 18 h, 20 h, 24 h, 26 h, 28 h and 30 h of incubation. A control with only C+Y 
medium was also done for all time points and the values were subtracted to those measured 
for all strains.  
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Quantitative determination of biofilm formation was also evaluated in the presence of 
deoxyribonuclease I (DNase I) and DNA, incorporated in the medium. DNase I (Sigma, 
Steinheim, Germany) was used at a final concentration of 0.5, 5 or 50 µg/ml and biofilm mass 
was measured after 24 h of incubation. DNA from R36A strain or salmon sperm was added at 
10, 100 or 1000 ng/ml to the medium and determination of biofilm formation was carried out 
24 h post incubation. Values obtained from medium supplemented with DNAse I and DNA 
were subtracted in all strains. To test if DNA was important in biofilm adherence, the plate 
wells were incubated with 1000 ng/ml of R36A DNA overnight at 4ºC to condition the plastic 
surface. The solution was then discarded and the biofilm was seeded as described before. 
Biofilm mass was determined at 24 h post incubation. To determine if the impact of DNA on 
biofilm formation was due to a structural role, DNA from R36A was broken by sonication for 5 
min at 0.63 A and 50–60 Hz in a Transsonic T570 (Elma, Germany), and added to the medium 
at 1000 ng/ml. DNA fragmentation was confirmed by agarose gel electrophoresis. Biofilm 
formation was compared to biofilms grown in the presence of 1000 ng/ml of intact DNA. 
 
Biofilm colony forming units (CFU) assays 
 
Biofilms were grown in 96-well plates at 37ºC as described for the biofilm biomass 
quantification assay. CFUs were determined at the selected time points between 6 h and 30 h 
of incubation. Liquid medium with bacteria was gently removed from the wells, which were 
washed twice with phosphate buffered saline (PBS) 1x, pH 7.2 (Invitrogen, Grand Island, New 
York) to eliminate unbound bacteria without disturbing the adherent biofilm. 200 µl of PBS 
were then added to each well and biofilms were scraped thoroughly, including well edges. The 
well contents were recovered and the total CFU number was determined by serial dilution and 
plating on appropriate media. 
To test the effect of DNase I and DNA on biofilm development, DNase I was added to the 
growth medium to a final concentration of 0.5, 5 or 50 µg/ml. After 24 h of incubation at 37ºC, 
CFUs were determined as described above. When using DNA to evaluate its effect on biofilm 
formation, DNA from salmon sperm was added to the growth medium at a final concentration 
of 1000 ng/ml and CFUs were determined as described above.  
 
Phage plaque assays 
 
Plaque assays were performed as described elsewhere [32]. In detail, basal plates were 
made by pouring C+Y medium with 170 U catalase per ml and 1% agar into Petri dishes. A lawn 
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culture of R36A strain grown to an OD600nm of 0.2 was mixed with soft agar containing C+Y 
supplemented with 170 U catalase per ml and 0.35% agar. The entire mixture was spread onto 
basal plates. After hardening, phage preparations were applied in 10 µL aliquots directly on the 
soft agar with the R36A indicator strain. Incubation was performed at 30 ºC for 18 h. To obtain 
the phage preparation, at the chosen time points after biofilm seeding each well was scraped 
thoroughly including well edges. The harvested biofilms were filtered through a 0.45 µm-pore-
size membrane followed by filtering with a 100 000 MWCO polyethersulfone membrane 
(Vivaspin concentrator, Sartorius Stedim biotech, Goettingen, Germany), that retains and 
concentrates the SV1 phage [32]. The phage concentrate was stored at 4ºC for a maximum of 
24 h until usage. The filtrate containing proteins < 100 KDa, that could cause bacterial lysis 
such as LytA and bacteriocins, was also used to eliminate the possibility that lysis of the 
indicator strain was caused by bacterial products and not caused by phage infection. Images of 
the plates were acquired with the high-performance stereo-microscope Leica MZ7.5 (Leica 
Microsystems, Germany) and the number of plaque forming units (PFUs) was counted 
manually by visual inspection of the image. 
 
Confocal laser scanning microscopy (CLSM) 
 
Biofilms were stained by using a Live/Dead BacLight bacterial viability kit (Invitrogen, 
Carlbad, USA) and examined by CLSM. Syto 9/PI labelled biofilms allowed for monitoring the 
viability of bacterial populations as a function of the membrane integrity of the cell. Cells with 
a compromised membrane (dead cells) will stain red whereas cells with an intact membrane 
(live cells) will stain green. Whenever DNA and DNase I effects were tested, the medium was 
supplemented before biofilm seeding (t=0). In all experiments, biofilms were analyzed after 24 
h of incubation. Images were acquired on a Zeiss LSM510 META confocal microscope (Carl 
Zeiss, Jena, Germany) using a PlanApochromat 63x/1.4 objective for cell viability assays and a 
C-AproChromat 40x/1.2. Syto 9 fluorescence was detected using the 488 nm laser line of an Ar 
laser (45 mW nominal output) and a BP 505–550 filter. PI fluorescence was detected using a 
DPSS 561 nm laser (15 mW nominal output) and a LP 575 filter. For imaging, the laser power 
was attenuated to 1-2% of its maximum value. The pinhole aperture was set to 1 Airy unit. 
 
Purification and quantification of eDNA 
 
Biofilms were grown in 96-well plates at 37ºC as reported above. eDNA was purified from 
24-h biofilms exactly as previously described [34]. eDNA was quantified by real-time PCR using 
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the primes gdh-up (5´-ATGGACAAACCAGCNAGYTT) and gdh-dn (5´-GCTTGAGGTCCCATRCTNCC) 
and spi-up (5´-TTATTCCTCCTGATTCTGTC) and spi-dn (5´-GTGATTGGCCAGAAGCGGAA), 
amplifying the gdh and spi genes used for multilocus sequence typing (MLST), respectively. 
These are housekeeping genes located far apart in the R36A chromosome. PCRs were 
performed on nondiluted samples with the SYBR Green Jump Start Taq Ready Mix (Sigma, 
Steinheim, Germany), according to the manufacturer’s recommendations. Purified R36A 
genomic DNA at known concentrations was also subjected to quantitative real-time PCR with 
each primer pair to generate a standard curve used to calculate the concentration of eDNA in 
the unknown samples. PCR was performed in a 7500 Fast Real-Time PCR System (Applied 
Biosystems, Life Technologies, Carlsbad, California, USA). To account for potential differences 
in biomass, the average OD595nm of each biofilm was determined and used to calculate the 
relative OD595nm of each biofilm with respect to the OD595nm of the wild-type R36A biofilm. The 
nanogram of eDNA per relative biomass of each biofilm was then calculated by dividing its 





















Lysogenic phages enhance biofilm development 
 
In order to evaluate the impact of lysogeny in biofilm formation a well-established in vitro 
system, based on an abiotic surface as the growth substrate, was used allowing proper 
investigation of the initial stages of biofilm formation [8-10,22,23]. We started by monitoring 
biofilm development of the isogenic pair of S. pneumoniae strains R36A and R36AP, which 
differ only in the presence of a prophage (R36AP is a lysogen of phage SV1). Biofilm growth 
was followed at specific time points between 6 h and 30 h of incubation by biomass 
quantification and viable cell counts (Fig.IV.1A and B). The evaluation of cell viability by CFUs 
was consistent with biomass quantification obtained by crystal-violet staining. The biofilm of 
the lysogenic strain R36AP reaches its maximal development at 24 h and from that time 
onwards a decrease in biomass occurs. We reasoned that this decrease is inherent to the 
experimental conditions used, probably due to nutrient depletion, accumulation of toxic 
substances or intrinsic properties of the biofilm. In contrast, for the wild-type nonlysogenic 
strain R36A the highest biofilm mass values are registered at 26 h, decreasing afterwards in a 
behavior similar to that of strain R36AP. This observation is consistent with a slower biofilm 
growth of strain R36A, resulting in delayed development. The lysogenic strain showed 
improved biofilm growth at all time points and also a higher maximal biofilm mass than its 
nonlysogenic parent. In agreement with these findings, images of CLSM show denser and 
thicker biofilms for R36AP (Fig.IV.2A and B). Since the lysogen R36AP is indistinguishable from 
its parental strain R36A in planktonic growth [32], the differences observed must be attributed 
to the influence of the lysogenic phage on biofilm formation. 
 
Spontaneous prophage induction enhances biofilm development due to host lysis 
 
It was previously shown that the main pneumococcal autolysin LytA is important in 
normal biofilm development since its inactivation resulted in diminished biofilm formation, 
possibly by a mechanism dependent on its regulated lytic activity [23]. Thus, autolytic events 
may be helpful in the establishment of robust S. pneumoniae biofilms. It is well known that 
spontaneous phage induction results in the lysis of a fraction of the bacterial population [29] 
and we speculated that such induction could also occur within pneumococcal biofilms. 
Accordingly, the enhanced biofilm formation of the lysogenic strain R36AP could be explained 
by limited phage-triggered lysis. To test this hypothesis, we compared biofilm development of 
the lysogenic strain R36AP to that of the derived mutants for phage lysin Svl (strain 
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R36APΔsvl), bacterial autolysin LytA (R36APΔlytA) or both lysins (R36APΔlytAΔsvl). As shown in 
Fig.IV.1A and B, biofilm growth is significantly impaired in the absence of the phage lysin with a 
shift in the biofilm biomass peak from 24 h to 26 h, analogous to the growth pattern observed 
for the nonlysogenic strain (R36A). A similar behavior was observed for the lysogen in the 
absence of the bacterial autolysin. In fact, the presence of at least one lysin is essential, as the 
double mutant was largely deficient in biofilm formation. Accordingly, the nonlysogenic 
R36AΔlytA strain is also severely impaired in biofilm formation, supporting an important role 
of bacterial lysis in biofilm formation. This inability to form biofilms is not due to a growth 
defect since all mutants presented identical planktonic growth to the parent lysogen [32]. 
These results are consistent with the hypothesis that the positive impact of prophages in 
pneumococcal biofilm development is due to spontaneous induction of the lytic cycle resulting 
in cell lysis.  
In order to confirm if phage induction was indeed occurring in the biofilm, we measured 
the phage particles released during biofilm development of strain R36AP by determining the 
number of PFUs throughout biofilm growth (Fig.IV.1C). We observed the presence of phages in 
the biofilm at all time points, indicating that spontaneous phage induction is occurring 
continuously and paralleling the increase in viable cells. A substantial increase in the number 
of PFUs coincides with the peak of biofilm development (Fig.IV.1A and B), indicating increased 
phage induction at the later stages of biofilm formation. This higher phage induction is not due 
to a massive triggering of the phage lytic cycle related to this stage of biofilm growth since no 
increase of PFUs concomitant with biofilm dispersal was observed. Altogether, these results 
strongly support a role of spontaneous phage induction during biofilm development in the 
















Figure IV.1. Effect of lysogeny and phage induction in Streptococcus pneumoniae biofilm development. (A) Biofilm 
development monitored as biomass from 6 h to 30 h. R36A nonlysogenic strain; R36AP lysogenic derivative of R36A; 
R36APΔsvl, R36APΔlytA, R36AΔlytA and R36APΔlytAΔsvl are mutants in which the phage lysin (Svl), the bacterial 
autolysin (LytA) or both were deleted. Results are an average of 9 independent replicates. (B) Biofilm development 
monitored as CFUs from 6 h to 30 h. The strains are the same indicated in panel A. Results are an average of 6 
independent replicates. (C) The presence of phage in the R36AP biofilm was determined by the production of 
plaques on R36A. PFUs were determined throughout biofilm development from 6 h to 30 h. Results are an average 
of 2 to 7 independent replicates for each time point. In all panels error bars represent 95% confidence intervals for 


































































































































































Figure IV.2. Confocal laser scanning microscopy images of R3A6P and R36A biofilms. Staining was done with     
Syto 9/PI (Live/Dead BacLight Bacterial Viability kit) and images were acquired at 630x amplification. Live cells 
internalize only Syto 9 (fluorescing green) whereas dead cells allow the uptake of PI (fluorescing red). The large 
images are optical sections of top views and the small images to the right and above are optical sections of side 
views. The depth of the biofilm is indicated by the height of the z-stack. The inset scale bar represents 5 µm. (A) 
Biofilm formed by the lysogenic strain R36AP. (B) Biofilm of the nonlysogenic strain R36A. (C) The biofilm was grown 
in the presence of salmon sperm DNA at 1000 ng/ml. (D) The biofilm was grown in medium supplemented with 
DNase I at 50 µg/ml. In all panels the results are representative images of 3 independent experiments and biofilm 
growth was evaluated at 24 h. 
 
 
Released eDNA through phage-mediated lysis is a key factor for biofilm enhancement 
 
Extracellular DNA is an essential matrix component produced by many bacterial species 
during biofilm development [12,15,16,35,36]. Therefore, we hypothesized that in S. 
pneumoniae phage-mediated lysis of a fraction of the bacterial population within the biofilm 
could provide an extra source of eDNA for incorporation in the biofilm matrix.  
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We performed a DNase I susceptibility assay by incubating this enzyme for 24 h with R36A 
and R36AP in conditions allowing biofilm formation. A gradient of DNase I concentrations, 
ranging from 0.5 to 50 µg/ml was used. Biofilm biomass quantification indicates that DNase I 
reduces biofilm formation in a dose-dependent way (Fig.IV.3A). As expected, the biomass 
reduction is directly related to a decrease of viable cells in the biofilm (data not shown). The 
effect of DNase I is similar in R36A and R36AP biofilms, however, R36AP biofilms always show 
a higher biomass than R36A biofilms at all tested DNase I concentrations, suggesting that 
R36AP biofilms are richer in eDNA. In fact, the biomass of the R36AP biofilm incubated with 0.5 
µg/ml of DNase I, is similar to that of the R36A biofilm incubated in the absence of DNase I, 
indicating that the presence of this enzyme reduced the extra eDNA present in the R36AP 
matrix, resulting in a biofilm similar to that of R36A. Taken together, the data enable an 
argument to be made for the beneficial effect of lysogenic phages in biofilm development due 
to an increased presence of eDNA in the matrix. 
To further explore this potential role of eDNA on biofilm development, we decided to 
determine the effect of the addition of external DNA to the medium since the time of seeding, 
on biofilm mass measured at 24 h of growth. DNA was extracted from the R36A strain 
(homologous DNA) and used at a final concentration of 10, 100 and 1000 ng/ml. To rule out 
any specific effect of pneumococcal DNA, the same experiments were repeated using DNA 
isolated from salmon sperm (heterologous DNA). As shown in Fig.IV.3B, incubation with DNA 
since biofilm seeding enhances biofilm development in a dose-dependent manner, with a 
significant effect detected with as little as 10 ng/ml. This biomass increase parallels the 
number of viable cells in the biofilm (data not shown). Moreover, this effect is observed with 
both homologous and heterologous DNA, indicating that this was due to an intrinsic property 
of the DNA molecule and independent of the exact nucleotide sequence and donor organism. 
Microscopy was used to explore the differences between untreated R36AP biofilms and 
those treated with 50 µg/ml of DNase I and 1000 ng/ml of DNA. In agreement with the results 
obtained by biomass quantification, treatment with DNase I resulted in sparser and thinner 
biofilms when compared to control (Fig.IV.2A and D). On the other hand, supplementation of 
the medium with DNA resulted in a more densely packed and thicker biofilm (Fig.IV.2A and C). 
These results further support that the limited lysis promoted by lysogenic phages during 







Figure IV.3. Effect of DNAse I and DNA on biofilm mass. (A) The lysogenic strain R36AP and its nonlysogenic parent 
R36A were exposed from seeding to DNAse I at final concentrations of 0.5, 5 and 50 µg/ml. Biofilm mass was 
quantified after 24 h of incubation. (B) R36AP and R36A were exposed from seeding to DNA from R36A or salmon 
sperm at final concentrations of 10, 100 and 1000 ng/ml. In separate experiments, the effect on biofilm 
development of coating the wells with 1000 ng/ml of R36A DNA prior to seeding and the addition of sonicated R36A 
DNA at 1000 ng/ml since the time of seeding was also determined. Biofilm mass was assessed at 24 h of incubation. 
In all panels, the results are an average of 9 independent replicates and error bars represent 95% confidence 
intervals for the sample mean. 
 
 
Due to the different kinetics of biofilm development of the lysogenic and nonlysogenic 
strains, we wanted to clarify if the role of DNA was only critical in the initial steps of biofilm 
establishment (initial cell attachment) or if its presence was necessary throughout the 
subsequent early phases of biofilm development. To this end, the wells where the biofilms 
were grown were precoated with DNA followed by incubation of the bacteria in DNA-free 
medium. After 24 h, biofilm mass was similar to the uncoated control (Fig.IV.3B), indicating 
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Furthermore, we also examined whether DNA acts as a structural component of the 
biofilm or if the availability of extra nutrients, due to the presence of DNA in the medium, 
could explain the enhanced biofilm development. With that in mind, we grew biofilms in the 
presence of sonicated DNA and compared them with biofilms formed in the presence of intact 
DNA, using both homologous and heterologous DNA. In the presence of fragmented DNA, 
biofilm development assessed at 24 h was similar to that of biofilms grown in the absence of 
DNA and substantially less to that observed with intact DNA (Fig.IV.3B). This data revealed that 
large DNA fragments were essential for the enhancement of biofilm growth and suggested 
that DNA had an important structural role in biofilm architecture.  
To confirm if a higher eDNA release due to phage spontaneous induction is related to a 
strong biofilm development we determined the actual eDNA released into the biofilm of each 
strain, after 24 h of growth, by quantitative real-time PCR. Strains with a higher capacity to 
form biofilm (R36AP, R36A, R36APΔsvl and R36APΔlytA) contain significantly more eDNA in 
comparison to the almost undetectable levels present in R36APΔlytAΔsvl and R36AΔlytA, two 
strains with poor biofilm forming capacity (Fig.IV.4A). The marked difference observed 
between lytic and nonlytic strains suggest that lytic events resulting in eDNA release have a 
strong positive impact in biofilm development. 
DNA release upon phage induction is dependent on lysis. So, we reasoned that the 
addition of external DNA to biofilms of the mutant strains R36APΔsvl, R36APΔlytA and 
R36APΔlytAΔsvl would allow the development of more robust biofilms. Indeed, when the 
mutant strains were given exogenous DNA, biofilm development was strongly increased in 
R36APΔsvl and R36APΔlytA (Fig.IV.4B and S1A). The addition of a large excess of DNA 
overcomes the impairments created by the ablation of either the phage or bacterial lysins, 
with the formation of more biofilm in the presence of DNA by these mutants than that 
observed when R36AP, where both lysins are functional, was incubated in the absence of 
exogenous DNA (Fig.IV.4B and S1A). As pointed out previously, the mutant lacking both lysin 
activities (R36APΔlytAΔsvl) was incompetent to form stable biofilms and, even in the presence 
of excess DNA, failed to recover to the R36AP level. Thus the addition of DNA does not fully 
overcome the abolishment of the two major lysins present in R36AP. This is in contrast to 
R36AΔlytA that responds well to the addition of external DNA. Although both mutants present 
similar amounts of eDNA (Fig.IV.4A), the R36AΔlytA strain forms more biofilm biomass than 
strain R36APΔlytAΔsvl (Fig.IV.1A) and this effect is even more pronounced in the number of 
viable bacteria in the biofilm (Fig.IV.1B). It has been previously shown that even when phage 
and bacterial lysins are deleted, phage induction decreases cell viability as phages express 
holins that collapse the cell membrane potential resulting in host cell death [32]. Thus, this 
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difference in cell viability between R36AΔlytA and R36APΔlytAΔsvl may be sufficient to 
compromise the enhancement of biofilm development in the presence of added DNA 
observed in the later strain. 
 
Figure IV.4. eDNA quantification and DNA impact on biofilm mass. (A) Extracellular DNA was isolated from the 
biofilm matrices of R36A, R36AΔlytA, R36AP, R36APΔsvl, R36APΔlytA and R36APΔlytAΔsvl and quantitative real-time 
PCR of two chromosomal genes, spi and gdh, was done. The relative biomass was quantified at OD595nm and the 
eDNA measurements were normalized to total biofilm mass. (B) The effect of salmon sperm DNA (1000 ng/ml) 
added from seeding on biofilm biomass at 24 h was tested. R36APΔsvl, R36APΔlytA, R36AΔlytA and R36APΔlytAΔsvl 
are mutants in which the phage lysin (Svl), the bacterial autolysin (LytA) or both were deleted. (C) The same 
experiments described in panel B were done with the encapsulated wild-type host of phage SV1, strain SVMC28, 
and its mutants. SVMC28Δsvl, SVMC28ΔlytA and SVMC28ΔlytAΔsvl are mutants in which the phage lysin (Svl), the 
bacterial autolysin (LytA) or both were deleted. In all panels, the results are an average of 9 independent replicates 
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To test if the presence of a capsular polysaccharide could influence our results, we 
characterized the behavior of strain SVMC28 and its mutants in both phage and bacterial 
lysins. SVMC28 is an encapsulated strain and the natural host of the SV1 phage. The results 
obtained were superimposable to those of strain R36AP and its mutants, with the same 
relative biomass produced by the parental strain and its mutants in the absence of DNA and 
the same effect seen upon DNA addition (Fig.IV.4C). Again, the number of viable cells was 
consistent with the biomass quantification (Fig.IV.S1B). This indicates that our observations 
were reproducible in different genetic backgrounds and, more importantly, that the capsule 
did not qualitatively alter our conclusions. Overall, our results indicate that the release of 
eDNA through controlled lytic events is a key factor for biofilm formation in S. pneumoniae and 
that lysogenic phages are important adjuvants for its incorporation in the biofilm matrix 



















Prophages are extremely common among S. pneumoniae isolates causing infections in 
humans [24]. The lysogenic lifestyle results in the establishment of the phage genome inside 
the bacterial host where it can remain in a dormant state replicating together with the 
bacterial chromosome. An important feature is the possible transition from the repressed 
lysogenic state to lytic development that ultimately leads to host cell death and release of the 
newly produced phage particles. Prophage induction can occur spontaneously in a fraction of 
the lysogenic bacterial population or massively upon external stimuli [26,27]. 
Here we investigated the impact of lysogeny in S. pneumoniae biofilm formation exploring 
its role in the early development of these structures. Our data provided evidence that 
prophage carriage had a positive impact on pneumococcal biofilm formation through 
spontaneous induction of the lytic cycle. Phage induction results in the death of their bacterial 
hosts, however we showed that this phage-mediated lysis enhances biofilm formation, 
suggesting that in this context the bacterial population as a whole could benefit from limited 
prophage induction. Studies on gene expression in biofilms of various species have identified 
phage genes as overexpressed relative to planktonic growth while other studies showed the 
existence of lysis inside biofilms and proposed that it could increase biofilm fitness [37-42]. 
Our results corroborate this previous proposal in the context of S. pneumoniae biofilms, clearly 
identifying the phage activated lytic machinery as a key player in this effect. Interestingly, 
phage-mediated bacterial lysis within the biofilm has also been described in other bacterial 
species. However, in contrast to our study, in those cases, phage induction results in the death 
of a large fraction of the bacterial population and occurs in the later stages of biofilm 
development [39-42]. 
The impact of lysogenic phages on pneumococcal populations is still an open question 
since comparative genomic analysis did not reveal any phage-encoded virulence factors, 
contrary to other related streptococcal pathogens such as Streptococcus pyogenes [43,44]. The 
observed biofilm potentiating role of lysogenic phages and the proposed importance of these 
structures in colonization [11] could explain in part the high incidence of lysogeny in S. 
pneumoniae natural populations [24,25]. Furthermore, a high frequency of lysogeny is 
characteristic of many bacterial pathogens [45] as well as of bacterial populations in the 
environment [46], raising the possibility that the influence of lysogeny on the ability of 
pneumococci to form biofilms could be paralleled in other bacterial species. 
The mechanism by which spontaneous prophage-mediated cell lysis leads to increased 
biofilm development was also addressed in this study. We gathered evidence that DNA 
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released through this process to the extracellular environment contributes to biofilm 
formation in S. pneumoniae. An approximately six-fold increase in eDNA was detected in 
strains carrying prophages and functional bacterial or phage lysins. These lysogenic strains 
were also characterized by forming biofilms with a higher biomass and cell viability. This role of 
eDNA is consistent with previous findings in this species, although in those studies the source 
of eDNA was not identified [5,23]. We observed that eDNA is not involved in the initial 
attachment stage, since pretreatment of the plastic substrate with DNA did not increase 
biofilm formation. In agreement, a high concentration of DNAse I added from the onset of 
biofilm incubation still allowed bacterial surface attachment and biofilm formation, although in 
these conditions bacteria failed to form the thick and dense structures observed in the 
absence of DNase I. To our knowledge, this is the first study of the role of eDNA in initial 
adhesion of pneumococcal cells to a surface. Although in some bacterial species eDNA plays an 
important role in this initial step [16,47], similar results to ours were already observed with 
another Gram-positive bacterium [12]. Being such a complex lifestyle, it is plausible that in 
different microorganisms the importance of the various mechanisms for biofilm establishment 
is also different. The factors or substances that promote initial attachment remain to be 
identified in S. pneumoniae. However, eDNA played an important role already in the early 
stages of biofilm development, since spontaneous phage-induced lysis is detected in the early 
hours of biofilm establishment and the R36AP lysogen showed a more robust biofilm 
development at all time points. Accordingly, a mutant lacking the phage lysin produced less 
biofilm and in a delayed fashion, a behavior that was similar to the mutants lacking the major 
bacterial autolysin LytA. Both observations are consistent with a possibly slower accumulation 
of eDNA in the matrix and with an important role of eDNA at various stages of biofilm 
formation. 
Our data indicates that eDNA is an important structural component of S. pneumoniae 
biofilms, ensuring stability of the overall architecture of these structures. Although DNAse I 
treatment resulted in eDNA degradation with the consequent reduction in biofilm formation, 
the critical result that definitely establishes this structural role of DNA was the observation 
that addition of fragmented DNA did not affect biofilm development, whereas intact DNA led 
to increases in both mass and bacterial viability in biofilms, indicating that the long strands of 
DNA may allow more intercellular cohesion thereby increasing biofilm stability. These results 
are supported by studies in other species that have proposed DNA as an essential component 
of the extracellular polymeric substance that constitutes the biofilm matrix [12,15,16,23,48]. 
Thus, cell lysis mediated by lysogenic phages influences the matrix composition, thereby 
contributing to the pneumococcal biofilm structural stability. Since spontaneous phage 
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induction occurs in different areas of the biofilm, it is expected to contribute significantly to 
the abundance and widespread localization of eDNA. 
In contrast to limited cell lysis due to spontaneous phage induction, massive phage 
induction in the presence of an external inducing agent could disrupt biofilms drastically, an 
hypothesis supported by the use of lytic phages as powerful antibiofilm agents active against 
different microorganisms [49,50]. In fact, preliminary results from our group indicate that 
mitomycin C phage induction is able to disrupt to a large extent biofilms of lysogenic strains 
(supplementary data, Fig.IV.S2). If the proportion of induced cells is large, more cells lyse than 
are contributing to the biofilm resulting in an overall loss of biofilm mass. This is in agreement 
with the natural biofilm demise mediated by substantial phage induction proposed for some 
Pseudomonas aeruginosa strains that facilitate differentiation and dispersal of biofilm 
associated bacteria [39,41,42]. The beneficial or detrimental effect of prophage induction on 
biofilm formation seems to be quantitatively regulated by the proportion of lysogenic bacteria 
undergoing lytic induction. 
In conclusion, we showed that limited activation of prophages into the lytic cycle, thereby 
promoting host lysis and eDNA release, contributes to enhanced pneumococcal biofilm 
production. This more efficient biofilm development afforded by lysogenic phages may be an 
important aspect in the biology of the bacteria since lysogeny is highly prevalent in 
pneumococci. Our data provided new insights into the factors that influence the formation and 
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7.  SUPPLEMENTARY DATA  
 





Figure IV.S1. DNA impact on biofilm cell viability. (A) The effect of salmon sperm DNA (1000 ng/ml) added from 
seeding on biofilm cell viability (CFUs) at 24 h was tested on R36A, R36AP and derivative mutants. (B) The same 
experiments described in panel A were done with the encapsulated wild-type host of phage SV1, strain SVMC28, 
and its mutants. In all panels, the results are an average of 6 independent replicates and error bars represent 95% 








































































































































Figure IV.S2. Effect of agent-mediated phage induction in Streptococcus pneumoniae biofilm development. (A and 
B) SVMC28 wild-type strain was exposed from seeding to mitomycin C (MitC+) to induce the phage lytic cycle at a 
final concentration of 0.1 μg/ml. A control without MitC was also done (MitC-). Biofilm mass was quantified after 6 
h (A) and 24 h (B) of incubation, as described in material and methods. At both time points, SVMC28 treated with 
MitC shows a significant decrease on biofilm mass compared to the untreated control. Thus, MitC phage induction 
at the onset of biofilm formation hindered biofilm development. (C and D) Biofilms grown for 24 h were exposed to 
MitC for 2 h (C) or 4 h (D). After 4 h of incubation with MitC, SVMC28 has a significant decrease on biofilm mass. 
Thus, MitC phage induction degraded grown biofilms. In all panels, error bars represent 95% confidence intervals 
for the sample mean. *, P < 10
-4
 as compared with untreated strain; C+Y, control of culture medium (the values 
were not subtracted to those measured for SVMC28). (E and F) Confocal laser scanning microscopy images of 
SVMC28 biofilms were obtained at 24 h of incubation (E) and at 24 h of incubation followed by 4 h of MitC exposure 
(F), following the procedure described before. Staining was done with Syto 9/PI and images were acquired at 630x 
amplification. Live cells internalize only Syto 9 (fluorescing green) whereas dead cells allow the uptake of PI 
(fluorescing red). The large images are optical sections of top views and the small images to the right and above are 
optical sections of side views. The depth of the biofilm is indicated by the height of the z-stack. The inset scale bar 
represents 5 μm. In all panels, the results are representative images of 3 independent experiments. In agreement 
with the results obtained by biomass quantification, treatment with MitC reduces drastically biofilms. Altogether, 
these results suggest that massive prophage induction, in the presence of an external inducing agent, could disrupt 
























































































6 h 24 h + 2 h
24 h 24 h + 4 h
LYSOGENIC PHAGES FOSTER PNEUMOCOCCAL BIOFILMS 
146 
8.  CHAPTER REFERENCES 
 
1. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of 
persistent infections. Science 284: 1318-1322. 
2. Hall-Stoodley L, Stoodley P (2009) Evolving concepts in biofilm infections. Cell Microbiol 11: 
1034-1043. 
3. Kolter R, Greenberg EP (2006) Microbial sciences: the superficial life of microbes. Nature 
441: 300-302. 
4. Mah TF, O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends 
Microbiol 9: 34-39. 
5. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, et al. (2006) Direct detection of 
bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Jama 
296: 202-211. 
6. Sanderson AR, Leid JG, Hunsaker D (2006) Bacterial biofilms on the sinus mucosa of human 
subjects with chronic rhinosinusitis. Laryngoscope 116: 1121-1126. 
7. Reid SD, Hong W, Dew KE, Winn DR, Pang B, et al. (2009) Streptococcus pneumoniae forms 
surface-attached communities in the middle ear of experimentally infected chinchillas. 
J Infect Dis 199: 786-794. 
8. Lizcano A, Chin T, Sauer K, Tuomanen EI, Orihuela CJ (2010) Early biofilm formation on 
microtiter plates is not correlated with the invasive disease potential of Streptococcus 
pneumoniae. Microb Pathog 48: 124-130. 
9. Tapiainen T, Kujala T, Kaijalainen T, Ikaheimo I, Saukkoriipi A, et al. (2010) Biofilm formation 
by Streptococcus pneumoniae isolates from paediatric patients. Apmis 118: 255-260. 
10. Oggioni MR, Trappetti C, Kadioglu A, Cassone M, Iannelli F, et al. (2006) Switch from 
planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol 
61: 1196-1210. 
11. Muñoz-Elias EJ, Marcano J, Camilli A (2008) Isolation of Streptococcus pneumoniae biofilm 
mutants and their characterization during nasopharyngeal colonization. Infect Immun 
76: 5049-5061. 
12. Guiton PS, Hung CS, Kline KA, Roth R, Kau AL, et al. (2009) Contribution of autolysin and 
sortase A during Enterococcus faecalis DNA-dependent biofilm development. Infect 
Immun 77: 3626-3638. 
13. Mulcahy H, Charron-Mazenod L, Lewenza S (2008) Extracellular DNA chelates cations and 
induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 4: 
e1000213. 
14. Vilain S, Pretorius JM, Theron J, Brozel VS (2009) DNA as an adhesin: Bacillus cereus 
requires extracellular DNA to form biofilms. Appl Environ Microbiol 75: 2861-2868. 
15. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS (2002) Extracellular DNA required for 
bacterial biofilm formation. Science 295: 1487. 
16. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, et al. (2007) Role of autolysin-mediated DNA 
release in biofilm formation of Staphylococcus epidermidis. Microbiology 153: 2083-
2092. 
17. Thomas VC, Hiromasa Y, Harms N, Thurlow L, Tomich J, et al. (2009) A fratricidal 
mechanism is responsible for eDNA release and contributes to biofilm development of 
Enterococcus faecalis. Mol Microbiol 72: 1022-1036. 
18. Thomas VC, Thurlow LR, Boyle D, Hancock LE (2008) Regulation of autolysis-dependent 
extracellular DNA release by Enterococcus faecalis extracellular proteases influences 
biofilm development. J Bacteriol 190: 5690-5698. 
19. Tomasz A, Moreillon P, Pozzi G (1988) Insertional inactivation of the major autolysin gene 
of Streptococcus pneumoniae. J Bacteriol 170: 5931-5934. 
CHAPTER IV 
147 
20. Moscoso M, Claverys JP (2004) Release of DNA into the medium by competent 
Streptococcus pneumoniae: kinetics, mechanism and stability of the liberated DNA. 
Mol Microbiol 54: 783-794. 
21. Steinmoen H, Knutsen E, Havarstein LS (2002) Induction of natural competence in 
Streptococcus pneumoniae triggers lysis and DNA release from a subfraction of the cell 
population. Proc Natl Acad Sci U S A 99: 7681-7686. 
22. Hall-Stoodley L, Nistico L, Sambanthamoorthy K, Dice B, Nguyen D, et al. (2008) 
Characterization of biofilm matrix, degradation by DNase treatment and evidence of 
capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol 
8: 173. 
23. Moscoso M, Garcia E, Lopez R (2006) Biofilm formation by Streptococcus pneumoniae: role 
of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J 
Bacteriol 188: 7785-7795. 
24. Ramirez M, Severina E, Tomasz A (1999) A high incidence of prophage carriage among 
natural isolates of Streptococcus pneumoniae. J Bacteriol 181: 3618-3625. 
25. Severina E, Ramirez M, Tomasz A (1999) Prophage carriage as a molecular epidemiological 
marker in Streptococcus pneumoniae. J Clin Microbiol 37: 3308-3315. 
26. Little JW (2005) Lysogeny, prophage induction, and lysogenic conversion. In: Waldor MK, 
Friedman, DI, Adhya SL, editors. Phages, their role in bacterial pathogenesis and 
biotechnology. Washington, DC: ASM Press. pp 37-54. 
27. Lwoff A (1953) Lysogeny. Bacteriol Rev 17: 269-337. 
28. Figueroa-Bossi N, Bossi L (1999) Inducible prophages contribute to Salmonella virulence in 
mice. Mol Microbiol 33: 167-176. 
29. Bossi L, Fuentes JA, Mora G, Figueroa-Bossi N (2003) Prophage contribution to bacterial 
population dynamics. J Bacteriol 185: 6467-6471. 
30. Livny J, Friedman DI (2004) Characterizing spontaneous induction of Stx encoding phages 
using a selectable reporter system. Mol Microbiol 51: 1691-1704. 
31. Lopez R, Garcia E (2004) Recent trends on the molecular biology of pneumococcal capsules, 
lytic enzymes, and bacteriophage. FEMS Microbiol Rev 28: 553-580. 
32. Frias MJ, Melo-Cristino J, Ramirez M (2009) The autolysin LytA contributes to efficient 
bacteriophage progeny release in Streptococcus pneumoniae. J Bacteriol 191: 5428-
5440. 
33. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, et al. (1999) Current protocols in 
molecular biology. New York, NY: Wiley-Inter-science. 
34. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, et al. (2009) Modulation of eDNA release 
and degradation affects Staphylococcus aureus biofilm maturation. PLoS One 4: e5822. 
35. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, et al. (2006) A characterization of 
DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59: 
1114-1128. 
36. Spoering AL, Gilmore MS (2006) Quorum sensing and DNA release in bacterial biofilms. 
Curr Opin Microbiol 9: 133-137. 
37. Mai-Prochnow A, Evans F, Dalisay-Saludes D, Stelzer S, Egan S, et al. (2004) Biofilm 
development and cell death in the marine bacterium Pseudoalteromonas tunicata. 
Appl Environ Microbiol 70: 3232-3238. 
38. Mai-Prochnow A, Webb JS, Ferrari BC, Kjelleberg S (2006) Ecological advantages of 
autolysis during the development and dispersal of Pseudoalteromonas tunicata 
biofilms. Appl Environ Microbiol 72: 5414-5420. 
39. Rice SA, Tan CH, Mikkelsen PJ, Kung V, Woo J, et al. (2009) The biofilm life cycle and 
virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. Isme 
J 3: 271-282. 
40. Webb JS, Lau M, Kjelleberg S (2004) Bacteriophage and phenotypic variation in 
Pseudomonas aeruginosa biofilm development. J Bacteriol 186: 8066-8073. 
LYSOGENIC PHAGES FOSTER PNEUMOCOCCAL BIOFILMS 
148 
41. Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, et al. (2003) Cell death in 
Pseudomonas aeruginosa biofilm development. J Bacteriol 185: 4585-4592. 
42. Kirov SM, Webb JS, O'May C Y, Reid DW, Woo JK, et al. (2007) Biofilm differentiation and 
dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic 
fibrosis. Microbiology 153: 3264-3274. 
43. Banks DJ, Beres SB, Musser JM (2002) The fundamental contribution of phages to GAS 
evolution, genome diversification and strain emergence. Trends Microbiol 10: 515-521. 
44. Desiere F, McShan WM, van Sinderen D, Ferretti JJ, Brussow H (2001) Comparative 
genomics reveals close genetic relationships between phages from dairy bacteria and 
pathogenic streptococci: evolutionary implications for prophage-host interactions. 
Virology 288: 325-341. 
45. Brussow H, Canchaya C, Hardt WD (2004) Phages and the evolution of bacterial pathogens: 
from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68: 
560-602. 
46. Williamson SJ, Cary SC, Williamson KE, Helton RR, Bench SR, et al. (2008) Lysogenic virus-
host interactions predominate at deep-sea diffuse-flow hydrothermal vents. Isme J 2: 
1112-1121. 
47. Harmsen M, Lappann M, Knochel S, Molin S (2010) Role of extracellular DNA during biofilm 
formation by Listeria monocytogenes. Appl Environ Microbiol 76: 2271-2279. 
48. Moscoso M, Garcia E, Lopez R (2009) Pneumococcal biofilms. Int Microbiol 12: 77-85. 
49. Donlan RM (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. 
Trends Microbiol 17: 66-72. 
50. Lu TK, Collins JJ (2007) Dispersing biofilms with engineered enzymatic bacteriophage. Proc 































































































1. CONCLUDING REMARKS 
 
Pneumococcal prophages are extremely frequent among strains associated with infection 
[1-6] but no role in pathogenesis has so far been attributed to them. A potential contribution 
may be through bacterial lysis, either by releasing proinflammatory and virulence factors 
resembling LytA [7-13], or by enhancing biofilm development since the ability to form these 
structures is apparently important in pneumococcal infection [14-17]. Therefore, this study 
concentrated on the lysis strategy of Streptococcus pneumoniae phages to release their 
progeny specifically the precise mechanisms involved and its implications on the bacterial host 
in the context of biofilms.   
Concerning the study of the holin-lysin system in pneumococcal phage-induced lysis, a 
global picture for phage release emerged (Fig.V.1). S. pneumoniae phages encode their own 
lysins which apparently exploit the host Sec system to target the cell wall. In the 
extracytoplasmic environment, the phage lysins are bound to choline residues and inactive due 
to the energized membrane. Upon proton motive force (pmf) dissipation provoked by the 
holin action at the membrane level, lysin activation is accomplished. This in turn, also 
guarantees the activation of the host autolysin LytA also positioned in the cell wall via choline 
(Fig.V.1). By exploring the autolysin lytic activity, the pneumococcal phages optimize their 
exiting strategy maximizing the number of phage particles released. Also, with both lysins 
already positioned in the cell wall target, this may ensure a quicker hydrolysis of the thicker 
peptidoglycan of this Gram-positive bacterium allowing a more prompt phage egress. 
Interestingly, it was observed that DNA damage by mitomycin C (MitC) treatment results in 
increased recA expression (dependent on the development of competence) [18,19] and, in the 
absence of RecA, does not lead to prophage induction and cell lysis [19]. Also, an 
overexpression of lytA is observed during competence development as it is cotranscribed with 
recA [20-22]. It is therefore tempting to speculate that upon prophage induction higher 
concentrations of LytA would therefore be at phage disposal.     
The establishment of this lysis mechanism was based on the particular lysogenic phage 
SV1 but a generalization is highly plausible given the presence of the typical holin-lysin cassette 
in all pneumococcal phages [5,6,23-26], the ubiquitous presence of LytA in S. pneumoniae 
strains, the absence of signal sequences in all phage lysins and the high similarity between 
lysins of different phages including the presence of a choline binding domain [1,23,27-30]. Our 
findings that bacterial and phage lysins are under similar physiological control and are both cell 
surface localized is also coherent with previous reported observations namely the culture lysis 
only in the stationary phase promoted by the phage lysins Cpl-1 and Hbl, replacing the 
CONCLUDING REMARKS 
152 
autolysin in a lytA mutant, despite their constitutive expression as assessed by deoxycholate 
(DOC)-lysis induction during exponential growth [31].  
It was initially assumed that pneumococcal phage lysins depended on holin to gain access 
to the cell wall [23,24,32,33] similarly to the accepted mechanism operating in the majority of 
Gram-positive bacteria phages, which are also typically devoid of secretory signal sequences in 
their lysins [34-36]. Additionally, the observed membrane lesions induced by Cph-1 and Ejh 
holins were large enough for lysins to pass through [24,26,32]. Our findings, although 
contradicting this model, are similar to the results reported for phages Cp-1 and EJ-1 [24,26], 
since holins indeed control phage lysin activation but by membrane deenergization. We also 
observed that bacterial lysis is prevented in the presence of only the holin or the lysin, 
although it is induced in the presence of both functions. The holin, but not the lysin, induces 
membrane permeabilization in conformity with the described holin- but not lysin-induced 
viability loss. The alleged role of holin permeabilization in lysin transport could not however 
explain the puzzling observation that the pneumococcal autolysin was able to lyse Escherichia 
coli cells when expressed together with the phage holin [24,26] despite LytA being found in the 
cell envelope of E. coli and its expression in the absence of holin did not result in cell lysis 
[24,26,37].  
In conclusion, pneumococcal phages carry exolysins, operating through the holin-exolysin 
system, therefore dependent for activity on the holin deenergizing role. This lysis strategy may 
be more widespread than originally thought since, similarly to what happened in S. 
pneumoniae, it is possible that it might have been overlooked. Interestingly, in Gram-positive 
bacteria, phage lysins typically have a cell wall binding domain to target them to the cell 
surface and in some cases a signal sequence seems to be present [35,38-41]. Moreover, some 
bacterial cell wall hydrolases are unusually deprived of known signal sequences but are still 
translocated across the membrane (via SecA2 system) [42], and membrane pmf dissipation can 
trigger lysis in a few bacteria [43,44], which would imply the same influence on phage lysins. It 
should be mentioned however, that one particularity of S. pneumoniae is the high similarity 
and absence of export signals in both phage lysins and the bacterial autolysin [23].  
Research on bacterial autolysins has been stimulated by a desire to determine the 
mechanisms by which these potentially lethal enzymes are controlled. In this regard, the study 
of S. pneumoniae phage lysis mechanism revealed to be of great value. Indeed, we determined 
that autolysin LytA is regulated by the membrane pmf, similarly to the phage lysins. However, 
the exact mechanisms by which loss of membrane energization is a precursor for lysis remain 
to be determined. The holin-induced membrane deenergization (possibly inducing cell surface 
perturbations) could be the triggering event of the general disorganization of the lysin-lysin 
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inhibitor (e.g. the lipoteichoic acid) complex, leading to the uncontrolled action of the lysins or 
otherwise signal an independent pathway. Another possible explanation relies on pH. The 
regulation of autolytic enzymes in Bacillus subtilis, shown to be dependent on the energized 
state of the membrane, is proposed to be due to the resulting relatively low pH of the cell wall 
environment [43,45,46]. Dissipation of pmf would alter the local cell wall pH and, in turn, 
activate the autolysins [45,46]. Curiously, in S. pneumoniae, it was reported that acid stress 
triggered LytA-mediated lysis even though it was suggested that an intracellular signalling 

















Figure V.1. Proposed model of pneumococcal phage-mediated cell lysis, based on experimental observations 
with SV1 lysogenic phage. The phage lysin (Svl) is continuously targeted to the cell wall during phage assembly, 
apparently through the host Sec system, where its activity is regulated by the energized cytoplasmic membrane 
(CM). Meanwhile, the holins probably accumulate in the CM without affecting the membrane integrity, similarly to 
what has been proposed for holin Ejh of S. pneumoniae phage EJ-1 which accumulates in the CM until it reaches 
the lesion-forming concentration [32,33]. At the time the holins permeabilize the CM, the induced membrane 
deenergization results in the activation of the phage lysin and the cell wall localized bacterial autolysin (LytA), 
which then digest the peptidoglycan (PG) promoting phage release. LytA and phage lysin Svl are coloured in purple 
and orange, respectively. For simplicity, lysins attachment via teichoic acids is not represented and holins are 
drawn as single membrane-spanning rectangles in green. Energized membrane is illustrated as “plus” and “minus” 
charges enclosed in circles.  
 
 
Furthermore, β-lactamic antibiotics have been shown to induce autolysis and to 
depolarize the cell membrane potential in Streptomyces griseus [48]. Both permeabilization 
and depolarization of the membrane were also shown to occur when Staphylococcus aureus 
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and Micrococcus luteus are treated with amoxicillin [49]. It is known that pneumococci lyse 
with β-lactams [50] and we observed that membrane deenergization triggers LytA, which is 
suggestive that these compounds may also induce membrane depolarization in S. pneumoniae 
and thereby activate LytA. This would fit in the Cid model proposed by Morreilon et al. [51], in 
which the putative holin-like protein Cid would cause injury to the cell membrane when 
present at large concentrations induced by β-lactams. In the absence of antibiotics, Cid protein 
at normal physiological concentrations, acting in the membrane, would control the transport 
of LytA to the cell wall. However, in light of our results, it can be speculated that the loss of 
membrane integrity would serve to deenergized the membrane rather than allowing the 
release of large amounts or unregulated forms of LytA. Of interest, the CidA protein of S. 
aureus was actually demonstrated to form membrane lesions similar to holins, to control lysis 
and to induce an increased sensitivity to penicillin-induced killing, which led to the proposal 
that this protein may cause the membrane pmf to collapse [52,53]. It should be noted that 
inhibition of pneumococcal cell wall synthesis by β-lactams apparently promotes the release of 
lipoteichoic acids suggesting that it destabilizes inhibitor complexes [50], involving or not pmf 
dissipation. Furthermore, a function of Cid to mediate LytA export could be discarded if LytA 
follows the Sec pathway like we suggest for the pneumococcal phage lysins.  
Remarkably, besides possessing the general Sec system, S. pneumoniae apparently also 
shares the uncommon property of comprising a SecA2-dependent protein secretion [54,55] 
with some other Gram-positive bacteria including some streptococci [56-60]. Indeed, the 
secA2 gene is highly frequent among pneumococci [54] and the detailed analysis of the 
accessory secA2 locus in pneumococcal strain TIGR4 revealed that it is very similar to that of 
other Streptococcus species especially S. gordonii [54,58], in which some SecA2-dependent 
proteins were already identified [42,57,59]. It is possible then that in S. pneumoniae this could 
as well represent a specialized transport system that might also export, similar to Listeria 
monocytogenes, a specific subset of unusual proteins lacking known signal sequences 
including, for instance, some choline binding proteins and even the long-thought cytoplasmic 
pneumolysin [42,55,61,62]. Thus, as the transport of LytA remains so far unidentified despite 
several efforts, the hypothesis of the involvement of the accessory SecA2 protein secretion 
system in lysin transport is important to address.   
One biological function of lysis induced by pneumococcal lysogenic phages, demonstrated 
in the present study, is the enhancement of biofilm formation. The entire bacterial population 
within the biofilm benefits from the spontaneous prophage induction in a subfraction of cells. 
These random lytic events contribute to early development of S. pneumoniae biofilms by 
causing release of genomic DNA, which ultimately becomes a critical component of the biofilm 
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matrix. A structural role of extracellular DNA (eDNA) was definitely confirmed in agreement 
with the already described eDNA presence in pneumococcal biofilms and its influence in their 
formation [63,64]. A feature of lysogenic cells is that all are characterized by the presence of a 
prophage. Therefore, within the biofilm, spontaneous phage induction provides a widespread 
eDNA source for optimal development of stable biofilms, rather than spatially and temporally 
confined as proposed for autolytic events [65]. The process of spontaneous induction is not 
very well understood but it is seems dependent on bacterial physiological conditions [66-68]. 
Differently from planktonic growth, altered transcriptional profiles associated with phenotypic 
changes are a characteristic of the complex biofilm form of living [14,69,70] and also vary 
during biofilm development, as was indeed detected in pneumococcal biofilms [69]. Therefore, 
it is reasonable to believe that biofilm physiological heterogeneity can play a role in different 
levels of spontaneous induction and consequently in DNA availability within these structures. It 
should be mentioned that the fact that few dead cells were detected in the biofilms of wild-
type lysogens comparing to the ones of nonlysogens seems to be in agreement with the fast 
kinetics of the lytic process observed earlier, where intermediary dead cells are present only 
for a very short time. Indeed, our flow cytometry analysis of MitC-induced wild-type lysogens 
detected very few permeabilized cells. 
Besides the phage positive contribution to pneumococcal biofilm, in this study it was also 
confirmed that LytA stimulates the formation of these structures as previously described [63]. 
Since eDNA is important in S. pneumoniae biofilms, we explored this relationship further in a 
phage free context by demonstrating that DNA release from pneumococcal cells is in fact 
mainly mediated by the autolysin. Elimination of LytA reduced drastically eDNA and DNA 
addition restored the ability to form robust biofilms in a lytA mutant. These results are in 
agreement with the reported release of eDNA by autolysins in biofilms of other species [71-
74]. Because LytA has a lytic activity which is accompanied by DNA release in liquid culture [75-
77], it is highly likely that, within the biofilms, LytA activity also results in lysis. How 
pneumococcal LytA-mediated lysis is limited to a subpopulation of bacteria within the entire 
biofilm population is a challenging subject to explore.  
Although bacterial autolytic events were proposed to exist in biofilms favoring their 
development [65,71,72,78], the involvement of lysogenic phages in bacterial biofilms has been 
disregarded. In biofilms of S. aureus phage activities were detected but their impact was not 
evaluated [79]. Despite this, the relevance of phage-mediated lysis has been described in 
Pseudomonas aeruginosa biofilms, where it influences the processes of differentiation and 
dispersal in already mature biofilms [80,81]. Although in these cases phage induction occurs in 
a substantial fraction of cells, it is still an advantage for the biofilm life cycle [80,81]. Our 
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analysis provides a different perspective in the context of S. pneumoniae biofilms, namely the 
impact of the limited lysis intrinsic of the lysogenic state in the early establishment of these 
structures. In S. pneumoniae, this could be of major importance since lysogeny is extremely 
abundant. Additionally, given the widespread nature of lysogenic phages, it is possible that 
lysis controlled by them can be as well a key mechanism in biofilm development in other 
species. Indeed, subsequent studies in P. aeruginosa and Shewanella oneidensis biofilms 
support this hypothesis as it was demonstrated, similarly to our findings, a beneficial role for 
restricted prophage-induced lysis and eDNA release [82,83].           
Contrasting with the favorable role of spontaneous fashion of phage induction, massive 
induction by an external stimulus and consequent substantial lysis seems to destroy to a great 
extent the biofilms of pneumococcal lysogenic strains. In fact, MitC was able to penetrate the 
cells encased in the biofilm matrix and disrupted almost completely the biofilms, in agreement 
with the successful use of lytic phages to eliminate biofilms of different species [84-86]. 
Interestingly, S. pneumoniae phage lytic enzymes, and even the bacterial autolysin LytA, have 
been shown as efficient weapons in killing pneumococci in vitro and in vivo [87-92]. Even 
though the potential of these lysins as antibiofilm agents is little studied, the lysin of phage 
Cp-1 is likely to prevent biofilm formation in vivo [16,17,93]. Furthermore, it was very recently 
demonstrated their ability to destroy pneumococcal biofilms produced in vitro, in spite of not 
all showing a high disintegrative capacity [94]. This highlights the importance of further 
investigating the usage of the phage lytic ability.  
After exploring the lysis mechanism of S. pneumoniae phages and its contribution to 
biofilms, a question comes to mind especially considering the high prevalence of 
pneumococcal prophages [1]. What could be the potential role of the lysis mediated by phages 
in pneumococcal virulence? It can be speculated that in the human host, spontaneous phage 
induction could favor biofilms potentially contributing to pneumococcal colonization and 
infection as biofilms have been implicated in both these processes [14,95]. Moreover, 
independently of pneumococci existence in biofilms, massive phage induction, and to a less 
extent spontaneous induction, could contribute to virulence in a similar fashion to LytA by 
releasing cell wall fragments with proinflammatory activity and cytoplasmic virulence factors 
[7-10]. Interestingly, if virulence factors encoded in pneumococcal prophage genomes are 
found, prophage induction could increase their expression similarly to what happens in other 
bacterial species [96]. Actually, prophage-inducing factors are present in the human body 
including agents produced by human cells such as reactive oxygen species during inflammation 
in colonization and infection [96,97]. Importantly, although antibiotics are effective at killing 
pathogens, they could also induce massive phage induction including not only quinolones that 
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interfere with DNA replication, and therefore are more expected to destabilize the prophage 
state through SOS response activation, but also β-lactams [98-101]. Although in S. pneumoniae 
the prophage induction by quinolones was not yet studied, it was shown that they also hamper 
DNA topoisomerases activity [102-104] and seem to induce recA, similarly to the DNA damage 
caused by MitC as mentioned above [18]. Curiously, some quinolones were shown to cause 
lytA overexpression [105], which might be a favorable scenario for phages entering the lytic 
cycle as hypothesized before. Therefore, the usage of antibiotics could have a negative 
outcome to the human host as suggested in studies with S. pneumoniae where 
nonbacteriolytic antibiotics (that do not induce LytA activity) reduced release of pneumolysin 
and reduced the inflammatory host reaction in animal models of infection [12,13].  
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